<SEC-DOCUMENT>0001641172-25-012395.txt : 20250527
<SEC-HEADER>0001641172-25-012395.hdr.sgml : 20250527
<ACCEPTANCE-DATETIME>20250527073056
ACCESSION NUMBER:		0001641172-25-012395
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20250523
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250527
DATE AS OF CHANGE:		20250527

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Imunon, Inc.
		CENTRAL INDEX KEY:			0000749647
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				521256615
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15911
		FILM NUMBER:		25984200

	BUSINESS ADDRESS:	
		STREET 1:		997 LENOX DRIVE
		STREET 2:		SUITE 100
		CITY:			LAWRENCEVILLE
		STATE:			NJ
		ZIP:			08648
		BUSINESS PHONE:		(609) 896-9100

	MAIL ADDRESS:	
		STREET 1:		997 LENOX DRIVE
		STREET 2:		SUITE 100
		CITY:			LAWRENCEVILLE
		STATE:			NJ
		ZIP:			08648

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Celsion CORP
		DATE OF NAME CHANGE:	20071121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CELSION CORP
		DATE OF NAME CHANGE:	19980515

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CHEUNG LABORATORIES INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:IMNN="http://imunon.com/20250523">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_034_IMNN_imunon.com_20250523 -->
<!-- Field: Set; Name: xdx; ID: xdx_048_20250523_20250523 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DEntityCentralIndexKey_0000749647 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-05-23" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-05-23" id="Fact000004" name="dei:EntityCentralIndexKey">0000749647</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="imnn-20250523.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-05-23">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000749647</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-05-23</xbrli:startDate>
        <xbrli:endDate>2025-05-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
DC 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_90A_edei--DocumentType_c20250523__20250523_zRKUqiEjXAxe"><ix:nonNumeric contextRef="AsOf2025-05-23" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d) of The Securities Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date
of Report (Date of earliest event reported): <span id="xdx_90A_edei--DocumentPeriodEndDate_c20250523__20250523_zVqy2eiiLdL5"><ix:nonNumeric contextRef="AsOf2025-05-23" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">May 23, 2025</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_90C_edei--EntityRegistrantName_c20250523__20250523_zj4yLvLByVba"><ix:nonNumeric contextRef="AsOf2025-05-23" id="Fact000011" name="dei:EntityRegistrantName">IMUNON,
INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Exact
name of registrant as specified in its Charter)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--EntityIncorporationStateCountryCode_c20250523__20250523_zvNTDKZYOnC4"><ix:nonNumeric contextRef="AsOf2025-05-23" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--EntityFileNumber_c20250523__20250523_zF08Mral9lei"><ix:nonNumeric contextRef="AsOf2025-05-23" id="Fact000013" name="dei:EntityFileNumber">001-15911</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; width: 32%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_905_edei--EntityTaxIdentificationNumber_c20250523__20250523_z6N6rn3csYT1"><ix:nonNumeric contextRef="AsOf2025-05-23" id="Fact000014" name="dei:EntityTaxIdentificationNumber">52-1256615</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(State
                                            or other jurisdiction</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of
    incorporation)</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Commission</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>File
    Number)</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(IRS
                                            Employer</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Identification
    No.)</b></span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--EntityAddressAddressLine1_c20250523__20250523_zylOn028WlEj"><ix:nonNumeric contextRef="AsOf2025-05-23" id="Fact000015" name="dei:EntityAddressAddressLine1">997
    Lenox Drive</ix:nonNumeric></span>, <span id="xdx_900_edei--EntityAddressAddressLine2_c20250523__20250523_zzm2lIe3olBi"><ix:nonNumeric contextRef="AsOf2025-05-23" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite 100</ix:nonNumeric></span>, <span id="xdx_909_edei--EntityAddressCityOrTown_c20250523__20250523_zb1q8V3abgwd"><ix:nonNumeric contextRef="AsOf2025-05-23" id="Fact000017" name="dei:EntityAddressCityOrTown">Lawrenceville</ix:nonNumeric></span>, <span id="xdx_90D_edei--EntityAddressStateOrProvince_c20250523__20250523_zUHagVv70S8j"><ix:nonNumeric contextRef="AsOf2025-05-23" id="Fact000018" name="dei:EntityAddressStateOrProvince">NJ</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 34%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90C_edei--EntityAddressPostalZipCode_c20250523__20250523_zN9iTDbNXYq"><ix:nonNumeric contextRef="AsOf2025-05-23" id="Fact000019" name="dei:EntityAddressPostalZipCode">08648-2311</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Address
    of principal executive offices)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Zip
    Code)</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--CityAreaCode_c20250523__20250523_zeuHBvwR1ubk"><ix:nonNumeric contextRef="AsOf2025-05-23" id="Fact000020" name="dei:CityAreaCode">(609)</ix:nonNumeric></span>
<span id="xdx_900_edei--LocalPhoneNumber_c20250523__20250523_zC5GsPQUQLR7"><ix:nonNumeric contextRef="AsOf2025-05-23" id="Fact000021" name="dei:LocalPhoneNumber">896-9100</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Registrant&#8217;s
telephone number, including area code)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>N/A</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Former
name or former address, if changed since last report.)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--WrittenCommunications_c20250523__20250523_zu5UaVRxZ135"><ix:nonNumeric contextRef="AsOf2025-05-23" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--SolicitingMaterial_c20250523__20250523_zIwCgqLmSCy3"><ix:nonNumeric contextRef="AsOf2025-05-23" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--PreCommencementTenderOffer_c20250523__20250523_zpz8m9JvwhUb"><ix:nonNumeric contextRef="AsOf2025-05-23" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--PreCommencementIssuerTenderOffer_c20250523__20250523_zHBcV6c0z6F4"><ix:nonNumeric contextRef="AsOf2025-05-23" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    symbol(s)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of each exchange on which registered</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--Security12bTitle_c20250523__20250523_zHHUcNm0En8"><ix:nonNumeric contextRef="AsOf2025-05-23" id="Fact000026" name="dei:Security12bTitle">Common
    stock, par value $0.01 per share</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--TradingSymbol_c20250523__20250523_zY5bQRyIVFue"><ix:nonNumeric contextRef="AsOf2025-05-23" id="Fact000027" name="dei:TradingSymbol">IMNN</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--SecurityExchangeName_c20250523__20250523_z4HFyQXczrNg"><ix:nonNumeric contextRef="AsOf2025-05-23" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">The
    Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_90E_edei--EntityEmergingGrowthCompany_c20250523__20250523_zkeRn0xWleF6"><ix:nonNumeric contextRef="AsOf2025-05-23" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    1.01</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Entry
into a Material Definitive Agreement. </b></span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 23, 2025, Imunon, Inc. (the &#8220;Company&#8221;) entered into a securities purchase agreement (the &#8220;Purchase Agreement&#8221;)
with certain institutional and accredited investors (each, a &#8220;Purchaser&#8221; and collectively, the &#8220;Purchasers&#8221;)
for the issuance and sale in a private placement (the &#8220;Private Placement&#8221;) of (i) 2,777,779 shares (the &#8220;Shares&#8221;)
of the Company&#8217;s common stock, par value $0.01 per share (&#8220;Common Stock&#8221;), (ii) pre-funded warrants (the &#8220;Pre-Funded
Warrants&#8221;) to purchase up to 4,444,444 shares of Common Stock at an exercise price of $0.0001 per share, and (iii) warrants (the
&#8220;Warrants&#8221;) to purchase up to 14,444,446 shares of Common Stock at an exercise price of $0.45 per share. The Private Placement
was priced at the market at a combined purchase price per Share and accompanying Warrant of $0.45. The closing of the Private Placement
is expected to occur on or about May 27, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate gross proceeds to the Company from the Private Placement were approximately $3.25 million, prior to deducting placement agent
fees and estimated offering expenses payable by the Company. The Company would receive an additional approximate $6.5 million
in aggregate gross proceeds if all of the Warrants were exercised via a cash exercise. The Company plans to use the proceeds from the
Private Placement for working capital and general corporate purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Prefunded Warrants will be exercisable from the date of issuance until exercised in full. The Warrants will be exercisable upon receipt
of such approval as may be required by the applicable rules and regulations of the Nasdaq Stock Market (or any successor entity) from
the stockholders of the Company with respect to issuance of all of the Warrants and the shares of Common Stock upon the exercise thereof
(&#8220;Stockholder Approval,&#8221; and such date, the &#8220;Stockholder Approval Date&#8221;) and have a term of three years from
the Stockholder Approval Date. Further, the Company agreed to hold a stockholder meeting on or prior to the date that is 90 days following
the closing date of the Private Placement for the purpose of obtaining Stockholder Approval, with the recommendation of the Company&#8217;s
Board of Directors that such proposals are approved, and the Company will solicit proxies from its stockholders in connection therewith
in the same manner as all other management proposals in such proxy statement and all management appointed proxyholders will vote their
proxies in favor of such proposals. The Company agreed to file such proxy statement within 20 days following the closing date of the
Private Placement and to use the record date that was previously set on May 13, 2025 for the stockholder meeting to seek Stockholder
Approval. If the Company does not obtain Stockholder Approval at the first meeting, the Company will call a meeting every 90 days thereafter
to seek Stockholder Approval until the earlier of the date on which Stockholder Approval is obtained or the Warrants are no longer outstanding.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
holder of the Pre-Funded Warrants and the Warrants may not exercise any portion of such holder&#8217;s Pre-Funded Warrants or Warrants
to the extent that the holder, together with its affiliates, would beneficially own more than 4.99% (or, at the election of the holder,
9.99%) of the Company&#8217;s outstanding shares of Common Stock immediately after exercise, except that upon at least 61 days&#8217;
prior notice from the holder to the Company, the holder may increase the beneficial ownership limitation to up to 9.99% of the number
of shares of Common Stock outstanding immediately after giving effect to the exercise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Private Placement, the Company entered into a registration rights agreement (the &#8220;Registration Rights Agreement&#8221;),
dated as of May 23, 2025, with the Purchasers, pursuant to which the Company agreed to prepare and file a registration statement with
the Securities and Exchange Commission (the &#8220;SEC&#8221;) registering the resale of the Shares and the shares of Common Stock underlying
the Pre-Funded Warrants and the Warrants no later than 15 calendar days after the date of the Registration Rights Agreement (the &#8220;Registration
Statement&#8221;), and to use its best efforts to have the Registration Statement declared effective as promptly as practical thereafter,
and in any event no later than 45 calendar days following the date of the Registration Rights Agreement (or 75 calendar days following
the date of the Registration Rights Agreement in the event of a &#8220;full review&#8221; by the SEC).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.C.
Wainwright &amp; Co., LLC (&#8220;Wainwright&#8221;) is acting as the Company&#8217;s lead placement agent, and Brookline Capital
Markets, a division of Arcadia Securities, LLC, is acting as co-placement agent, in connection with the Private Placement, pursuant
to that certain engagement letter, dated as of May 22, 2025, between the Company and Wainwright (the &#8220;Engagement Letter&#8221;).
Pursuant to the Engagement Letter, the Company will pay Wainwright a total cash fee equal to 7.0% of the aggregate gross proceeds of
the Private Placement, as well as certain expenses, including $50,000 for legal fees and expenses, $35,000 for non-accountable expenses,
and the fees for the escrow agent, and Brookline will receive up to 15% of the cash fee. In addition, the Company will issue to Wainwright
warrants (the &#8220;Placement Agent Warrants&#8221;) to purchase up to an aggregate of 361,111 shares of Common Stock at an exercise
price equal to $0.5625 per share. The Placement Agent Warrants will have substantially the same terms as the Warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Purchase Agreement contains customary representations and warranties of the Company, on the one hand, and the Purchasers, on the other
hand, and customary conditions to closing. In addition, pursuant to the Purchase Agreement, the Company agreed not to issue any shares
of Common Stock or Common Stock equivalents or to file any other registration statement with the SEC (in each case, subject to certain
exceptions) until 30 days after the effective date of the Registration Statement. The Company has also agreed not to effect any Variable
Rate Transaction (as defined in the Purchase Agreement) until one year after the effective date of the Registration Statement (subject
to certain exceptions). Further, as part of the Purchase Agreement, subject to certain exceptions, the Company&#8217;s officers and directors
entered into lock-up agreements, pursuant to which they agreed not to sell or otherwise dispose of any shares of Common Stock or securities
convertible, exchangeable or exercisable into shares of Common Stock for a period of 30 days after the effective date of the Registration
Statement (as defined in the Purchase Agreement).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing descriptions of terms and conditions of the Purchase Agreement, the Pre-Funded Warrants, the Warrants, the Placement Agent
Warrants and the Registration Rights Agreement do not purport to be complete and are qualified in their entirety by the full text of
the form of the Purchase Agreement, the form of the Pre-Funded Warrant, the form of the Warrant, the form of Placement Agent Warrant
and the form of the Registration Rights Agreement, which are attached hereto as <a href="ex10-1.htm">Exhibit 10.1</a>, <a href="ex4-1.htm">Exhibit
4.1</a>, <a href="ex4-2.htm">Exhibit 4.2</a>, <a href="ex4-3.htm">Exhibit 4.3</a> and <a href="ex10-2.htm">Exhibit 10.2</a>, respectively. The Purchase Agreement
and the Registration Rights Agreement are incorporated herein by reference only to provide investors with information regarding the terms
of the such agreements and not to provide investors with any other factual information regarding the Company or its business and investors,
and the public should look to other disclosures contained in the Company&#8217;s filings with the Commission for any other such factual
information. Neither this Current Report on Form 8-K, nor the exhibits attached hereto, is an offer to sell or the solicitation of an
offer to buy the securities described herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    3.02</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unregistered
                                            Sales of Equity Securities.</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information contained in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference. Neither the issuance of the
Shares, the Pre-Funded Warrants, the Warrants, or the Placement Agent Warrants, nor the shares of Common Stock issuable upon exercise
thereof, as applicable, were registered under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) or any state
securities laws. The issuance of the Shares, the Pre-Funded Warrants, the Warrants, and the Placement Agent Warrants were, and the shares
of Common Stock issuable upon the exercise of such warrants will be, issued in reliance on the exemptions from registration provided
by Section 4(a)(2) under the Securities Act and/or Regulation D promulgated thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    8.01</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Other
Events.</b></span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued a press release announcing the
pricing of the Private Placement on May 23, 2025. A copy of the press release is furnished herewith as <a href="ex99-1.htm">Exhibit 99.1</a> and is incorporated
by reference herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cautionary
Note Regarding Forward-Looking Statements </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
for the factual statements made herein, information contained in this report consists of forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995 that involve risks, uncertainties and assumptions that are difficult to predict.
Words such as &#8220;will,&#8221; &#8220;believes,&#8221; &#8220;intends,&#8221; &#8220;expects,&#8221; &#8220;plans,&#8221; and similar
expressions, or the use of future tense, identify forward-looking statements, but their absence does not mean that a statement is not
forward-looking. Such forward-looking statements are not guarantees of performance and actual actions or events could differ materially
from those contained in such statements. The forward-looking statements contained in this report speak only as of the date of this report
and the Company undertakes no obligation to publicly update any forward-looking statements to reflect changes in information, events
or circumstances after the date of this report, unless required by law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
    9.01</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial
Statements and Exhibits.</b></span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Exhibits</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
    Number</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4-1.htm">Form of Pre-Funded Warrant.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4-2.htm">Form of Warrant.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex4-3.htm">Form of Placement Agent Warrant.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-1.htm">Form of Securities Purchase Agreement.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex10-2.htm">Form of Registration Rights Agreement.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-1.htm">Press Release of Imunon, Inc., dated May 23, 2025.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCECFF">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>IMUNON,
    INC.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 47%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    May 27, 2025</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Susan Eylward</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Susan
    Eylward</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
    Counsel and Corporate Secretary</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjU0KwkAMhU/QO4RZFzut2kV3WqqIVaSIuB1slMF2UjLj35G8pWOLGAIhee/LEyIUS1roBhmO86qEPbZdoxxChWdkNCf0jny1zsDPCi/aOlbG9esPzMkz6Jl0JE/+3jvv2mKdgZxGSRolU5BxNhnDbCOCr56TOesajdOqAWVq2DF1rNEpfg0f9upJhtpXn3RAtppMBvFIDvIbEhknsKW7ehBfLZRlLoKwr0AsmW6ddxVPh+ZLQtFg6+PsQP87+ADDfEpO -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ex4-1.htm
<DESCRIPTION>EX-4.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PREFUNDED
WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TO
PURCHASE SHARES OF COMMON STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Imunon,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
    Shares: _______</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Initial
    Exercise Date: May 27, 2025</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
PREFUNDED WARRANT TO PURCHASE SHARES OF COMMON STOCK (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____ or
its assigns (the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions
hereinafter set forth, at any time on or after the date hereof (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) until this Warrant is
exercised in full (the &ldquo;<U>Termination Date</U>&rdquo;) but not thereafter, to subscribe for and purchase from Imunon, Inc., a
Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to ___ shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant
Shares</U>&rdquo;) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise
Price, as defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain
Securities Purchase Agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated May 23, 2025, among the Company and the purchasers
signatory thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Exercise of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF
copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto as Exhibit A (the &ldquo;<U>Notice
of Exercise</U>&rdquo;). Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement
Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise
Price for the Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United
States bank unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise.
No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization)
of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically
surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has
been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation as soon as reasonably
practicable following the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting
in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding
number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and
the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver
any objection to any Notice of Exercise within one (1) Business Day of receipt of such notice. <B>The Holder and any assignee, by acceptance
of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the
Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount
stated on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Exercise Price</U>. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant Share,
was pre-funded to the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the
nominal exercise price of $0.0001 per Warrant Share) shall be required to be paid by the Holder to any Person to effect any exercise
of this Warrant. The Holder shall not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise
price under any circumstance or for any reason whatsoever. The remaining unpaid exercise price per share of Common Stock under this Warrant
shall be $0.0001, subject to adjustment hereunder (the &ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Cashless Exercise</U>. This Warrant may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo;
in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by
(A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.35in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
    applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
    Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed
    and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined
    in Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder,
    either (x) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise or (y) the Bid Price of
    the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of
    the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of Exercise is executed during &ldquo;regular trading
    hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of
    &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable
    Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered
    pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading Day;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Exercise Price of this Warrant, as adjusted hereunder; and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
    =</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
    exercise were by means of a cash exercise rather than a cashless exercise.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant. The Company
agrees not to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if the OTCQB Venture Market (&ldquo;OTCQB&rdquo;) or the OTCQX Best Market
(&ldquo;OTCQX&rdquo;) is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding
date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices
for the Common Stock are then reported on the Pink Open Market (&ldquo;Pink Market&rdquo;) operated by the OTC Markets, Inc. (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Mechanics of Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Delivery of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Transfer Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale
of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale
limitations pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered
in the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder
is entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earlier
of (i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise and (ii) the number of Trading Days comprising
the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery
Date</U>&rdquo;), provided that payment of the aggregate Exercise Price (other than in connection with a cashless exercise) is received
by the Company by such date. Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become
the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery
of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received
within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period following
delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice
of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty,
for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice
of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery Date)
for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise.
The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding
and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a
number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery
of the Notice of Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 31.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Delivery of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 31.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.
<U>Rescission Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 31.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv.
<U>Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to
the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions
of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required
by its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases shares of Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise
of this Warrant for Warrant Shares with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A)
of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written
notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount
of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in
equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure
to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 31.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.
<U>No Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 31.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi.
<U>Charges, Taxes and Expenses</U>. The issuance and delivery of Warrant Shares shall be made without charge to the Holder for any issue
or transfer tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall
be paid by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed
by the Holder; <U>provided</U>, <U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name
of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto as Exhibit B duly
executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer
tax incidental thereto, and if any portion of this Warrant remains unexercised, a new Warrant in the form hereof shall be delivered by
the Company to the assignee. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise
and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for
same-day electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 31.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii.
<U>Closing of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the
right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other
Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of Warrant Shares issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the
number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially
owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted
portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation
on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution
Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in
accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the
Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act
and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation
contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned
by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the
sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether
this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties)
and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall
have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated
above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder,
and the Company shall have no obligation to verify or confirm the accuracy of such determination. For purposes of this Section 2(e),
in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock
as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more
recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the
number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within one Trading Day
confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding
shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including
this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of
Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be [4.99%] [9.99%] of the number of shares
of Common Stock outstanding immediately after giving effect to the issuance of Warrant Shares issuable upon exercise of this Warrant.
The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e),
provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately
after giving effect to the issuance of Warrant Shares upon exercise of this Warrant held by the Holder and the provisions of this Section
2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day
after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise
than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective
or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable
to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Stock Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any Warrant Shares issued by the Company upon exercise of this Warrant),
(ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock
split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common
Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
[RESERVED]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Subsequent Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time that this Warrant is
outstanding the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other
property pro rata to the record holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder
will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could
have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without
regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the
date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as
of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent
(or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to
such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding
the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Pro Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial
Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent
(or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such
Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result
in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary),
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender
or exchange their shares for other securities, cash or property and has been accepted by the holders of greater than 50% of the outstanding
Common Stock or greater than 50% of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in
one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory
share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property,
or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other
business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with
another Person or group of Persons whereby such other Person or group acquires greater than 50% of the outstanding shares of Common Stock
or greater than 50% of the voting power of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then
following such Fundamental Transaction the Holder shall have the right to receive, upon exercise of this Warrant, the same amount and
kind of securities, cash or property as it would have been entitled to receive upon the occurrence of such Fundamental Transaction if
it had been, immediately prior to such Fundamental Transaction, the holder of the number of Warrant Shares then issuable upon exercise
in full of this Warrant without regard to any limitations on exercise contained herein (the &ldquo;<U>Alternate Consideration</U>&rdquo;).
For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate
Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction,
and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value
of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash
or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor entity in
a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all
of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions of this Section
3(e) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable
delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant
a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which
is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the
shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of
this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such shares
of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and
the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the purpose of protecting
the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory
in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to
the term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction,
each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead
to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor
Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity
or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and the other Transaction Documents
with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the
Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this Section 3(e) regardless
of (i) whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares and/or (ii) whether a
Fundamental Transaction occurs prior to the Initial Exercise Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Calculations</U>. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Notice to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.
<U>Adjustment to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.
<U>Notice to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any
sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into
other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding
up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email
address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective
date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution,
redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to
be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a
Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>Transferability</U>. Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof
and to the provisions of Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation,
any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company
or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by
the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such
surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee
or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to
the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder
has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days
of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned
in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>New Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Initial Exercise Date and
shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Warrant Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
&ldquo;<U>Warrant Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Transfer Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer
of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under
applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public
information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or
transferee of this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Representation by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant
and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to
or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities
law, except pursuant to sales registered or exempted under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)
<U>No Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly
set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant
to Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be
required to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)
<U>Loss, Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c)
<U>Saturdays, Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)
<U>Authorized Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Jurisdiction</U>. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined
in accordance with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f)
<U>Restrictions</U>. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and
the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g)
<U>Nonwaiver and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision
of this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant,
which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover
any costs and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred
by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h)
<U>Notices</U>. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i)
<U>Limitation of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j)
<U>Remedies</U>. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k)
<U>Successors and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l)
<U>Amendment</U>. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and
the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m)
<U>Severability</U>. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n)
<U>Headings</U>. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Imunon,
    INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>IMUNON,
    inc.</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Payment shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
&nbsp;&nbsp;] in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[
&nbsp;&nbsp;] the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c), to
exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure set
forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
<U>Accredited Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the
Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ___________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ____________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
________________________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address: </FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, ______</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
Signature:_______________________</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address:________________________</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>ex4-2.htm
<DESCRIPTION>EX-4.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TO
PURCHASE SHARES OF COMMON STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Imunon,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant Shares: _______</FONT></TD>
  <TD STYLE="text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue Date: May 27, 2025</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
WARRANT TO PURCHASE SHARES OF COMMON STOCK (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____ or its assigns
(the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after the Stockholder Approval Date (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on or prior to
5:00 p.m. (New York City time) on the date that is the three (3) year anniversary of the Initial Exercise Date, provided that,
if such date is not a Trading Day, the date that is the immediately following Trading Day (the &ldquo;<U>Termination Date</U>&rdquo;)
but not thereafter, to subscribe for and purchase from Imunon, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to
___ shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price of one share
of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain
Securities Purchase Agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated May 23, 2025, among the Company and the purchasers
signatory thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted
by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto as <U>Exhibit A</U> (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank
unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original
Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of
Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this
Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised
in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation as soon as reasonably practicable following
the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases
of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall
maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection
to any Notice of Exercise within one (1) Business Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this
Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant
Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated
on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be <B>$0.45</B>, subject to adjustment hereunder (the
&ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Cashless
Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained
therein is not available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole or in
part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant
Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
  <TD STYLE="text-align: justify; width: 0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A) = </FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> as applicable: (i) the VWAP on the Trading Day immediately
preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant to Section
2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior
to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities
laws) on such Trading Day, (ii) at the option of the Holder, either (x) the VWAP on the Trading Day immediately preceding the date of
the applicable Notice of Exercise or (y) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P.
(&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such Notice of
Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours thereafter (including
until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof or (iii)
the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of
Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such
Trading Day;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 99pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 99pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 99pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
  <TD STYLE="text-align: justify; width: 0.35in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B) =</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> the Exercise Price of this Warrant, as adjusted hereunder;
and</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD STYLE="text-align: justify">&nbsp;</TD>
  <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)</FONT> =</TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the number of Warrant Shares that would be issuable upon
exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a
cashless exercise.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant. The Company
agrees not to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if the OTCQB Venture Market (&ldquo;OTCQB&rdquo;) or the OTCQX Best Market
(&ldquo;OTCQX&rdquo;) is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding
date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices
for the Common Stock are then reported on the Pink Open Market (&ldquo;Pink Market&rdquo;) operated by the OTC Markets, Inc. (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Mechanics of Exercise</U>.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i. <U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust
Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such
system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the
Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations
pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered in
the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is
entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earlier of
(i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise and (ii) the number of Trading Days comprising the
Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery
Date</U>&rdquo;), provided that payment of the aggregate Exercise Price (other than in connection with a cashless exercise) is received
by the Company by such date. Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become
the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery
of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received
within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period following
delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice
of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty,
for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice
of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery Date)
for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise.
The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding
and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a
number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery
of the Notice of Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other
respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by
its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases shares of Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise
of this Warrant for Warrant Shares with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A)
of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written
notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount
of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in
equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure
to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v. <U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi. <U>Charges,
Taxes and Expenses</U>. The issuance and delivery of Warrant Shares shall be made without charge to the Holder for any issue or transfer
tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the
Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder;
<U>provided</U>, <U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder,
this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto as Exhibit B duly executed by
the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax
incidental thereto, and if any portion of this Warrant remains unexercised, a new Warrant in the form hereof shall be delivered by the
Company to the assignee. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and
all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day
electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii. <U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of Warrant Shares issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the
number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially
owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted
portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation
on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution
Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in
accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the
Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act
and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation
contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned
by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the
sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether
this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties)
and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall
have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated
above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder,
and the Company shall have no obligation to verify or confirm the accuracy of such determination. For purposes of this Section 2(e),
in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock
as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more
recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the
number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within one Trading Day
confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding
shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including
this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of
Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be [4.99%] [9.99%] of the number of shares
of Common Stock outstanding immediately after giving effect to the issuance of Warrant Shares issuable upon exercise of this Warrant.
The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e),
provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately
after giving effect to the issuance of Warrant Shares upon exercise of this Warrant held by the Holder and the provisions of this Section
2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day
after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise
than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective
or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable
to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any Warrant Shares issued by the Company upon exercise of this Warrant),
(ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock
split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common
Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) [RESERVED]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time that this Warrant is outstanding
the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property
pro rata to the record holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will
be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have
acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard
to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date
on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which
the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent
(or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to
such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding
the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including,
without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete
exercise of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership
Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as
of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder&rsquo;s right to participate in any such Distribution would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent
(or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such
Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result
in the Holder exceeding the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e)
<U>Fundamental Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary),
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender
or exchange their shares for other securities, cash or property and has been accepted by the holders of greater than 50% of the outstanding
Common Stock or greater than 50% of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in
one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory
share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property,
or (v) the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other
business combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with
another Person or group of Persons whereby such other Person or group acquires greater than 50% of the outstanding shares of Common Stock
or greater than 50% of the voting power of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then
following such Fundamental Transaction the Holder shall have the right to receive, upon exercise of this Warrant, the same amount and
kind of securities, cash or property as it would have been entitled to receive upon the occurrence of such Fundamental Transaction if
it had been, immediately prior to such Fundamental Transaction, the holder of the number of Warrant Shares then issuable upon exercise
in full of this Warrant without regard to any limitations on exercise contained herein (the &ldquo;<U>Alternate Consideration</U>&rdquo;).
For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate
Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction,
and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value
of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash
or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration
it receives upon any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the
event of a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable
at any time concurrently with, or within thirty (30) days after, the consummation of the Fundamental Transaction (or, if later, the date
of the public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder
an amount of cash equal to the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date
of consummation of such Fundamental Transaction; <U>provided</U>, <U>however</U>, that, if the Fundamental Transaction is not within
the Company&rsquo;s control, including not approved by the Company&rsquo;s Board of Directors, the Holder shall only be entitled to receive
from the Company or any Successor Entity the same type or form of consideration (and in the same proportion), valued at the Black Scholes
Value of the unexercised portion of this Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection
with the Fundamental Transaction, whether that consideration be in the form of cash, stock or any combination thereof, or whether the
holders of Common Stock are given the choice to receive from among alternative forms of consideration in connection with the Fundamental
Transaction; provided, further, that if holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental
Transaction, such holders of Common Stock will be deemed to have received common stock of the Successor Entity (which Successor Entity
may be the Company following such Fundamental Transaction) in such Fundamental Transaction and a Holder shall receive common stock of
the Successor Entity in the amount of the Black Scholes Value. &ldquo;<U>Black Scholes Value</U>&rdquo; means the value of this Warrant
based on the Black-Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg determined as of the day of
consummation of the applicable Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding
to the U.S. Treasury rate for a period equal to the time between the date of the public announcement of the applicable contemplated Fundamental
Transaction and the Termination Date, (B) an expected volatility equal to the 100 day volatility obtained from the HVT function on Bloomberg
(determined utilizing a 365-day annualization factor) as of the Trading Day immediately following the public announcement of the applicable
Fundamental Transaction, (C) the underlying price per share used in such calculation shall be the greater of (i) the sum of the
price per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered in such Fundamental
Transaction and (ii) the VWAP immediately preceding the public announcement of the applicable contemplated Fundamental Transaction
(or the consummation of the applicable Fundamental Transaction, if earlier), (D) a remaining option time equal to the time between
the date of the public announcement of the applicable Fundamental Transaction and the Termination Date, and (E) a zero cost of borrow.
The payment of the Black Scholes Value will be made within five Trading Days of the Holder&rsquo;s election (or, if later, on the effective
date of the Fundamental Transaction). The Company shall cause any successor entity in a Fundamental Transaction in which the Company
is not the survivor (the &ldquo;<U>Successor Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this
Warrant and the other Transaction Documents in accordance with the provisions of this Section 3(e) pursuant to written agreements in
form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental
Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity
evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for a corresponding
number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable
and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental
Transaction, and with an exercise price which applies the exercise price hereunder to such shares of capital stock (but taking into account
the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock,
such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant
immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to
the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall be added to the term &ldquo;Company&rdquo;
under this Warrant (so that from and after the occurrence or consummation of such Fundamental Transaction, each and every provision of
this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo; shall refer instead to each of the Company and
the Successor Entity or Successor Entities, jointly and severally), and the Successor Entity or Successor Entities, jointly and severally
with the Company, may exercise every right and power of the Company prior thereto and the Successor Entity or Successor Entities shall
assume all of the obligations of the Company prior thereto under this Warrant and the other Transaction Documents with the same effect
as if the Company and such Successor Entity or Successor Entities, jointly and severally, had been named as the Company herein. For the
avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this Section 3(e) regardless of (i) whether the
Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares and/or (ii) whether a Fundamental Transaction
occurs prior to the Initial Exercise Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g) <U>Notice
to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii. <U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of
all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall
appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter
specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,
rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled
to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a
Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Transferability</U>.
Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions of
Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration rights)
are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent,
together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent
or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required,
such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable,
and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing
the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything herein to the contrary,
the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder has assigned this Warrant in full,
in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days of the date on which the Holder delivers
an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned in accordance herewith, may be exercised
by a new holder for the purchase of Warrant Shares without having a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in
accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Initial Exercise Date and shall be identical
with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Transfer
Restrictions</U>. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this
Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under applicable
state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public information
requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or transferee of
this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Representation
by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to
Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required
to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Authorized
Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance
with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of
this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which
results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs
and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the
Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h) <U>Notices</U>.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered
in accordance with the notice provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this
Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Imunon, INC.</B></FONT></P>

</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%">&nbsp;</TD>
    <TD STYLE="width: 45%">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></P></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Name:</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title:</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To: <B>Imunon,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1) The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2) Payment
shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;] in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;] if permitted, the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3) Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">_______________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
<U>Accredited Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the
Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ___________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ____________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
________________________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U> </U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U> </U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address:</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______________________________________</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">______________________________________</FONT></P></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, ______</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature:______________________<U> </U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address:_______________________<U> </U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>4
<FILENAME>ex4-3.htm
<DESCRIPTION>EX-4.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
4.3</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PLACEMENT
AGENT WARRANT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TO
PURCHASE SHARES OF COMMON STOCK </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Imunon,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 70%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant Shares:
_______</FONT></TD><TD STYLE="width: 5%"></TD><TD STYLE="text-align: justify; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issue
Date: May 27, 2025</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
PLACEMENT AGENT WARRANT TO PURCHASE SHARES OF COMMON STOCK (the &ldquo;<U>Warrant</U>&rdquo;) certifies that, for value received, _____
or its assigns (the &ldquo;<U>Holder</U>&rdquo;) is entitled, upon the terms and subject to the limitations on exercise and the conditions
hereinafter set forth, at any time on or after the Stockholder Approval Date (the &ldquo;<U>Initial Exercise Date</U>&rdquo;) and on
or prior to 5:00 p.m. (New York City time) on the date that is the three (3) year anniversary of the Initial Exercise Date, provided
that, if such date is not a Trading Day, the date that is the immediately following Trading Day (the &ldquo;<U>Termination Date</U>&rdquo;)
but not thereafter, to subscribe for and purchase from Imunon, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), up to
___ shares (as subject to adjustment hereunder, the &ldquo;<U>Warrant Shares</U>&rdquo;) of Common Stock. The purchase price of one share
of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant
to that certain Engagement Agreement between the Company and H.C. Wainwright &amp; Co., LLC, dated as of May 22, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
1</U>. <U>Definitions</U>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain
Securities Purchase Agreement (the &ldquo;<U>Purchase Agreement</U>&rdquo;), dated May 23, 2025, among the Company and the purchasers
signatory thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
2</U>. <U>Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF copy submitted
by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto as <U>Exhibit A</U> (the &ldquo;<U>Notice of Exercise</U>&rdquo;).
Within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(d)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank
unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original
Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of
Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this
Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised
in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation as soon as reasonably practicable following
the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases
of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall
maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection
to any Notice of Exercise within one (1) Business Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this
Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant
Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated
on the face hereof.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Exercise
Price</U>. The exercise price per share of Common Stock under this Warrant shall be <B>$</B>0.5625, subject to adjustment hereunder (the
&ldquo;<U>Exercise Price</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Cashless
Exercise</U>. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus contained
therein is not available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised, in whole or in
part, at such time by means of a &ldquo;cashless exercise&rdquo; in which the Holder shall be entitled to receive a number of Warrant
Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
                                            =</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as
                                            applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable
                                            Notice of Exercise if such Notice of Exercise is (1) both executed and delivered pursuant
                                            to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered
                                            pursuant to Section 2(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading
                                            hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated under the federal securities
                                            laws) on such Trading Day, (ii) at the option of the Holder, either (x) the VWAP on the Trading
                                            Day immediately preceding the date of the applicable Notice of Exercise or (y) the Bid Price
                                            of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;)
                                            as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise if such
                                            Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day
                                            and is delivered within two (2) hours thereafter (including until two (2) hours after the
                                            close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section 2(a) hereof
                                            or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice
                                            of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered pursuant
                                            to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo; on such Trading
                                            Day;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
                                            =</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            Exercise Price of this Warrant, as adjusted hereunder; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(X)
                                            =</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance
                                            with the terms of this Warrant if such exercise were by means of a cash exercise rather than
                                            a cashless exercise.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 103.5pt; text-align: justify; text-indent: -31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the holding period of the Warrant Shares being issued may be tacked on to the holding period of this Warrant. The Company
agrees not to take any position contrary to this Section 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Bid
Price</U>&rdquo; means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock
is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price
of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then
listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m.
(New York City time) to 4:02 p.m. (New York City time)), (b) if the OTCQB Venture Market (&ldquo;OTCQB&rdquo;) or the OTCQX Best Market
(&ldquo;OTCQX&rdquo;) is not a Trading Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding
date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices
for the Common Stock are then reported on the Pink Open Market (&ldquo;Pink Market&rdquo;) operated by the OTC Markets, Inc. (or a similar
organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of the Common Stock so reported,
or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good
faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d)</FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Mechanics of Exercise</U>.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i. <U>Delivery
of Warrant Shares Upon Exercise</U>. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by the Transfer
Agent to the Holder by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with The Depository Trust
Company through its Deposit or Withdrawal at Custodian system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such
system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale of the
Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale limitations
pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise by physical delivery of a certificate, registered in
the Company&rsquo;s share register in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is
entitled pursuant to such exercise to the address specified by the Holder in the Notice of Exercise by the date that is the earlier of
(i) one (1) Trading Day after the delivery to the Company of the Notice of Exercise and (ii) the number of Trading Days comprising the
Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date, the &ldquo;<U>Warrant Share Delivery
Date</U>&rdquo;), provided that payment of the aggregate Exercise Price (other than in connection with a cashless exercise) is received
by the Company by such date. Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become
the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery
of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received
within the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period following
delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice
of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as a penalty,
for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable Notice
of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery Date)
for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise.
The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding
and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a
number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery
of the Notice of Exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii. <U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other
respects be identical with this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii. <U>Rescission
Rights</U>. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">iv. <U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date the Holder is required by
its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, shares
of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon
such exercise (a &ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x)
the Holder&rsquo;s total purchase price (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
(y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to the Holder in connection
with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation was executed, and (B)
at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise
was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. For example, if the
Holder purchases shares of Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise
of this Warrant for Warrant Shares with an aggregate sale price giving rise to such purchase obligation of $10,000, under clause (A)
of the immediately preceding sentence the Company shall be required to pay the Holder $1,000. The Holder shall provide the Company written
notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount
of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in
equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure
to timely deliver shares of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">v. <U>No
Fractional Shares or Scrip</U>. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this
Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall,
at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the
Exercise Price or round up to the next whole share of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vi. <U>Charges,
Taxes and Expenses</U>. The issuance and delivery of Warrant Shares shall be made without charge to the Holder for any issue or transfer
tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the
Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder;
<U>provided</U>, <U>however</U>, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder,
this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto as Exhibit B duly executed by
the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax
incidental thereto, and if any portion of this Warrant remains unexercised, a new Warrant in the form hereof shall be delivered by the
Company to the assignee. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and
all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day
electronic delivery of the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">vii. <U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 117pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Holder&rsquo;s
Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise
any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance after exercise
as set forth on the applicable Notice of Exercise, the Holder (together with the Holder&rsquo;s Affiliates, and any other Persons acting
as a group together with the Holder or any of the Holder&rsquo;s Affiliates (such Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of Warrant Shares issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude the
number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially
owned by the Holder or any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted
portion of any other securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation
on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution
Parties. Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in
accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the
Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act
and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation
contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned
by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the
sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether
this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties)
and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall
have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated
above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder,
and the Company shall have no obligation to verify or confirm the accuracy of such determination. For purposes of this Section 2(e),
in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock
as reflected in (A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more
recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the
number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within one Trading Day
confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding
shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including
this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of
Common Stock was reported. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be [4.99%] [9.99%] of the number of shares
of Common Stock outstanding immediately after giving effect to the issuance of Warrant Shares issuable upon exercise of this Warrant.
The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e),
provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately
after giving effect to the issuance of Warrant Shares upon exercise of this Warrant held by the Holder and the provisions of this Section
2(e) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61<SUP>st</SUP> day
after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise
than in strict conformity with the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective
or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable
to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
3</U>. <U>Certain Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares of
Common Stock (which, for avoidance of doubt, shall not include any Warrant Shares issued by the Company upon exercise of this Warrant),
(ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse stock
split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the Common
Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which the
numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) [RESERVED]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Subsequent
Rights Offerings</U>. In addition to any adjustments pursuant to Section 3(a) above, if at any time that this Warrant is outstanding
the Company grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property
pro rata to the record holders of any class of shares of Common Stock (the &ldquo;<U>Purchase Rights</U>&rdquo;), then the Holder will
be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have
acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard
to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date
on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which
the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (<U>provided</U>,
<U>however</U>, that, to the extent that the Holder&rsquo;s right to participate in any such Purchase Right would result in the Holder
exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent
(or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to
such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding
the Beneficial Ownership Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT CLASS="DeltaViewInsertion" STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>d) </U></FONT><U><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pro
Rata Distributions</FONT></U><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">. During such time as this Warrant
is outstanding, if the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire its assets)
to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of cash,
stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement
or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after the issuance of this Warrant, then, in each such
case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein
if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any
limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which
a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common
Stock are to be determined for the participation in such Distribution (<U>provided</U>, <U>however</U>, that, to the extent that the
Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation,
then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares
of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the
benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership
Limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT CLASS="DeltaViewInsertion" STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Fundamental
Transaction</U>. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions
effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary), directly or indirectly,
effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in
one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the
Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares
for other securities, cash or property and has been accepted by the holders of greater than 50% of the outstanding Common Stock or greater
than 50% of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one or more related transactions
effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which
the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly,
in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons whereby
such other Person or group acquires greater than 50% of the outstanding shares of Common Stock or greater than 50% of the voting power
of the common equity of the Company (each a &ldquo;<U>Fundamental Transaction</U>&rdquo;), then following such Fundamental Transaction
the Holder shall have the right to receive, upon exercise of this Warrant, the same amount and kind of securities, cash or property as
it would have been entitled to receive upon the occurrence of such Fundamental Transaction if it had been, immediately prior to such
Fundamental Transaction, the holder of the number of Warrant Shares then issuable upon exercise in full of this Warrant without regard
to any limitations on exercise contained herein (the &ldquo;<U>Alternate Consideration</U>&rdquo;). For purposes of any such exercise,
the determination of the Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount
of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion
the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components
of the Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received
in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise
of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the event of a Fundamental Transaction,
the Company or any Successor Entity (as defined below) shall, at the Holder&rsquo;s option, exercisable at any time concurrently with,
or within thirty (30) days after, the consummation of the Fundamental Transaction (or, if later, the date of the public announcement
of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the Holder an amount of cash equal to
the Black Scholes Value (as defined below) of the remaining unexercised portion of this Warrant on the date of consummation of such Fundamental
Transaction; <U>provided</U>, <U>however</U>, that, if the Fundamental Transaction is not within the Company&rsquo;s control, including
not approved by the Company&rsquo;s Board of Directors, the Holder shall only be entitled to receive from the Company or any Successor
Entity the same type or form of consideration (and in the same proportion), valued at the Black Scholes Value of the unexercised portion
of this Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction,
whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock are given
the choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction; provided, further,
that if holders of Common Stock of the Company are not offered or paid any consideration in such Fundamental Transaction, such holders
of Common Stock will be deemed to have received common stock of the Successor Entity (which Successor Entity may be the Company following
such Fundamental Transaction) in such Fundamental Transaction and a Holder shall receive common stock of the Successor Entity in the
amount of the Black Scholes Value. &ldquo;<U>Black Scholes Value</U>&rdquo; means the value of this Warrant based on the Black-Scholes
Option Pricing Model obtained from the &ldquo;OV&rdquo; function on Bloomberg determined as of the day of consummation of the applicable
Fundamental Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate for
a period equal to the time between the date of the public announcement of the applicable contemplated Fundamental Transaction and the
Termination Date, (B) an expected volatility equal to the 100 day volatility obtained from the HVT function on Bloomberg (determined
utilizing a 365-day annualization factor) as of the Trading Day immediately following the public announcement of the applicable Fundamental
Transaction, (C) the underlying price per share used in such calculation shall be the greater of (i) the sum of the price per share being
offered in cash, if any, plus the value of any non-cash consideration, if any, being offered in such Fundamental Transaction and (ii)
the VWAP immediately preceding the public announcement of the applicable contemplated Fundamental Transaction (or the consummation of
the applicable Fundamental Transaction, if earlier), (D) a remaining option time equal to the time between the date of the public announcement
of the applicable Fundamental Transaction and the Termination Date, and (E) a zero cost of borrow. The payment of the Black Scholes Value
will be made within five Trading Days of the Holder&rsquo;s election (or, if later, on the effective date of the Fundamental Transaction).
The Company shall cause any successor entity in a Fundamental Transaction in which the Company is not the survivor (the &ldquo;<U>Successor
Entity</U>&rdquo;) to assume in writing all of the obligations of the Company under this Warrant and the other Transaction Documents
in accordance with the provisions of this Section 3(e) pursuant to written agreements in form and substance reasonably satisfactory to
the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of
the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor Entity evidenced by a written instrument substantially
similar in form and substance to this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor
Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without
regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies
the exercise price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock
pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such
exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental
Transaction), and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction,
the Successor Entity shall be added to the term &ldquo;Company&rdquo; under this Warrant (so that from and after the occurrence or consummation
of such Fundamental Transaction, each and every provision of this Warrant and the other Transaction Documents referring to the &ldquo;Company&rdquo;
shall refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor
Entity or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto
and the Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and
the other Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally,
had been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this
Section 3(e) regardless of (i) whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares
and/or (ii) whether a Fundamental Transaction occurs prior to the Initial Exercise Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f) <U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For purposes
of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be the sum of the
number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g) <U>Notice
to Holder</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i. <U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company shall promptly
deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number
of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii. <U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock
of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any sale or transfer of
all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into other securities,
cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email address as it shall
appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter
specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,
rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled
to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a
Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
4</U>. <U>Transfer of Warrant</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>Transferability</U>.
Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof and to the provisions of
Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation, any registration rights)
are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent,
together with a written assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent
or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required,
such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable,
and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing
the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. <FONT CLASS="DeltaViewInsertion"><U>Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder
has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days
of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. </U></FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant, if properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having
a new Warrant issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>New
Warrants</U>. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company,
together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or
its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division or combination,
the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in
accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Initial Exercise Date and shall be identical
with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Warrant
Register</U>. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the &ldquo;<U>Warrant
Register</U>&rdquo;), in the name of the record Holder hereof from time to time. The Company may deem and treat the registered Holder
of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder, and for all other
purposes, absent actual notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT CLASS="DeltaViewInsertion" STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>d)
</U></FONT><U><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer Restrictions</FONT></U><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
<FONT CLASS="DeltaViewInsertion">If</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">, at the <FONT CLASS="DeltaViewInsertion">time
of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer of this Warrant shall not be either (i)
registered pursuant to an effective </FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">registration
<FONT CLASS="DeltaViewInsertion">statement under the Securities Act</FONT></FONT> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
<FONT CLASS="DeltaViewInsertion">under applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale
restrictions or current public information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such
transfer, that the Holder or transferee of this Warrant, as the case may be, provides to the Company an opinion of counsel in form and
substance reasonably satisfactory to the Company to the effect that the transfer of this Warrant does not require registration under
the Securities Act.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT CLASS="DeltaViewInsertion" STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Representation
by the Holder</U>. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant and, upon any exercise
hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to or for distributing or
reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities law, except pursuant
to sales registered or exempted under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section
5</U>. <U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a) <U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to
Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required
to net cash settle an exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b) <U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c) <U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">d) <U>Authorized
Shares</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a
sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with
the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all
such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any
applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be listed. The Company covenants
that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise
of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly
issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in respect of the issue thereof
(other than taxes in respect of any transfer occurring contemporaneously with such issue).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending
its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale
of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary
or appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise
immediately prior to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company
may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially
reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof,
as may be, necessary to enable the Company to perform its obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the
Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from
any public regulatory body or bodies having jurisdiction thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">e) <U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined in accordance
with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">f) <U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">g) <U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of
this Warrant or the Purchase Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which
results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs
and expenses including, but not limited to, reasonable attorneys&rsquo; fees, including those of appellate proceedings, incurred by the
Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">h) <U>Notices</U>.
Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall be delivered
to the address of the Holder in the Warrant Register.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i) <U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">j) <U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">k) <U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">l) <U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">m) <U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">n) <U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this
Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Page Follows)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Imunon,
    INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTICE
OF EXERCISE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">To: <B>Imunon,
INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1) The
undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised
in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2) Payment
shall take the form of (check applicable box):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in">&#9744;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
 in lawful money of the United States; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744; if permitted, the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3) Please
issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 33%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrant Shares shall be delivered to the following DWAC Account Number:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 33%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 33%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 33%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
<U>Accredited Investor</U>. The undersigned is an &ldquo;accredited investor&rdquo; as defined in Regulation D promulgated under the
Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
OF HOLDER]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Investing Entity: ________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Investing Entity</I>: _________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ___________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: ____________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
________________________________________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">ASSIGNMENT
FORM</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 10.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U></U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U></U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Please
    Print)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT CLASS="DeltaViewInsertion" STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone
    Number:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT CLASS="DeltaViewInsertion" STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT CLASS="DeltaViewInsertion" STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
    Address: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT CLASS="DeltaViewInsertion" STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    _______________ __, ______</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 12%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Signature:<U> </U></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 38%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder&rsquo;s
    Address:<U> </U></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>5
<FILENAME>ex10-1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Securities Purchase Agreement (this &ldquo;<U>Agreement</U>&rdquo;) is dated as of May 23, 2025, between Imunon, Inc., a Delaware corporation
(the &ldquo;<U>Company</U>&rdquo;), and each purchaser identified on the signature pages hereto (each, including its successors and assigns,
a &ldquo;<U>Purchaser</U>&rdquo; and collectively, the &ldquo;<U>Purchasers</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act (as defined below),
and Rule 506 promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly,
desires to purchase from the Company, securities of the Company as more fully described in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt
and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
I.<BR>
DEFINITIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
<U>Definitions</U>. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms
have the meanings set forth in this Section 1.1:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Acquiring
Person</U>&rdquo; shall have the meaning ascribed to such term in Section 4.5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(j).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Business
Day</U>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York are authorized
or required by law to remain closed; <FONT STYLE="background-color: white"><U>provided</U>, <U>however</U>, for clarification, commercial
banks shall not be deemed to be authorized or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;,
&ldquo;non-essential employee&rdquo; or any other similar orders or restrictions or the closure of any physical branch locations at the
direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial
banks in The City of New York are generally open for use by customers on such day</FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to Section 2.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto, and all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii) the Company&rsquo;s
obligations to deliver the Securities, in each case, have been satisfied or waived.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock</U>&rdquo; means the common stock of the Company, par value $0.01 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Common Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Common
Warrants</U>&rdquo; means, collectively, the Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance
with Section 2.2(a) hereof, which Common Warrants shall be exercisable on and after the Stockholder Approval Date and have a term of
exercise equal to three (3) years after the initial exercise date, in the form of <U>Exhibit C</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Company
Counsel</U>&rdquo; means Thompson Hine LLP, with offices located at 3900 Key Center, 127 Public Square, Cleveland, Ohio 44114.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disclosure
Schedules</U>&rdquo; means the Disclosure Schedules of the Company delivered concurrently herewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Disclosure
Time</U>&rdquo; means, (i) if this Agreement is signed on a day that is not a Trading Day or after 9:00 a.m. (New York City time) and
before midnight (New York City time) on any Trading Day, 9:01 a.m. (New York City time) on the Trading Day immediately following the
date hereof, unless otherwise instructed as to an earlier time by the Placement Agent, and (ii) if this Agreement is signed between midnight
(New York City time) and 9:00 a.m. (New York City time) on any Trading Day, no later than 9:01 a.m. (New York City time) on the date
hereof, unless otherwise instructed as to an earlier time by the Placement Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Effective
Date</U>&rdquo; means the earliest of the date that (a) the initial Registration Statement has been declared effective by the Commission,
(b) all of the Shares and Warrant Shares have been sold pursuant to Rule 144 or may be sold pursuant to Rule 144 without the requirement
for the Company to be in compliance with the current public information required under Rule 144 and without volume or manner-of-sale
restrictions, (c) following the one year anniversary of the Closing Date provided that a holder of Shares or Warrant Shares is not an
Affiliate of the Company, or (d) all of the Shares and Warrant Shares may be sold pursuant to an exemption from registration under Section
4(a)(1) of the Securities Act without volume or manner-of-sale restrictions and Company Counsel has delivered to such holders a standing
written unqualified opinion that resales may then be made by such holders of the Shares and Warrant Shares pursuant to such exemption
which opinion shall be in form and substance reasonably acceptable to such holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>EGS</U>&rdquo;
means Ellenoff Grossman &amp; Schole LLP, with offices located at 1345 Avenue of the Americas, New York, New York 10105-0302.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Escrow
Agent</U>&rdquo; means Continental Stock Transfer &amp; Trust Company, with offices at 1 State Street, 30th Floor, New York, NY 10004.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Escrow
Agreement</U>&rdquo; means the escrow agreement entered into prior to the date hereof, by and among the Company, the Escrow Agent and
the Placement Agent pursuant to which the Purchasers shall deposit Subscription Amounts with the Escrow Agent to be applied to the transactions
contemplated hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Evaluation
Date</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Exempt
Issuance</U>&rdquo; means the issuance of (a) shares of Common Stock, restricted stock units, options or other equity awards to employees,
officers or directors of the Company pursuant to any stock or option plan duly adopted for such purpose, by a majority of the non-employee
members of the Board of Directors or a majority of the members of a committee of non-employee directors established for such purpose
for services rendered to the Company, (b) warrants to the Placement Agent in connection with the transactions pursuant to this Agreement
and any securities upon exercise of warrants to the Placement Agent, securities upon the exercise or exchange of or conversion of any
Securities issued hereunder and/or other securities exercisable or exchangeable for or convertible into shares of Common Stock issued
and outstanding on the date of this Agreement, provided that such securities have not been amended since the date of this Agreement to
increase the number of such securities or to decrease the exercise price, exchange price or conversion price of such securities (other
than in connection with stock splits or combinations) or to extend the term of such securities (other than the extension of the term
of exercise for stock options to employees, officers or directors of the Company pursuant to any stock or option plan described in clause
(a) of this definition), and (c) securities issued pursuant to acquisitions or strategic transactions approved by a majority of the disinterested
directors of the Company, provided that such securities are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and
carry no registration rights that require or permit the filing of any registration statement in connection therewith during the prohibition
period in Section 4.12(a) herein, and provided that any such issuance shall only be to a Person (or to the equityholders of a Person)
which is, itself or through its subsidiaries, an operating company or an owner of an asset in a business synergistic with the business
of the Company and shall provide to the Company additional benefits in addition to the investment of funds, but shall not include a transaction
in which the Company is issuing securities primarily for the purpose of raising capital or to an entity whose primary business is investing
in securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(bb).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(p).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Legend
Removal Date</U>&rdquo; shall have the meaning ascribed to such term in Section 4.1(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Lock-Up
Agreement</U>&rdquo; means the Lock-Up Agreement, dated as of the date hereof, by and among the Company and the directors and officers
of the Company, in the form of <U>Exhibit D</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Material
Permits</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(n).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Per
Share Purchase Price</U>&rdquo; equals $0.45, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations
and other similar transactions of the Common Stock that occur after the date of this Agreement, provided that the purchase price per
Prefunded Warrant shall be the Per Share Purchase Price minus $0.0001.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Placement
Agent</U>&rdquo; means H.C. Wainwright &amp; Co., LLC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prefunded
Warrant Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Prefunded Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prefunded
Warrants</U>&rdquo; means, collectively, the Prefunded Common Stock purchase warrants delivered to the Purchasers at the Closing in accordance
with Section 2.2(a) hereof, which Prefunded Warrants shall be exercisable immediately and shall expire when exercised in full, in the
form of <U>Exhibit B</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Public
Information Failure</U>&rdquo; shall have the meaning ascribed to such term in Section 4.2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Public
Information Failure Payments</U>&rdquo; shall have the meaning ascribed to such term in Section 4.2(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in Section 4.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Rights Agreement</U>&rdquo; means the Registration Rights Agreement, dated on or about the date hereof, among the Company and the Purchasers,
in the form of <U>Exhibit A</U> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; means a registration statement meeting the requirements set forth in the Registration Rights Agreement and covering
the resale by the Purchasers of the Shares and the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
144</U>&rdquo; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
424</U>&rdquo; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>SEC
Reports</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(h).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities</U>&rdquo;
means the Shares, the Warrants and the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Shares</U>&rdquo;
means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be
deemed to include locating and/or borrowing shares of Common Stock).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Stockholder
Approval</U>&rdquo; means such approval as may be required by the applicable rules and regulations of the Nasdaq Stock Market (or any
successor entity) from the stockholders of the Company with respect to the issuance of all the Common Warrants and the Common Warrant
Shares upon the exercise thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Stockholder
Approval Date</U>&rdquo; means the date on which Stockholder Approval is received and deemed effective under Delaware law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in; color: blue"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-underline-style: double; letter-spacing: 0pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subscription
Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for Shares and Warrants purchased hereunder as specified
below such Purchaser&rsquo;s name on the signature page of this Agreement and next to the heading &ldquo;Subscription Amount,&rdquo;
in United States dollars and in immediately available funds (minus, if applicable, a Purchaser&rsquo;s aggregate exercise price of the
Prefunded Warrants, which amounts shall be paid as and when such Prefunded Warrants are exercised).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth on <U>Schedule 3.1(a)</U> and shall, where applicable, also include any direct or indirect
subsidiary of the Company formed or acquired after the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, or the New York
Stock Exchange (or any successors to any of the foregoing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, the Warrants, the Registration Rights Agreement, the Lock-Up Agreement, the Escrow Agreement,
all exhibits and schedules thereto and hereto and any other documents or agreements executed in connection with the transactions contemplated
hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Transfer
Agent</U>&rdquo; means Equiniti Trust Company, LLC, the current transfer agent of the Company, with a mailing address of 55 Challenger
Road, Ridgefield Park, New Jersey 07660, and any successor transfer agent of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Variable
Rate Transaction</U>&rdquo; shall have the meaning ascribed to such term in Section 4.12(b).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed
or quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB Venture Market (&ldquo;<U>OTCQB</U>&rdquo;) or OTCQX Best
Market (&ldquo;<U>OTCQX</U>&rdquo;) is not a Trading Market, the volume weighted average price of the Common Stock for such date (or
the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB
or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (&ldquo;<U>Pink Market</U>&rdquo;) operated by
OTC Markets, Inc. (or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per
share of the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an
independent appraiser selected in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably
acceptable to the Company, the fees and expenses of which shall be paid by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrant
Shares</U>&rdquo; means, collectively, the Prefunded Warrant Shares and the Common Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Warrants</U>&rdquo;
means, collectively, the Prefunded Warrants and the Common Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
II.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURCHASE
AND SALE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
<U>Closing</U>. On the Closing Date, upon the terms and subject to the conditions set forth herein, the Company agrees to sell, and the
Purchasers, severally and not jointly, agree to purchase, up to an aggregate of $3,250,001 of Shares and Common Warrants; <U>provided</U>,
<U>however</U>, that, to the extent that a Purchaser determines, in its sole discretion, that such Purchaser (together with such Purchaser&rsquo;s
Affiliates, and any Person acting as a group together with such Purchaser or any of such Purchaser&rsquo;s Affiliates) would beneficially
own in excess of the Beneficial Ownership Limitation, or as such Purchaser may otherwise choose, in lieu of purchasing Shares, such Purchaser
may elect to purchase Prefunded Warrants in lieu of Shares in such manner to result in the same aggregate purchase price being paid by
such Purchaser to the Company. The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% (or, with respect to each Purchaser,
at the election of such Purchaser at Closing, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving
effect to the issuance of the Securities on the Closing Date. Each Purchaser shall deliver to the Escrow Agent, via wire transfer or
a certified check, immediately available funds equal to such Purchaser&rsquo;s Subscription Amount as set forth on the signature page
hereto executed by such Purchaser, and the Company shall deliver to each Purchaser its respective Shares and Common Warrants and, if
applicable, a Prefunded Warrant, as determined pursuant to Section 2.2(a), and the Company and each Purchaser shall deliver the other
items set forth in Section 2.2 deliverable at the Closing. Upon satisfaction of the covenants and conditions set forth in Sections 2.2
and 2.3, the Closing shall take place remotely by electronic transfer of the Closing documentation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2
<U>Deliveries</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
On or prior to the Closing Date (except as indicated below), the Company shall deliver or cause to be delivered to each Purchaser the
following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
this Agreement duly executed by the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
a legal opinion of Company Counsel, directed to the Placement Agent and the Purchasers, in a form reasonably acceptable to the Placement
Agent and Purchasers;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
a copy of the irrevocable instructions to the Transfer Agent instructing the Transfer Agent to deliver, on an expedited basis, a certificate
evidencing a number of Shares equal to such Purchaser&rsquo;s Subscription Amount divided by the Per Share Purchase Price, registered
in the name of such Purchaser, or, at the election of such Purchaser, evidence of the issuance of such Purchaser&rsquo;s Shares hereunder
as held in DRS book-entry form by the Transfer Agent and registered in the name of such Purchaser, which evidence shall be reasonably
satisfactory to such Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
the Company shall have provided each Purchaser with the Escrow Agent&rsquo;s wire instructions, on Company letterhead and executed by
the Chief Executive Officer or Chief Financial Officer;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
for each Purchaser of Prefunded Warrants pursuant to Section 2.1, a Prefunded Warrant registered in the name of such Purchaser to purchase
up to a number of shares of Common Stock equal to the portion of such Purchaser&rsquo;s Subscription Amount applicable to Prefunded Warrants
divided by the Per Share Purchase Price minus $0.0001, with an exercise price equal to $0.0001, subject to adjustment therein;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
a Common Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to 200% of the sum
of such Purchaser&rsquo;s Shares and Prefunded Warrants, with an exercise price equal to $0.45, subject to adjustment therein;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
on the date hereof, the Lock-Up Agreements; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
the Registration Rights Agreement duly executed by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
On or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company or the Escrow Agent, as applicable,
the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
this Agreement duly executed by such Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
to the Escrow Agent, such Purchaser&rsquo;s Subscription Amount (less the aggregate exercise price of the Prefunded Warrants issuable
to such Purchaser hereunder, if applicable) by wire transfer to the account specified in writing by the Company; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the Registration Rights Agreement duly executed by such Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3
<U>Closing Conditions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">(a)
The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality, in all respects)
when made and on the Closing Date of the representations and warranties of the Purchasers contained herein (unless such representation
and warranty is as of a specific date therein in which case they shall be accurate in all material respects (or, to the extent representations
or warranties are qualified by materiality, in all respects) as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been
performed; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless
such representation and warranty as of a specific date therein in which case they shall be accurate in all material respects or, to the
extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) as of such date);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
there shall have been no Material Adverse Effect with respect to the Company since the date hereof; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
from the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company&rsquo;s
principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall
not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such
service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities
nor shall there have occurred after the date of this Agreement any material outbreak or escalation of hostilities or other national or
international calamity of such magnitude in its effect on, or any material adverse change in, any financial market which, in each case,
in the reasonable judgment of such Purchaser, makes it impracticable or inadvisable to purchase the Securities at the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
III.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REPRESENTATIONS
AND WARRANTIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
<U>Representations and Warranties of the Company</U>. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall
be deemed a part hereof and shall qualify any representation made herein to the extent of the disclosure contained in the corresponding
section of the Disclosure Schedules, the Company hereby makes the following representations and warranties to each Purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Subsidiaries</U>. All of the direct and indirect subsidiaries of the Company are set forth on <U>Schedule 3.1(a)</U>. The Company
owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and
all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and
free of preemptive and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references
to the Subsidiaries or any of them in the Transaction Documents shall be disregarded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Organization and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized,
validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power
and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any
Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or
other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good
standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned
by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, would
not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction
Document, (ii) a material adverse effect on the results of operations, assets, business or condition (financial or otherwise) of the
Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in any material
respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a &ldquo;<U>Material Adverse Effect</U>&rdquo;;
provided, however, that the following shall not be deemed to constitute or be taken into account in determining whether there has been,
or would reasonably be expected to be, a Material Adverse Effect: (i) any event, occurrence, circumstance, change or effect generally
affecting the industry in which the Company operates, or in the economy generally or other general business, financial or market conditions;
(ii) any change, circumstance, condition, development, effect, event, occurrence or state of facts arising directly or indirectly from
or otherwise relating to any act of terrorism (including cyber-terrorism), war (whether or not declared), national or international calamity,
natural disaster, pandemic, epidemic or disease outbreak (including COVID-19) or any other similar event; (iii) provided that, any change,
circumstance, condition, development, effect, event, occurrence or state of facts referred to in the foregoing clauses may be taken into
account in determining whether there is, or would be reasonably expected to be, a Material Adverse Effect to the extent such change,
circumstance, condition, development, effect, event, occurrence or state of facts disproportionately affects the Company relative to
other participants in the industry in which the Company operates) and no Proceeding has been instituted in any such jurisdiction revoking,
limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Authorization; Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions
contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder.
The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of
the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no
further action is required by the Company, the Board of Directors, a committee of the Board of Directors, or the Company&rsquo;s stockholders
in connection herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document
to which the Company is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance
with the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in
accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization,
moratorium and other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws
relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification
and contribution provisions may be limited by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>No Conflicts</U>. Except as set forth on <U>Schedule 3.1(d)</U>, the execution, delivery and performance by the Company of this Agreement
and the other Transaction Documents to which it is a party, the issuance and sale of the Securities and the consummation by it of the
transactions contemplated hereby and thereby do not and will not (i) conflict with or violate any provision of the Company&rsquo;s or
any Subsidiary&rsquo;s certificate or articles of incorporation, bylaws or other organizational or charter documents, or (ii) conflict
with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation
of any Lien upon any of the properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment,
anti-dilution or similar adjustments, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement,
credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the
Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or affected, or (iii)
subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction,
decree or other restriction of any court or governmental authority to which the Company or a Subsidiary is subject (including federal
and state securities laws and regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except
in the case of each of clauses (ii) and (iii), such as would not have or reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Filings, Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any
notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other
Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings
required pursuant to Section 4.4 of this Agreement, (ii) the filing with the Commission pursuant to the Registration Rights Agreement,
(iii) the notice and/or application(s) to each applicable Trading Market for the issuance and sale of the Securities and the listing
of the Shares and Warrant Shares for trading thereon in the time and manner required thereby, and (iv) the filing of Form D with the
Commission and such filings as are required to be made under applicable state securities laws (collectively, the &ldquo;<U>Required Approvals</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Issuance of the Securities</U>. The Securities are duly authorized and, when issued and paid for in accordance with the applicable
Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company
other than restrictions on transfer provided for in the Transaction Documents. The Warrant Shares, when issued in accordance with the
terms of the Warrants, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company
other than restrictions on transfer provided for in the Transaction Documents. The Company has reserved from its duly authorized capital
stock the maximum number of shares of Common Stock issuable pursuant to this Agreement and the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Capitalization</U>. The capitalization of the Company as of the date hereof is as set forth on <U>Schedule 3.1(g)</U>, which <U>Schedule
3.1(g)</U> shall also include the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as
of the date hereof. Except as set forth on <U>Schedule 3.1(g)</U>, the Company has not issued any capital stock since its most recently
filed periodic report under the Exchange Act, other than pursuant to the exercise of employee stock options under the Company&rsquo;s
stock option plans, the issuance of shares of Common Stock to employees pursuant to the Company&rsquo;s employee stock purchase plans
and pursuant to the conversion and/or exercise of Common Stock Equivalents outstanding as of the date of the most recently filed periodic
report under the Exchange Act. No Person has any right of first refusal, preemptive right, right of participation, or any similar right
to participate in the transactions contemplated by the Transaction Documents. Except as a result of the purchase and sale of the Securities
and as set forth on <U>Schedule 3.1(g)</U>, there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments
of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or
giving any Person any right to subscribe for or acquire, any shares of Common Stock or the capital stock of any Subsidiary, or contracts,
commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to issue additional shares
of Common Stock or Common Stock Equivalents or capital stock of any Subsidiary. The issuance and sale of the Securities will not obligate
the Company or any Subsidiary to issue shares of Common Stock or other securities to any Person (other than the Purchasers). There are
no outstanding securities or instruments of the Company or any Subsidiary with any provision that adjusts the exercise, conversion, exchange
or reset price of such security or instrument upon an issuance of securities by the Company or any Subsidiary. There are no outstanding
securities or instruments of the Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts,
commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the
Company or such Subsidiary. The Company does not have any stock appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements
or any similar plan or agreement. All of the outstanding shares of capital stock of the Company are duly authorized, validly issued,
fully paid and nonassessable, have been issued in compliance with all federal and state securities laws, and none of such outstanding
shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities. Except for the Required
Approvals, no further approval or authorization of any stockholder, the Board of Directors or others is required for the issuance and
sale of the Securities. There are no stockholders agreements, voting agreements or other similar agreements with respect to the Company&rsquo;s
capital stock to which the Company is a party or, to the knowledge of the Company, between or among any of the Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>SEC Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required
to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the
two years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the
foregoing materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein
as the &ldquo;<U>SEC Reports</U>&rdquo;) on a timely basis or has received a valid extension of such time of filing and has filed any
such SEC Reports prior to the expiration of any such extension. The Company has never been an issuer subject to Rule 144(i) under the
Securities Act. As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities
Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or
omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of
the circumstances under which they were made, not misleading. The financial statements of the Company included in the SEC Reports comply
in all material respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto
as in effect at the time of filing. Such financial statements have been prepared in accordance with United States generally accepted
accounting principles applied on a consistent basis during the periods involved (&ldquo;<U>GAAP</U>&rdquo;), except as may be otherwise
specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain all footnotes
required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated Subsidiaries
as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited
statements, to normal, immaterial, year-end audit adjustments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Material Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included
within the SEC Reports, except as set forth on <U>Schedule 3.1(i)</U>, (i) there has been no event, occurrence or development that has
had or that would reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent
or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice
and (B) liabilities not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings
made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend
or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or redeem any
shares of its capital stock, except as set forth on <U>Schedule 3.1(i)</U>, and (v) the Company has not issued any equity securities
to any officer, director or Affiliate, except pursuant to existing Company stock option plans. The Company does not have pending before
the Commission any request for confidential treatment of information. Except for the issuance of the Securities contemplated by this
Agreement or as set forth on <U>Schedule 3.1(i)</U>, no event, liability, fact, circumstance, occurrence or development has occurred
or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective businesses,
prospects, properties, operations, assets or financial condition that would be required to be disclosed by the Company under applicable
securities laws at the time this representation is made or deemed made that has not been publicly disclosed at least 1 Trading Day prior
to the date that this representation is made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Litigation</U>. Except as set forth on <U>Schedule 3.1(j)</U>, there is no action, suit, inquiry, notice of violation, proceeding
or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their
respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state,
county, local or foreign) (collectively, an &ldquo;<U>Action</U>&rdquo;), which (i) adversely affects or challenges the legality, validity
or enforceability of any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable decision, have or
reasonably be expected to result in a Material Adverse Effect. Except as set forth on <U>Schedule 3.1(j)</U>, neither the Company nor
any Subsidiary, nor any director or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability
under federal or state securities laws or a claim of breach of fiduciary duty, which could have or reasonably be expected to result in
a Material Adverse Effect. There has not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation
by the Commission involving the Company or any current or former director or officer of the Company. The Commission has not issued any
stop order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under the
Exchange Act or the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Labor Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees
of the Company, which would reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo;
employees is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither
the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe
that their relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary
is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary
information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third
party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability
with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all applicable U.S. federal, state,
local and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages
and hours, except where the failure to be in compliance would not, individually or in the aggregate, reasonably be expected to have a
Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Compliance</U>. Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that
has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor
has the Company or any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture,
loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound
(whether or not such default or violation has been waived), (ii) is in violation of any judgment, decree, or order of any court, arbitrator
or other governmental authority or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental
authority, including without limitation all foreign, federal, state and local laws relating to taxes, environmental protection, occupational
health and safety, product quality and safety and employment and labor matters, except in each case of (i), (ii) and (iii) as would not
have or reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Environmental Laws</U>. The Company and its Subsidiaries (i) are in compliance with all applicable federal, state, local and foreign
laws relating to pollution or protection of human health or the environment (including ambient air, surface water, groundwater, land
surface or subsurface strata), including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants,
contaminants, or toxic or hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment,
or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous
Materials, as well as all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice
letters, orders, permits, plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;);
(ii) have received all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective
businesses; and (iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i),
(ii) and (iii), the failure to so comply would be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Regulatory Permits</U>. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate
federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports,
except where the failure to possess such certificates, authorizations or permits would not reasonably be expected to result in a Material
Adverse Effect (&ldquo;<U>Material Permits</U>&rdquo;), and neither the Company nor any Subsidiary has received any notice of proceedings
relating to the revocation or modification of any Material Permit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<U>Title to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them
and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries,
in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially
interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment
of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and the payment of which
is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries
are held by them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance in all
material respects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
<U>Intellectual Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks,
trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights
and similar rights necessary or required for use in connection with their respective businesses as described in the SEC Reports and which
the failure to so have would reasonably be expected to have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property
Rights</U>&rdquo;). None of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the
Intellectual Property Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within
two (2) years from the date of this Agreement, except as would not reasonably be expected to have a Material Adverse Effect. Neither
the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within the SEC Reports,
a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the rights
of any Person, except as would not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the Company,
all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual
Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and
value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect. The Company has no knowledge of any facts that would preclude it from having valid license
rights or clear title to the Intellectual Property Rights. The Company has no knowledge that it lacks or will be unable to obtain any
rights or licenses to use all Intellectual Property Rights that are necessary to conduct its business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
<U>Insurance</U>. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses
and risks and in such amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including,
but not limited to, directors and officers insurance coverage at least equal to the aggregate Subscription Amount. Neither the Company
nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage
expires or to obtain similar coverage from similar insurers as may be necessary to continue its business without a significant increase
in cost.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
<U>Transactions with Affiliates and Employees</U>. Except as set forth on <U>Schedule 3.1(r)</U>, none of the officers or directors of
the Company or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently
a party to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including
any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal
property to or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any
officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee
has a substantial interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other
than for (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company
or a Subsidiary and (iii) other employee benefits, including stock option agreements under any stock option plan of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
<U>Sarbanes-Oxley; Internal Accounting Controls</U>. The Company and the Subsidiaries are in compliance in all material respects with
any and all applicable requirements of the Sarbanes-Oxley Act of 2002, as amended, that are effective as of the date hereof, and any
and all applicable rules and regulations promulgated by the Commission thereunder that are effective as of the date hereof and as of
the Closing Date. The Company and the Subsidiaries maintain a system of internal accounting controls sufficient to provide reasonable
assurance that: (i) transactions are executed in accordance with management&rsquo;s general or specific authorizations, (ii) transactions
are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability,
(iii) access to assets is permitted only in accordance with management&rsquo;s general or specific authorization, and (iv) the recorded
accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to
any differences. The Company and the Subsidiaries have established disclosure controls and procedures (as defined in Exchange Act Rules
13a-15(e) and 15d-15(e)) for the Company and the Subsidiaries and designed such disclosure controls and procedures to ensure that information
required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized
and reported, within the time periods specified in the Commission&rsquo;s rules and forms. The Company&rsquo;s certifying officers have
evaluated the effectiveness of the disclosure controls and procedures of the Company and the Subsidiaries as of the end of the period
covered by the most recently filed periodic report under the Exchange Act (such date, the &ldquo;<U>Evaluation Date</U>&rdquo;). The
Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying officers about
the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation
Date, there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange Act) of the
Company and its Subsidiaries that have materially affected, or is reasonably likely to materially affect, the internal control over financial
reporting of the Company and its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
<U>Certain Fees</U>. Except for fees payable by the Company to the Placement Agent, no brokerage or finder&rsquo;s fees or commissions
are or will be payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment
banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no
obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated
in this Section that may be due in connection with the transactions contemplated by the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
<U>Private Placement</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, no
registration under the Securities Act is required for the offer and sale of the Securities by the Company to the Purchasers as contemplated
hereby. The issuance and sale of the Securities hereunder does not contravene the rules and regulations of the Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<U>Investment Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities,
will not be or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended.
The Company shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration
under the Investment Company Act of 1940, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)
<U>Registration Rights</U>. Except as set forth on <U>Schedule 3.1(v)</U>, other than each of the Purchasers, no Person has any right
to cause the Company or any Subsidiary to effect the registration under the Securities Act of any securities of the Company or any Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
<U>Listing and Maintenance Requirements</U>. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and
the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration
of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating
such registration. Except as set forth on <U>Schedule 3.1(x)</U>, the Company has not, in the 12 months preceding the date hereof, received
notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance
with the listing or maintenance requirements of such Trading Market. The Company is, and has no reason to believe that it will not in
the foreseeable future continue to be, in compliance with all such listing and maintenance requirements. The Common Stock is currently
eligible for electronic transfer through the Depository Trust Company or another established clearing corporation and the Company is
current in payment of the fees to the Depository Trust Company (or such other established clearing corporation) in connection with such
electronic transfer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)
<U>Application of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order
to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement)
or other similar anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the
laws of its state of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company
fulfilling their obligations or exercising their rights under the Transaction Documents, including without limitation as a result of
the Company&rsquo;s issuance of the Securities and the Purchasers&rsquo; ownership of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)
<U>Disclosure</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
the Company confirms that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or
counsel with any information that it believes constitutes or might constitute material, non-public information. The Company understands
and confirms that the Purchasers will rely on the foregoing representation in effecting transactions in securities of the Company. All
of the disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries, their respective
businesses and the transactions contemplated hereby, including the Disclosure Schedules to this Agreement, is true and correct in all
material respects and does not contain any untrue statement of a material fact or omit to state any material fact necessary in order
to make the statements made therein, in the light of the circumstances under which they were made, not misleading. The press releases
disseminated by the Company during the twelve months preceding the date of this Agreement taken as a whole do not contain any untrue
statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements
therein, in the light of the circumstances under which they were made and when made, not misleading. The Company acknowledges and agrees
that no Purchaser makes or has made any representations or warranties with respect to the transactions contemplated hereby other than
those specifically set forth in Section 3.2 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)
<U>No Integrated Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2,
neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers
or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities
to be integrated with prior offerings by the Company for purposes of (i) the Securities Act which would require the registration of any
such securities under the Securities Act, or (ii) any applicable shareholder approval provisions of any Trading Market on which any of
the securities of the Company are listed or designated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)
<U>Indebtedness</U>. <U>Schedule 3.1(bb)</U> sets forth as of the date hereof all outstanding secured and unsecured Indebtedness of the
Company or any Subsidiary, or for which the Company or any Subsidiary has commitments. For the purposes of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo;
means (x) any liabilities for borrowed money or amounts owed in excess of $50,000 (other than trade accounts payable incurred in the
ordinary course of business), (y) all guaranties, endorsements and other contingent obligations in respect of indebtedness of others,
whether or not the same are or should be reflected in the Company&rsquo;s consolidated balance sheet (or the notes thereto), except guaranties
by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business; and (z)
the present value of any lease payments in excess of $50,000 due under leases required to be capitalized in accordance with GAAP. Neither
the Company nor any Subsidiary is in default with respect to any Indebtedness.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc) <U>Tax
Status</U>. Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a
Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local
income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is
subject, (ii) has paid all taxes and other governmental assessments, charges, fines or penalties that are material in amount, shown
or determined to be due on such returns, reports and declarations and (iii) has set aside on its financial statements provision
reasonably adequate for the payment of all material tax liability which has not been finally determined and all material taxes for
periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material
amount claimed to be due by the taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of
no basis for any such claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd) <U>No
General Solicitation</U>. Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the
Securities by any form of general solicitation or general advertising. The Company has offered the Securities for sale only to the
Purchasers and certain other &ldquo;accredited investors&rdquo; within the meaning of Rule 501 under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee) <U>Foreign
Corrupt Practices.</U> Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or
other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful
contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity, (ii) made any
unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or
campaigns from corporate funds, (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by
any person acting on its behalf of which the Company is aware) which is in violation of law or (iv) violated in any material respect
any provision of FCPA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)
<U>Accountants</U>. The Company&rsquo;s independent registered public accounting firm is WithumSmith+Brown, PC. To the knowledge and
belief of the Company, such accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall
express its opinion with respect to the financial statements to be included in the Company&rsquo;s Annual Report for the fiscal year
ending December 31, 2025.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)
<U>No Disagreements with Accountants and Lawyers.</U> There are no disagreements of any kind presently existing, or reasonably anticipated
by the Company to arise, between the Company and the accountants and lawyers formerly or presently employed by the Company and the Company
is current with respect to any fees owed to its accountants and lawyers which could affect the Company&rsquo;s ability to perform any
of its obligations under any of the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)
<U>Acknowledgment Regarding Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers
is acting solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated
thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar
capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or
any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby
is merely incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each Purchaser that the Company&rsquo;s
decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the
transactions contemplated hereby by the Company and its representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) <FONT STYLE="text-decoration: underline solid; letter-spacing: 0pt">Acknowledgment
Regarding Purchaser&rsquo;s Trading Activity.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration-style: double; letter-spacing: 0pt">
Anything in this Agreement or elsewhere herein to the contrary notwithstanding (except for Sections 3.2(g) and 4.14 hereof), it is
understood and acknowledged by the Company that: (i) none of the Purchasers has been asked by the Company to agree, nor has any
Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the Company, or &ldquo;derivative&rdquo;
securities based on securities issued by the Company or to hold the Securities for any specified term, (ii) past or future open
market or other transactions by any Purchaser, specifically including, without limitation, Short Sales or &ldquo;derivative&rdquo;
transactions, before or after the closing of this or future private placement transactions, may negatively impact the market price
of the Company&rsquo;s publicly-traded securities, (iii) any Purchaser, and counter-parties in &ldquo;derivative&rdquo; transactions
to which any such Purchaser is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the Common
Stock and (iv) each Purchaser shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party
in any &ldquo;derivative&rdquo; transaction. </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration-style: solid; letter-spacing: 0pt">The
Company further understands and acknowledges that (y) one or more Purchasers may engage in hedging activities at various times
during the period that the Securities are outstanding, including, without limitation, during the periods that the value of the
Warrant Shares deliverable with respect to Securities are being determined, and (z) such hedging activities (if any) could reduce
the value of the existing stockholders&rsquo; equity interests in the Company at and after the time that the hedging activities are
being conducted. The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any of the
Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)
<U>Regulation M Compliance.</U> The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly,
any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of, any
of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities
of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Placement Agent in connection with the placement
of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)
<U>Regulatory Matters; Compliance</U>. All preclinical and other nonclinical studies and clinical trials conducted by or on behalf of
the Company that are material to the Company have been adequately described in the SEC Reports in all material respects. The clinical
trials and nonclinical studies conducted by or on behalf of the Company that are described in the SEC Reports or the results of such
trials and studies which are referred to in the SEC Reports were and, if still ongoing, are being conducted in material compliance with
all laws and regulations applicable thereto in the jurisdictions in which they are being conducted. The descriptions in the SEC Reports
of the results of such trials and studies are accurate in all material respects, and the Company has no knowledge of any other trials
or studies, the results of which reasonably call into question the trial or study results described in the SEC Reports when viewed in
the context in which such results are described. Except as set forth on <U>Schedule 3.1(kk)</U>, the Company has not received any written
notices or other communications from the FDA, the European Medicines Agency (&ldquo;<U>EMA</U>&rdquo;) or any other governmental agency
or authority imposing, requiring, requesting or suggesting a clinical hold, termination, suspension or material modification of any clinical
trial that is described in the SEC Reports or the results of which are referred to in the SEC Reports. Except as set forth on <U>Schedule
3.1(kk)</U>, the Company has not received any written notices or other communications from the FDA, the EMA or any other governmental
agency, and otherwise has no knowledge of, or reason to believe that, (i) any investigational new drug application for a potential product
of the Company is or has been rejected or determined to be non-approvable or conditionally approvable; and (ii) any license, approval,
permit or authorization to conduct any clinical trial of any potential product of the Company has been, will be or may be suspended,
revoked, modified or limited<FONT STYLE="letter-spacing: -0.15pt">.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)
<U>Form S-1 Eligibility</U>. The Company is eligible to register the resale of the Securities for resale by the Purchaser on Form S-1
promulgated under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm)
<U>Stock Option Plans</U>. Each stock option granted by the Company under the Company&rsquo;s stock option plan or pursuant to an inducement
option grant was granted (i) in accordance with the terms of the Company&rsquo;s stock option plan or inducement option agreements and
(ii) with an exercise price at least equal to the fair market value of the Common Stock on the date such stock option would be considered
granted under GAAP and applicable law. No stock option granted under the Company&rsquo;s stock option plan has been backdated. The Company
has not knowingly granted, and there is no and has been no Company policy or practice to knowingly grant, stock options prior to, or
otherwise knowingly coordinate the grant of stock options with, the release or other public announcement of material information regarding
the Company or its Subsidiaries or their financial results or prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nn)
<U>Cybersecurity</U>. (i)(x) To the knowledge of the Company, there has been no material security breach or other compromise of or relating
to any of the Company&rsquo;s or any Subsidiary&rsquo;s information technology and computer systems, networks, hardware, software, data
(including the data of its respective customers, employees, suppliers, vendors and any third party data maintained by or on behalf of
it), equipment or technology (collectively, &ldquo;<U>IT Systems and Data</U>&rdquo;) and (y) the Company and the Subsidiaries have not
been notified of, and has no knowledge of any event or condition that would reasonably be expected to result in, any security breach
or other compromise to its IT Systems and Data; (ii) the Company and the Subsidiaries are presently in compliance with all applicable
laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority,
internal policies and contractual obligations relating to the privacy and security of IT Systems and Data and to the protection of such
IT Systems and Data from unauthorized use, access, misappropriation or modification, except as would not, individually or in the aggregate,
have a Material Adverse Effect; (iii) the Company and the Subsidiaries have implemented and maintained commercially reasonable safeguards
to maintain and protect its material confidential information and the integrity, continuous operation, redundancy and security of all
IT Systems and Data; and (iv) the Company and the Subsidiaries have implemented backup and disaster recovery technology consistent with
commercially reasonable industry standards and practices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(oo)
<U>Compliance with Data Privacy Laws</U>. (i) The Company and the Subsidiaries are, and at all times during the last three (3) years
were, in compliance with all applicable state, federal and foreign data privacy and security laws and regulations (collectively, &ldquo;<U>Privacy
Laws</U>&rdquo;); and (ii) the Company and the Subsidiaries have in place, comply with, and take commercially reasonable steps designed
to comply with their policies and procedures relating to data privacy and security and the collection, storage, use, disclosure, handling
and analysis of Personal Data (as defined below) (the &ldquo;<U>Policies</U>&rdquo;). &ldquo;<U>Personal Data</U>&rdquo; means (i) a
natural person&rsquo;s name, street address, telephone number, email address, photograph, social security number, bank information, or
customer or account number; and (ii) any other piece of information that allows the identification of such natural person, or his or
her family, or permits the collection or analysis of any identifiable data related to an identified person&rsquo;s health or sexual orientation.
(i) None of such disclosures made or contained in any of the Policies have been inaccurate, misleading, or deceptive in violation of
any Privacy Laws and (ii) the execution, delivery and performance of the Transaction Documents will not result in a breach of any Privacy
Laws or Policies. Neither the Company nor the Subsidiaries (is a party to any order, decree, or agreement by or with any court or arbitrator
or governmental or regulatory authority that imposed any obligation or liability under any Privacy Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pp)
<U>Office of Foreign Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director,
officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the
Office of Foreign Assets Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(qq)
<U>U.S. Real Property Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within
the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s
request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(rr)
<U>Bank Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company
Act of 1956, as amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the
&ldquo;<U>Federal Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly,
five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent or more of the total equity
of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries
or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and
to regulation by the Federal Reserve.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ss)
<U>Money Laundering</U>. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with
applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended,
applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;),
and no Action or Proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company
or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(tt)
<U>No Disqualification Events</U>. With respect to the Securities to be offered and sold hereunder in reliance on Rule 506 under the
Securities Act, none of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of
the Company participating in the offering hereunder, any beneficial owner of 20% or more of the Company&rsquo;s outstanding voting equity
securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act)
connected with the Company in any capacity at the time of sale (each, an &ldquo;<U>Issuer Covered Person</U>&rdquo; and, together, &ldquo;<U>Issuer
Covered Persons</U>&rdquo;) is subject to any of the &ldquo;Bad Actor&rdquo; disqualifications described in Rule 506(d)(1)(i) to (viii)
under the Securities Act (a &ldquo;<U>Disqualification Event</U>&rdquo;), except for a Disqualification Event covered by Rule 506(d)(2)
or (d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification
Event. The Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the
Purchasers a copy of any disclosures provided thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(uu)
<U>Other Covered Persons</U>. Other than the Placement Agent, the Company is not aware of any person (other than any Issuer Covered Person)
that has been or will be paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any
Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vv)
<U>Notice of Disqualification Events</U>. The Company will notify the Purchasers and the Placement Agent in writing, prior to the Closing
Date of (i) any Disqualification Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time,
become a Disqualification Event relating to any Issuer Covered Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
<U>Representations and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and
warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case
they shall be accurate as of such date):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Organization; Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and
in good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited
liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents
and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance
by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate,
partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to
which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof,
will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except
(i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general
application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited
by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Own Account</U>. Such Purchaser understands that the Securities are &ldquo;restricted securities&rdquo; and have not been registered
under the Securities Act or any applicable state securities law and is acquiring the Securities as principal for its own account and
not with a view to or for distributing or reselling such Securities or any part thereof in violation of the Securities Act or any applicable
state securities law, has no present intention of distributing any of such Securities in violation of the Securities Act or any applicable
state securities law and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the
distribution of such Securities in violation of the Securities Act or any applicable state securities law (this representation and warranty
not limiting such Purchaser&rsquo;s right to sell the Securities pursuant to the Registration Statement or otherwise in compliance with
applicable federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in the ordinary course of its business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Purchaser Status</U>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each
date on which it exercises any Warrants it will be, an &ldquo;accredited investor&rdquo; as defined in Rule 501(a)(1), (a)(2), (a)(3),
(a)(7), (a)(8), (a)(9), (a)(12), or (a)(13) under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Experience of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication
and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of
an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>General Solicitation</U>. Such Purchaser is not, to such Purchaser&rsquo;s knowledge, purchasing the Securities as a result of any
advertisement, article, notice or other communication regarding the Securities published in any newspaper, magazine or similar media
or broadcast over television or radio or presented at any seminar or, to the knowledge of such Purchaser, any other general solicitation
or general advertisement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Access to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including
all exhibits and schedules thereto) and the SEC Reports and has been afforded (i) the opportunity to ask such questions as it has deemed
necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the
Securities and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition,
results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the
opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that
is necessary to make an informed investment decision with respect to the investment. Such Purchaser acknowledges and agrees that neither
the Placement Agent nor any Affiliate of the Placement Agent has provided such Purchaser with any information or advice with respect
to the Securities nor is such information or advice necessary or desired. Neither the Placement Agent nor any Affiliate has made or makes
any representation as to the Company or the quality of the Securities and the Placement Agent and any Affiliate may have acquired non-public
information with respect to the Company which such Purchaser agrees need not be provided to it. In connection with the issuance of the
Securities to such Purchaser, neither the Placement Agent nor any of its Affiliates has acted as a financial advisor or fiduciary to
such Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Certain Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has
not, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any
purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such Purchaser
first received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material
terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing,
in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of
such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers
managing other portions of such Purchaser&rsquo;s assets, the representation set forth above shall only apply with respect to the portion
of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other
than to other Persons party to this Agreement or to such Purchaser&rsquo;s representatives, including, without limitation, its officers,
directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of
all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding
the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions,
with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s
right to rely on the Company&rsquo;s representations and warranties contained in this Agreement or any representations and warranties
contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement
or the consummation of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained
herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order
to effect Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
IV.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OTHER
AGREEMENTS OF THE PARTIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #000000">4.1</FONT>
<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: red"></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Transfer
Restrictions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Securities may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of Securities
other than pursuant to an effective registration statement or Rule 144, to the Company or to an Affiliate of a Purchaser or in connection
with a pledge as contemplated in Section 4.1(b), the Company may require the transferor thereof to provide to the Company an opinion
of counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably
satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Securities under the
Securities Act. As a condition of transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement and
the Registration Rights Agreement and shall have the rights and obligations of a Purchaser under this Agreement and the Registration
Rights Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Purchasers agree to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Securities in the following
form:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
SECURITY HAS NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON
AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), AND, ACCORDINGLY, MAY
NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION
FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
SECURITIES LAWS. THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER
LOAN WITH A FINANCIAL INSTITUTION THAT IS AN &ldquo;ACCREDITED INVESTOR&rdquo; AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR
OTHER LOAN SECURED BY SUCH SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered
broker-dealer or grant a security interest in some or all of the Securities to a financial institution that is an &ldquo;accredited investor&rdquo;
as defined in Rule 501(a) under the Securities Act and, if required under the terms of such arrangement, such Purchaser may transfer
pledged or secured Securities to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company
and no legal opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith. Further, no
notice shall be required of such pledge. At the appropriate Purchaser&rsquo;s expense, the Company will execute and deliver such reasonable
documentation as a pledgee or secured party of Securities may reasonably request in connection with a pledge or transfer of the Securities,
including, if the Securities are subject to registration pursuant to the Registration Rights Agreement, the preparation and filing of
any required prospectus supplement under Rule 424(b)(3) under the Securities Act or other applicable provision of the Securities Act
to appropriately amend the list of Selling Stockholders (as defined in the Registration Rights Agreement) thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Certificates evidencing the Shares and Warrant Shares shall not contain any legend (including the legend set forth in Section 4.1(b)
hereof), (i) while a registration statement (including the Registration Statement) covering the resale of such security is effective
under the Securities Act, (ii) following any sale of such Shares or Warrant Shares pursuant to Rule 144 (assuming cashless exercise of
the Warrants), (iii) if such Shares or Warrant Shares are eligible for sale under Rule 144 (assuming cashless exercise of the Warrants),
or (iv) if such legend is not required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements
issued by the staff of the Commission). The Company shall cause its counsel to issue a legal opinion to the Transfer Agent or the Purchaser
if required by the Transfer Agent to effect the removal of the legend hereunder, or if requested by a Purchaser, respectively. If all
or any portion of a Warrant is exercised at a time when there is an effective registration statement covering the resale of the Warrant
Shares, or if such Shares or Warrant Shares may be sold under Rule 144 and the Company is then in compliance with the current public
information required under Rule 144 (assuming cashless exercise of the Warrants), or if the Shares or Warrant Shares may be sold under
Rule 144 without the requirement for the Company to be in compliance with the current public information required under Rule 144 as to
such Shares or Warrant Shares or if such legend is not otherwise required under applicable requirements of the Securities Act (including
judicial interpretations and pronouncements issued by the staff of the Commission) then such Shares or Warrant Shares shall be issued
free of all legends. The Company agrees that at such time as such legend is no longer required under this Section 4.1(c), it will, no
later than the earlier of (i) one (1) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
below) following the delivery by a Purchaser to the Company or the Transfer Agent of a certificate representing Shares or Warrant Shares,
as the case may be, issued with a restrictive legend (such date, the &ldquo;<U>Legend Removal Date</U>&rdquo;), deliver or cause to be
delivered to such Purchaser a certificate representing such shares that is free from all restrictive and other legends. The Company may
not make any notation on its records or give instructions to the Transfer Agent that enlarge the restrictions on transfer set forth in
this Section 4. Certificates for Securities subject to legend removal hereunder shall be transmitted by the Transfer Agent to the Purchaser
by crediting the account of the Purchaser&rsquo;s prime broker with the Depository Trust Company System as directed by such Purchaser.
As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a number of Trading
Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of a certificate
representing Shares or Warrant Shares, as the case may be, issued with a restrictive legend.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
In addition to such Purchaser&rsquo;s other available remedies, the Company shall pay to a Purchaser, in cash, (i) as partial liquidated
damages and not as a penalty, for each $1,000 of Shares or Warrant Shares (based on the VWAP of the Common Stock on the date such Securities
are submitted to the Transfer Agent) delivered for removal of the restrictive legend and subject to Section 4.1(c), $5 per Trading Day
(increasing to $10 per Trading Day five (5) Trading Days after the Legend Removal Date) for each Trading Day after the Legend Removal
Date until such certificate is delivered without a legend and (ii) if the Company fails to (a) issue and deliver (or cause to be delivered)
to a Purchaser by the Legend Removal Date a certificate representing the Securities so delivered to the Company by such Purchaser that
is free from all restrictive and other legends and (b) if after the Legend Removal Date such Purchaser purchases (in an open market transaction
or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Purchaser of all or any portion of the number of shares
of Common Stock, or a sale of a number of shares of Common Stock equal to all or any portion of the number of shares of Common Stock
that such Purchaser anticipated receiving from the Company without any restrictive legend, then, an amount equal to the excess of such
Purchaser&rsquo;s total purchase price (including brokerage commissions and other out-of-pocket expenses, if any) for the shares of Common
Stock so purchased (including brokerage commissions and other out-of-pocket expenses, if any) (the &ldquo;<FONT STYLE="font-weight: normal"><U>Buy-In
Price</U></FONT>&rdquo;) over the product of (A) such number of Shares or Warrant Shares that the Company was required to deliver to
such Purchaser by the Legend Removal Date multiplied by (B) the lowest closing sale price of the Common Stock on any Trading Day during
the period commencing on the date of the delivery by such Purchaser to the Company of the applicable Shares or Warrant Shares (as the
case may be) and ending on the date of such delivery and payment under this clause (ii).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Each Purchaser, severally and not jointly with the other Purchasers, agrees with the Company that such Purchaser will sell any Securities
pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or
an exemption therefrom, and that if Securities are sold pursuant to a Registration Statement, they will be sold in compliance with the
plan of distribution set forth therein, and acknowledges that the removal of the restrictive legend from certificates representing Securities
as set forth in this Section 4.1 is predicated upon the Company&rsquo;s reliance upon this understanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
<U>Furnishing of Information; Public Information</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Until the earliest of the time that (i) no Purchaser owns Securities or (ii) the Common Warrants have expired, the Company covenants
to maintain the registration of the Common Stock under Section 12(b) or 12(g) of the Exchange Act and to timely file (or obtain extensions
in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof
pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
At any time during the period commencing from the six (6) month anniversary of the date hereof and ending at such time that all of the
Securities may be sold without the requirement for the Company to be in compliance with Rule 144(c)(1) and otherwise without restriction
or limitation pursuant to Rule 144, if the Company (i) shall fail for any reason to satisfy the current public information requirement
under Rule 144(c) or (ii) has ever been an issuer described in Rule 144(i)(1)(i) or becomes an issuer in the future, and the Company
shall fail to satisfy any condition set forth in Rule 144(i)(2) (a &ldquo;<U>Public Information Failure</U>&rdquo;) then, in addition
to such Purchaser&rsquo;s other available remedies, the Company shall pay to a Purchaser, in cash, as partial liquidated damages and
not as a penalty, by reason of any such delay in or reduction of its ability to sell the Securities, an amount in cash equal to one percent
(1.0%) of the aggregate Subscription Amount of such Purchaser&rsquo;s Securities on the day of a Public Information Failure and on every
thirtieth (30<SUP>th</SUP>) day (pro rated for periods totaling less than thirty days) thereafter until the earlier of (a) the date such
Public Information Failure is cured and (b) such time that such public information is no longer required for the Purchasers to transfer
the Shares and Warrant Shares pursuant to Rule 144. The payments to which a Purchaser shall be entitled pursuant to this Section 4.2(b)
are referred to herein as &ldquo;<U>Public Information Failure Payments</U>.&rdquo; Public Information Failure Payments shall be paid
on the earlier of (i) the last day of the calendar month during which such Public Information Failure Payments are incurred and (ii)
the third (3<SUP>rd</SUP>) Business Day after the event or failure giving rise to the Public Information Failure Payments is cured. In
the event the Company fails to make Public Information Failure Payments in a timely manner, such Public Information Failure Payments
shall bear interest at the rate of 1.5% per month (prorated for partial months) until paid in full. Nothing herein shall limit such Purchaser&rsquo;s
right to pursue actual damages for the Public Information Failure, and such Purchaser shall have the right to pursue all remedies available
to it at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
<U>Integration</U>. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security
(as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would
require the registration under the Securities Act of the sale of the Securities or that would be integrated with the offer or sale of
the Securities for purposes of the rules and regulations of any Trading Market such that it would require shareholder approval prior
to the closing of such other transaction unless shareholder approval is obtained before the closing of such subsequent transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4
<U>Securities Laws Disclosure; Publicity</U>. The Company shall (a) by the Disclosure Time, issue a press release disclosing the material
terms of the transactions contemplated hereby and (b) file a Current Report on Form 8-K, including the Transaction Documents as exhibits
thereto, with the Commission within the time required by the Exchange Act. From and after the issuance of such press release, the Company
represents to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of the Purchasers
by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees, Affiliates or agents, including,
without limitation, the Placement Agent, in connection with the transactions contemplated by the Transaction Documents. In addition,
effective upon the issuance of such press release, the Company acknowledges and agrees that any and all confidentiality or similar obligations
under any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors,
agents, employees, Affiliates or agents, including, without limitation, the Placement Agent, on the one hand, and any of the Purchasers
or any of their Affiliates on the other hand, shall terminate and be of no further force or effect. The Company understands and confirms
that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. The Company and
each Purchaser shall consult with each other in issuing any other press releases with respect to the transactions contemplated hereby,
and neither the Company nor any Purchaser shall issue any such press release nor otherwise make any such public statement without the
prior consent of the Company, with respect to any press release of any Purchaser, or without the prior consent of each Purchaser, with
respect to any press release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is
required by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement
or communication. Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name
of any Purchaser in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such
Purchaser, except (a) as required by federal securities law in connection with (i) any registration statement contemplated by the Registration
Rights Agreement and (ii) the filing of final Transaction Documents with the Commission and (b) to the extent such disclosure is required
by law or Trading Market regulations, in which case the Company shall provide the Purchasers with prior notice of such disclosure permitted
under this clause (b) and reasonably cooperate with such Purchaser regarding such disclosure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5
<U>Shareholder Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person,
that any Purchaser is an &ldquo;<U>Acquiring Person</U>&rdquo; under any control share acquisition, business combination, poison pill
(including any distribution under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by
the Company, or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving
Securities under the Transaction Documents or under any other agreement between the Company and the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6
<U>Non-Public Information</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction
Documents, which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other Person acting
on its behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes
constitutes, material non-public information, unless prior thereto such Purchaser shall have consented in writing to the receipt of such
information and agreed in writing with the Company to keep such information confidential. The Company understands and confirms that each
Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company,
any of its Subsidiaries, or any of their respective officers, directors, agents, employees or Affiliates delivers any material, non-public
information to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants and agrees that such Purchaser shall
not have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective officers, directors, employees,
Affiliates or agents, including, without limitation, the Placement Agent, or a duty to the Company, any of its Subsidiaries or any of
their respective officers, directors, employees, Affiliates or agents, including, without limitation, the Placement Agent, not to trade
on the basis of, such material, non-public information, provided that the Purchaser shall remain subject to applicable law. To the extent
that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the
Company or any Subsidiaries, the Company shall simultaneously with the delivery of such notice file such notice with the Commission pursuant
to a Current Report on Form 8-K. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant
in effecting transactions in securities of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7
<U>Use of Proceeds</U>. Except as set forth on <U>Schedule 4.7</U> hereto, the Company shall use the net proceeds from the sale of the
Securities hereunder for working capital purposes and shall not use such proceeds: (a) for the satisfaction of any portion of the Company&rsquo;s
debt (other than payment of trade payables in the ordinary course of the Company&rsquo;s business and prior practices), (b) for the redemption
of any Common Stock or Common Stock Equivalents, (c) for the settlement of any outstanding litigation or (d) in violation of FCPA or
OFAC regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8
<U>Indemnification of Purchasers</U>. Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser
and its directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent
role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser
(within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders,
agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding
a lack of such title or any other title) of such controlling persons (each, a &ldquo;Purchaser Party&rdquo;) harmless from any and all
losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements,
court costs and reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer or incur as a result
of or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement
or in the other Transaction Documents or (b) any action instituted against the Purchaser Parties in any capacity, or any of them or their
respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect to any of the
transactions contemplated by the Transaction Documents (unless such action is solely based upon a material breach of such Purchaser Party&rsquo;s
representations, warranties or covenants under the Transaction Documents or any agreements or understandings such Purchaser Party may
have with any such stockholder or any violations by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser
Party which is finally judicially determined to constitute fraud, gross negligence or willful misconduct. If any action shall be brought
against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly
notify the Company in writing, and, the Company shall have the right to assume the defense thereof with counsel of its own choosing reasonably
acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate counsel in any such action and participate
in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Purchaser Party except to the extent
that (i) the employment thereof has been specifically authorized by the Company in writing, (ii) the Company has failed after a reasonable
period of time to assume such defense and to employ counsel or (iii) in such action there is, in the reasonable opinion of counsel a
material conflict on any material issue between the position of the Company and the position of such Purchaser Party, in which case the
Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel. The Company will not be
liable to any Purchaser Party under this Agreement (y) for any settlement or compromise, or consent to the entry of judgment in, an Action
or Proceeding by a Purchaser Party effected without the Company&rsquo;s prior written consent, which shall not be unreasonably withheld
or delayed; or (z) to the extent, but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party&rsquo;s
breach of any of the representations, warranties, covenants or agreements made by such Purchaser Party in this Agreement or the other
Transaction Documents. The indemnification required by this Section 4.8 shall be made by periodic payments of the amount thereof during
the course of the investigation or defense, as and when bills are received or are incurred. The indemnity agreements contained herein
shall be in addition to any cause of action or similar right of any Purchaser Party against the Company or others and any liabilities
the Company may be subject to pursuant to law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9
<U>Reservation of Common Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep
available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company
to issue Shares pursuant to this Agreement and the Warrant Shares pursuant to any exercise of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10
<U>Listing of Common Stock</U>. The Company hereby agrees to use commercially reasonable best efforts to maintain the listing or quotation
of the Common Stock on the Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply
to list or quote all of the Shares and Warrant Shares on such Trading Market and promptly secure the listing of all of the Shares and
Warrant Shares on such Trading Market. The Company further agrees, if the Company applies to have the Common Stock traded on any other
Trading Market, it will then include in such application all of the Shares and Warrant Shares, and will take such other action as is
necessary to cause all of the Shares and Warrant Shares to be listed or quoted on such other Trading Market as promptly as possible.
The Company will then take all action reasonably necessary to continue the listing and trading of its Common Stock on a Trading Market
and will comply in all respects with the Company&rsquo;s reporting, filing and other obligations under the bylaws or rules of the Trading
Market. The Company agrees to use commercially reasonable best efforts to maintain the eligibility of the Common Stock for electronic
transfer through the Depository Trust Company or another established clearing corporation, including, without limitation, by timely payment
of fees to the Depository Trust Company or such other established clearing corporation in connection with such electronic transfer. In
addition, the Company shall hold an annual or special meeting of stockholders on or prior to the date that is ninety (90) days following
the Closing Date for the purpose of obtaining Stockholder Approval, with the recommendation of the Company&rsquo;s Board of Directors
that such proposals are approved, and the company shall solicit proxies from its stockholders in connection therewith in the same manner
as all other management proposals in such proxy statement and all management appointed proxyholders shall vote their proxies in favor
of such proposals. The Company shall file such proxy statement within twenty (20) days following the Closing Date and use the record
date that was previously set on May 13, 2025 for the annual or special meeting to seek Stockholder Approval. If the company does not
obtain Stockholder Approval at the first meeting, the Company shall call a meeting every ninety (90) days thereafter to seek Stockholder
Approval until the earlier of the date on which Stockholder Approval is obtained or the Common Warrants are no longer outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">4.11
[RESERVED]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.12
<U>Subsequent Equity Sales</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
From the date hereof until thirty (30) days after the Effective Date, neither the Company nor any Subsidiary shall (i) issue, enter into
any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents or (ii)
file any registration statement or any amendment or supplement thereto, in each case other than as contemplated pursuant to the Registration
Rights Agreement, or the filing of any amendment or supplement to any existing registration statement for an &ldquo;at the market&rdquo;
offering with the Placement Agent as sales agent, or the filing of a registration statement on Form S-8 in connection with any employee
benefit plan of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
From the date hereof until one (1) year after the Effective Date, the Company shall be prohibited from effecting or entering into an
agreement to effect any issuance by the Company or any of its Subsidiaries of shares of Common Stock or Common Stock Equivalents (or
a combination of units thereof) involving a Variable Rate Transaction. &ldquo;<U>Variable Rate Transaction</U>&rdquo; means a transaction
in which the Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable for, or
include the right to receive, additional shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or
other price that is based upon, and/or varies with, the trading prices of or quotations for the shares of Common Stock at any time after
the initial issuance of such debt or equity securities or (B) with a conversion, exercise or exchange price that is subject to being
reset at some future date after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent
events directly or indirectly related to the business of the Company or the market for the Common Stock or (ii) enters into, or effects
a transaction under, any agreement, including, but not limited to, an equity line of credit or an &ldquo;at-the-market offering&rdquo;,
whereby the Company may issue securities at a future determined price, regardless of whether shares pursuant to such agreement have actually
been issued and regardless of whether such agreement is subsequently canceled; <U>provided</U>, <U>however</U>, that, after prohibition
period in Section 4.12(a) herein, the entry into and/or issuance of shares of Common Stock in an &ldquo;at the market&rdquo; offering
with the Placement Agent as sales agent shall not be deemed a Variable Rate Transaction. Any Purchaser shall be entitled to obtain injunctive
relief against the Company to preclude any such issuance, which remedy shall be in addition to any right to collect damages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Notwithstanding the foregoing, this Section 4.12 shall not apply in respect of an Exempt Issuance, except that no Variable Rate Transaction
shall be an Exempt Issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.13
<U>Equal Treatment of Purchasers</U>. No consideration (including any modification of this Agreement) shall be offered or paid to any
Person to amend or consent to a waiver or modification of any provision of this Agreement unless the same consideration is also offered
to all of the parties to this Agreement. For clarification purposes, this provision constitutes a separate right granted to each Purchaser
by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers as a class and shall
not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition or voting of
Securities or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.14
<U>Certain Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that
neither it, nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including
Short Sales, of any of the Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at
such time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as
described in Section 4.4. Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the
transactions contemplated by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described
in Section 4.4, such Purchaser will maintain the confidentiality of the existence and terms of this transaction and the information included
in the Disclosure Schedules (other than as disclosed to its legal and other representatives). N<FONT STYLE="color: windowtext">otwithstanding
the foregoing and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees
that (i) no Purchaser makes any representation, warranty or covenant hereby that it will not engage in effecting transactions in any
securities of the Company after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to
the initial press release as described in Section 4.4, (ii) no Purchaser shall be restricted or prohibited from effecting any transactions
in any securities of the Company in accordance with applicable securities laws from and after the time that the transactions contemplated
by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4 and (iii) no Purchaser
shall have any duty of confidentiality or duty not to trade in the securities of the Company to the Company, any of its Subsidiaries,
or any of their respective officers, directors, employees, Affiliates or agent, including , without limitation, the Placement Agent after
the issuance of the initial press release as described in Section 4.4. </FONT>Notwithstanding the foregoing, in the case of a Purchaser
that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s assets
and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions
of such Purchaser&rsquo;s assets, the covenant set forth above shall only apply with respect to the portion of assets managed by the
portfolio manager that made the investment decision to purchase the Securities covered by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.15
<U>Form D; Blue Sky Filings</U>. The Company agrees to timely file a Form D with respect to the Securities as required under Regulation
D and to provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such action as the Company shall reasonably
determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchasers at the Closing under
applicable securities or &ldquo;Blue Sky&rdquo; laws of the states of the United States, and shall provide evidence of such actions promptly
upon request of any Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.16
<U>Capital Changes</U>. Until the one year anniversary of the Effective Date, the Company shall not undertake a reverse or forward stock
split or reclassification of the Common Stock without the prior written consent of the Purchasers holding a majority in interest of the
Shares and Prefunded Warrants other than in connection with a reverse stock split of the Common Stock that is required, in the good faith
determination of the Board of Directors, to maintain the listing of the Common Stock on the Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.17
<U>Acknowledgment of Dilution</U>. The Company acknowledges that the issuance of the Securities may result in dilution of the outstanding
shares of Common Stock, which dilution may be substantial under certain market conditions. The Company further acknowledges that its
obligations under the Transaction Documents, including, without limitation, its obligation to issue the Shares and Warrant Shares pursuant
to the Transaction Documents, are unconditional and absolute and not subject to any right of set off, counterclaim, delay or reduction,
regardless of the effect of any such dilution or any claim the Company may have against any Purchaser and regardless of the dilutive
effect that such issuance may have on the ownership of the other stockholders of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.18
<U>Exercise Procedures</U>. The form of Notice of Exercise included in the Warrants set forth the totality of the procedures required
of the Purchasers in order to exercise the Warrants. No additional legal opinion, other information or instructions shall be required
of the Purchasers to exercise their Warrants. Without limiting the preceding sentences, no ink-original Notice of Exercise shall be required,
nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required in order to
exercise the Warrants. The Company shall honor exercises of the Warrants and shall deliver Warrant Shares in accordance with the terms,
conditions and time periods set forth in the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.19
<U>Lock-Up Agreements</U>. The Company shall not amend, modify, waive or terminate any provision of any of the Lock-Up Agreements except
to extend the term of the lock-up period and shall enforce the provisions of each Lock-Up Agreement in accordance with its terms. If
any party to a Lock-Up Agreement breaches any provision of a Lock-Up Agreement, the Company shall promptly use its best efforts to seek
specific performance of the terms of such Lock-Up Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
V.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>MISCELLANEOUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
<U>Termination</U>. This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without
any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the
Closing has not been consummated on or before the fifth (5<SUP>th</SUP>) Trading Day following the date hereof; <U>provided</U>, <U>however</U>,
that no such termination will affect the right of any party to sue for any breach by any other party (or parties).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
<U>Fees and Expenses</U>. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and
expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the
negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including,
without limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any exercise notice
delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.3
<U>Entire Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding
of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written,
with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.4
<U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in
writing and shall be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is
delivered via facsimile at the facsimile number or email attachment at the email address as set forth on the signature pages attached
hereto at or prior to 5:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such
notice or communication is delivered via email attachment at the email address as set forth on the signature pages attached hereto on
a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2<SUP>nd</SUP>) Trading
Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the
party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the signature
pages attached hereto. To the extent that any notice provided pursuant to any Transaction Documents constitutes, or contains, material,
non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the Commission
pursuant to a Current Report on Form 8-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.5
<U>Amendments; Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument
signed, in the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Shares and Prefunded
Warrants based on the initial Subscription Amounts hereunder (or, prior to the Closing, the Company and each Purchaser) or, in the case
of a waiver, by the party against whom enforcement of any such waived provision is sought, provided that if any amendment, modification
or waiver disproportionately and adversely impacts a Purchaser (or multiple Purchasers), the consent of such disproportionately impacted
Purchaser (or at least 50.1% in interest of such multiple Purchasers) shall also be required. No waiver of any default with respect to
any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any
subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party
to exercise any right hereunder in any manner impair the exercise of any such right. Any amendment effected in accordance with this Section
5.5 shall be binding upon each Purchaser and holder of Securities and the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.6
<U>Headings</U>. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to
limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.7
<U>Successors and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and
permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent
of each Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom
such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the
transferred Securities, by the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.8
<U>No Third-Party Beneficiaries</U>. The Placement Agent shall be the third party beneficiary of the representations, warranties, and
covenants of the Company in this Agreement and the representations, warranties, and covenants of the Purchasers in this Agreement. This
Agreement is intended for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the
benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise set forth in Section 4.8 and this Section
5.8.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.9
<U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents
shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the
principles of conflicts of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and
defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto
or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively
in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction
of the state and federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or
in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of
any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Action or Proceeding, any claim that
it is not personally subject to the jurisdiction of any such court, that such Action or Proceeding is improper or is an inconvenient
venue for such Proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any
such Action or Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery)
to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and
sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process
in any other manner permitted by law. If any party shall commence an Action or Proceeding to enforce any provisions of the Transaction
Documents, then, in addition to the obligations of the Company under Section 4.8, the prevailing party in such Action or Proceeding shall
be reimbursed by the non-prevailing party for its reasonable attorneys&rsquo; fees and other costs and expenses incurred with the investigation,
preparation and prosecution of such Action or Proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.10
<U>Survival</U>. The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.11
<U>Execution</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one
and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party,
it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery
of a &ldquo;.pdf&rdquo; format data file, such signature shall create a valid and binding obligation of the party executing (or on whose
behalf such signature is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; signature page were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.12
<U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to
be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.13
<U>Rescission and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions
of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction
Document and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may
rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election
in whole or in part without prejudice to its future actions and rights; <U>provided</U>, <U>however</U>, that, in the case of a rescission
of an exercise of a Warrant, the applicable Purchaser shall be required to return any shares of Common Stock subject to any such rescinded
exercise notice concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company for such shares and
the restoration of such Purchaser&rsquo;s right to acquire such shares pursuant to such Purchaser&rsquo;s Warrant (including, issuance
of a replacement warrant certificate evidencing such restored right).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.14
<U>Replacement of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed,
the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation),
or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to
the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also
pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.15
<U>Remedies</U>. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages,
each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that
monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction
Documents and hereby agree to waive and not to assert in any Action for specific performance of any such obligation the defense that
a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.16
<U>Payment Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document
or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise
or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by
or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including,
without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such
restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect
as if such payment had not been made or such enforcement or setoff had not occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.17
<U>Independent Nature of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document
are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance
or non-performance of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other
Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as
a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way
acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each
Purchaser shall be entitled to independently protect and enforce its rights including, without limitation, the rights arising out of
this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional
party in any Proceeding for such purpose. Each Purchaser has been represented by its own separate legal counsel in its review and negotiation
of the Transaction Documents. For reasons of administrative convenience only, each Purchaser and its respective counsel have chosen to
communicate with the Company through EGS. EGS does not represent any of the Purchasers and only represents the Placement Agent. The Company
has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not because
it was required or requested to do so by any of the Purchasers. It is expressly understood and agreed that each provision contained in
this Agreement and in each other Transaction Document is between the Company and a Purchaser, solely, and not between the Company and
the Purchasers collectively and not between and among the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.18
<U>Liquidated Damages</U>. The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction
Documents is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts
have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts
are due and payable shall have been canceled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.19
<U>Saturdays, Sundays, Holidays, etc.</U> If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.20
<U>Construction</U>. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise
the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against
the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each
and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the
date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.21
<B><U>WAIVER OF JURY TRIAL</U>. <U>IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY,
THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY,
IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY. </U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Signature
Pages Follow)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Imunon, INC.</B></FONT></P>

</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
    for Notice:</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line; width: 48%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Email:</U></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
    a copy to (which shall not constitute notice):</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNATURE
PAGE FOR PURCHASER FOLLOWS]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[PURCHASER
SIGNATURE PAGES TO <FONT STYLE="text-transform: uppercase">IMNN</FONT> SECURITIES PURCHASE AGREEMENT]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Purchaser: ________________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Purchaser</I>: __________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: ____________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: _____________________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email
Address of Authorized Signatory: ______________________________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
for Notice to Purchaser:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
for Delivery of Securities to Purchaser (if not same as address for notice):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription
Amount: $_________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares:
_________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prefunded
Warrant Shares: __________________ Beneficial Ownership Blocker &#9744;  4.99% or &#9744;  9.99%</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
Warrant Shares: __________________ Beneficial Ownership Blocker &#9744;  4.99% or &#9744;  9.99%</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EIN
Number: _______________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
PAGES CONTINUE]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 42; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>6
<FILENAME>ex10-2.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.2</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">REGISTRATION
RIGHTS AGREEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Registration Rights Agreement (this &ldquo;<U>Agreement</U>&rdquo;) is made and entered into as of May 23, 2025, between Imunon, Inc.,
a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), and each of the several purchasers signatory hereto (each such purchaser,
a &ldquo;<U>Purchaser</U>&rdquo; and, collectively, the &ldquo;<U>Purchasers</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Agreement is made pursuant to the Securities Purchase Agreement, dated as of the date hereof, between the Company and each Purchaser
(the &ldquo;<U>Purchase Agreement</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and each Purchaser hereby agrees as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Definitions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Capitalized
terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the
Purchase Agreement.</B> As used in this Agreement, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Advice</U>&rdquo;
shall have the meaning set forth in Section 6(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Effectiveness
Date</U>&rdquo; means, with respect to the Initial Registration Statement required to be filed hereunder, the 45<SUP>th</SUP> calendar
day following the date hereof (or, in the event of a &ldquo;full review&rdquo; by the Commission, the 75<SUP>th</SUP> calendar day following
the date hereof) and with respect to any additional Registration Statements which may be required pursuant to Section 2(c) or Section
3(c), the 45<SUP>th</SUP> calendar day following the date on which an additional Registration Statement is required to be filed hereunder
(or, in the event of a &ldquo;full review&rdquo; by the Commission, the 75<SUP>th</SUP> calendar day following the date such additional
Registration Statement is required to be filed hereunder); <U>provided</U>, <U>however</U>, that in the event the Company is notified
by the Commission that one or more of the above Registration Statements will not be reviewed or is no longer subject to further review
and comments, the Effectiveness Date as to such Registration Statement shall be the fifth Trading Day following the date on which the
Company is so notified if such date precedes the dates otherwise required above, provided, further, if such Effectiveness Date falls
on a day that is not a Trading Day, then the Effectiveness Date shall be the next succeeding Trading Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Effectiveness
Period</U>&rdquo; shall have the meaning set forth in Section 2(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Event</U>&rdquo;
shall have the meaning set forth in Section 2(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Event
Date</U>&rdquo; shall have the meaning set forth in Section 2(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Filing
Date</U>&rdquo; means, with respect to the Initial Registration Statement required hereunder, the 15<SUP>th</SUP> calendar day following
the date hereof and, with respect to any additional Registration Statements which may be required pursuant to Section 2(c) or Section
3(c), the earliest practical date on which the Company is permitted by SEC Guidance to file such additional Registration Statement related
to the Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Holder</U>&rdquo;
or &ldquo;<U>Holders</U>&rdquo; means the holder or holders, as the case may be, from time to time of Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indemnified
Party</U>&rdquo; shall have the meaning set forth in Section 5(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Indemnifying
Party</U>&rdquo; shall have the meaning set forth in Section 5(c).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Initial
Registration Statement</U>&rdquo; means the initial Registration Statement filed pursuant to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Losses</U>&rdquo;
shall have the meaning set forth in Section 5(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Plan
of Distribution</U>&rdquo; shall have the meaning set forth in Section 2(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Prospectus</U>&rdquo;
means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information
previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated by the
Commission pursuant to the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the
offering of any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to
the Prospectus, including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference
in such Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registrable
Securities</U>&rdquo; means, as of any date of determination, (a) all Shares, (b) all Warrant Shares then issued and issuable upon exercise
of the Warrants (assuming on such date the Warrants are exercised in full without regard to any exercise limitations therein), (c) any
additional shares of Common Stock issued and issuable in connection with any anti-dilution provisions in the Warrants (without giving
effect to any limitations on exercise set forth in the Warrants) and (d) any securities issued or then issuable upon any stock split,
dividend or other distribution, recapitalization or similar event with respect to the foregoing; <U>provided, however</U>, that any such
Registrable Securities shall cease to be Registrable Securities (and the Company shall not be required to maintain the effectiveness
of any, or file another, Registration Statement hereunder with respect thereto) for so long as (a) a Registration Statement with respect
to the sale of such Registrable Securities is declared effective by the Commission under the Securities Act and such Registrable Securities
have been disposed of by the Holder in accordance with such effective Registration Statement, (b) such Registrable Securities have been
previously sold in accordance with Rule 144, or (c) such securities become eligible for resale without volume or manner-of-sale restrictions
and without current public information pursuant to Rule 144 as set forth in a written opinion letter to such effect, addressed, delivered
and acceptable to the Transfer Agent and the affected Holders (assuming that such securities and any securities issuable upon exercise,
conversion or exchange of which, or as a dividend upon which, such securities were issued or are issuable, were at no time held by any
Affiliate of the Company, as reasonably determined by the Company, upon the advice of counsel to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Registration
Statement</U>&rdquo; means any registration statement required to be filed hereunder pursuant to Section 2(a) and any additional registration
statements contemplated by Section 2(c) or Section 3(c), including (in each case) the Prospectus, amendments and supplements to any such
registration statement or Prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material incorporated
by reference or deemed to be incorporated by reference in any such registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
415</U>&rdquo; means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Rule
424</U>&rdquo; means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>Selling
Stockholder Questionnaire</U>&rdquo; shall have the meaning set forth in Section 3(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<U>SEC
Guidance</U>&rdquo; means (i) any publicly-available written or oral guidance of the Commission staff, or any comments, requirements
or requests of the Commission staff and (ii) the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Shelf Registration</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
On or prior to each Filing Date, the Company shall prepare and file with the Commission a Registration Statement covering the resale
of all of the Registrable Securities that are not then registered on an effective Registration Statement for an offering to be made on
a continuous basis pursuant to Rule 415. Each Registration Statement filed hereunder shall be on Form S-3 (except if the Company is not
then eligible to register for resale the Registrable Securities on Form S-3, in which case such registration shall be on another appropriate
form in accordance herewith, subject to the provisions of Section 2(e)) and shall contain (unless otherwise directed by at least 85%
in interest of the Holders) substantially the &ldquo;<U>Plan of Distribution</U>&rdquo; attached hereto as <U>Annex A</U> and substantially
the &ldquo;<U>Selling Stockholder</U>&rdquo; section attached hereto as <U>Annex B</U>; <U>provided</U>, <U>however</U>, that no Holder
shall be required to be named as an &ldquo;underwriter&rdquo; without such Holder&rsquo;s express prior written consent. Subject to the
terms of this Agreement, the Company shall use its best efforts to cause a Registration Statement filed under this Agreement (including,
without limitation, under Section 3(c)) to be declared effective under the Securities Act as promptly as possible after the filing thereof,
but in any event no later than the applicable Effectiveness Date, and shall use its best efforts to keep such Registration Statement
continuously effective under the Securities Act until the date that all Registrable Securities covered by such Registration Statement
(i) have been sold, thereunder or pursuant to Rule 144, or (ii) may be sold without volume or manner-of-sale restrictions pursuant to
Rule 144 and without the requirement for the Company to be in compliance with the current public information requirement under Rule 144,
as determined by the counsel to the Company pursuant to a written opinion letter to such effect, addressed and acceptable to the Transfer
Agent and the affected Holders (the &ldquo;<U>Effectiveness Period</U>&rdquo;). The Company shall telephonically request effectiveness
of a Registration Statement as of 5:00 p.m. (New York City time) on a Trading Day. The Company shall immediately notify the Holders via
e-mail of the effectiveness of a Registration Statement on the same Trading Day that the Company telephonically confirms effectiveness
with the Commission, which shall be the date requested for effectiveness of such Registration Statement. The Company shall, by 9:30 a.m.
(New York City time) on the Trading Day after the effective date of such Registration Statement, file a final Prospectus with the Commission
as required by Rule 424. Failure to so notify the Holder within one (1) Trading Day of such notification of effectiveness or failure
to file a final Prospectus as foresaid shall be deemed an Event under Section 2(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Notwithstanding the registration obligations set forth in Section 2(a), if the Commission informs the Company that all of the Registrable
Securities cannot, as a result of the application of Rule 415, be registered for resale as a secondary offering on a single registration
statement, the Company agrees to promptly inform each of the Holders thereof and use its commercially reasonable efforts to file amendments
to the Initial Registration Statement as required by the Commission, covering the maximum number of Registrable Securities permitted
to be registered by the Commission, on Form S-3 or such other form available to register for resale the Registrable Securities as a secondary
offering, subject to the provisions of Section 2(e); with respect to filing on Form S-3 or other appropriate form, and subject to the
provisions of Section 2(d) with respect to the payment of liquidated damages; <U>provided</U>, <U>however</U>, that prior to filing such
amendment, the Company shall be obligated to use its commercially reasonable efforts to advocate with the Commission for the registration
of all of the Registrable Securities in accordance with the SEC Guidance, including without limitation, Compliance and Disclosure Interpretation
612.09.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Notwithstanding any other provision of this Agreement and subject to the payment of liquidated damages pursuant to Section 2(d), if the
Commission or any SEC Guidance sets forth a limitation on the number of Registrable Securities permitted to be registered on a particular
Registration Statement as a secondary offering (and notwithstanding that the Company used diligent efforts to advocate with the Commission
for the registration of all or a greater portion of Registrable Securities), unless otherwise directed in writing by a Holder as to its
Registrable Securities, the number of Registrable Securities to be registered on such Registration Statement will be reduced as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">First,
    the Company shall reduce or eliminate any securities to be included other than Registrable Securities;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second,
    the Company shall reduce Registrable Securities represented by Common Warrant Shares (applied, in the case that some Common Warrant
    Shares may be registered, to the Holders on a pro rata basis based on the total number of unregistered Common Warrant Shares held
    by such Holders); and</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Third,
    the Company shall reduce Registrable Securities represented by Shares and Prefunded Warrant Shares (applied, in the case that some
    Shares and Prefunded Warrant Shares may be registered, to the Holders on a pro rata basis based on the total number of unregistered
    Shares and Prefunded Warrant Shares held by such Holders). </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of a cutback hereunder, the Company shall give the Holder at least three (3) Trading Days prior written notice along with the
calculations as to such Holder&rsquo;s allotment. In the event the Company amends the Initial Registration Statement in accordance with
the foregoing, the Company will use its best efforts to file with the Commission, as promptly as allowed by Commission or SEC Guidance
provided to the Company or to registrants of securities in general, one or more registration statements on Form S-3 or such other form
available to register for resale those Registrable Securities that were not registered for resale on the Initial Registration Statement,
as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
If: (i) the Initial Registration Statement is not filed on or prior to its Filing Date (if the Company files the Initial Registration
Statement without affording the Holders the opportunity to review and comment on the same as required by Section 3(a) herein or the Company
subsequent withdraws the filing of the Registration Statement, the Company shall be deemed to have not satisfied this clause (i) as of
the Filing Date), or (ii) the Company fails to file with the Commission a request for acceleration of a Registration Statement in accordance
with Rule 461 promulgated by the Commission pursuant to the Securities Act, within five Trading Days of the date that the Company is
notified (orally or in writing, whichever is earlier) by the Commission that such Registration Statement will not be &ldquo;reviewed&rdquo;
or will not be subject to further review, or (iii) prior to the effective date of a Registration Statement, the Company fails to file
a pre-effective amendment and otherwise respond in writing to comments made by the Commission in respect of such Registration Statement
within ten (10) calendar days after the receipt of comments by or notice from the Commission that such amendment is required in order
for such Registration Statement to be declared effective, or (iv) a Registration Statement registering for resale all of the Registrable
Securities is not declared effective by the Commission by the Effectiveness Date of the Initial Registration Statement (provided that,
if the Registration Statement does not allow for the resale of Registrable Securities at prevailing market prices (i.e., only allows
for fixed price sales), the Company shall have been deemed to have not satisfied this clause) or (v) after the effective date of a Registration
Statement, such Registration Statement ceases for any reason to remain continuously effective as to all Registrable Securities included
in such Registration Statement, or the Holders are otherwise not permitted to utilize the Prospectus therein to resell such Registrable
Securities, for more than ten (10) consecutive calendar days or more than an aggregate of fifteen (15) calendar days (which need not
be consecutive calendar days) during any 12-month period (any such failure or breach being referred to as an &ldquo;<U>Event</U>&rdquo;,
and for purposes of clauses (i) and (iv), the date on which such Event occurs, and for purpose of clause (ii) the date on which such
five (5) Trading Day period is exceeded, and for purpose of clause (iii) the date which such ten (10) calendar day period is exceeded,
and for purpose of clause (v) the date on which such ten (10) or fifteen (15) calendar day period, as applicable, is exceeded being referred
to as &ldquo;<U>Event Date</U>&rdquo;), then, in addition to any other rights the Holders may have hereunder or under applicable law,
on each such Event Date and on each monthly anniversary of each such Event Date (if the applicable Event shall not have been cured by
such date) until the applicable Event is cured, the Company shall pay to each Holder an amount in cash, as partial liquidated damages
and not as a penalty, equal to the product of 2.0% multiplied by the aggregate Subscription Amount paid by such Holder pursuant
to the Purchase Agreement. If the Company fails to pay any partial liquidated damages pursuant to this Section in full within seven days
after the date payable, the Company will pay interest thereon at a rate of 15% per annum (or such lesser maximum amount that is permitted
to be paid by applicable law) to the Holder, accruing daily from the date such partial liquidated damages are due until such amounts,
plus all such interest thereon, are paid in full. The partial liquidated damages pursuant to the terms hereof shall apply on a daily
pro rata basis for any portion of a month prior to the cure of an Event.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
If Form S-3 is not available for the registration of the resale of Registrable Securities hereunder, the Company shall (i) register the
resale of the Registrable Securities on another appropriate form and (ii) undertake to register the Registrable Securities on Form S-3
as soon as such form is available, provided that the Company shall maintain the effectiveness of the Registration Statement then in effect
until such time as a Registration Statement on Form S-3 covering the Registrable Securities has been declared effective by the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
Notwithstanding anything to the contrary contained herein, in no event shall the Company be permitted to name any Holder or affiliate
of a Holder as any &ldquo;underwriter&rdquo; without the prior written consent of such Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>Registration Procedures</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Company&rsquo;s registration obligations hereunder, the Company shall:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Not less than five (5) Trading Days prior to the filing of each Registration Statement and not less than one (1) Trading Day prior to
the filing of any related Prospectus or any amendment or supplement thereto (including any document that would be incorporated or deemed
to be incorporated therein by reference), the Company shall (i) furnish to each Holder copies of all such documents proposed to be filed,
which documents (other than those incorporated or deemed to be incorporated by reference) will be subject to the review of such Holders,
and (ii) cause its officers and directors, counsel and independent registered public accountants to respond to such inquiries as shall
be necessary, in the reasonable opinion of respective counsel to each Holder, to conduct a reasonable investigation within the meaning
of the Securities Act. The Company shall not file a Registration Statement or any such Prospectus or any amendments or supplements thereto
to which the Holders of a majority of the Registrable Securities shall reasonably object in good faith, provided that, the Company is
notified of such objection in writing no later than five (5) Trading Days after the Holders have been so furnished copies of a Registration
Statement or one (1) Trading Day after the Holders have been so furnished copies of any related Prospectus or amendments or supplements
thereto. Each Holder agrees to furnish to the Company a completed questionnaire in the form attached to this Agreement as <U>Annex C</U>
(a &ldquo;<U>Selling Stockholder Questionnaire</U>&rdquo;) on a date that is not less than two (2) Trading Days prior to the Filing Date
or by the end of the fourth (4<SUP>th</SUP>) Trading Day following the date on which such Holder receives draft materials in accordance
with this Section.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
(i) Prepare and file with the Commission such amendments, including post-effective amendments, to a Registration Statement and the Prospectus
used in connection therewith as may be necessary to keep a Registration Statement continuously effective as to the applicable Registrable
Securities for the Effectiveness Period and prepare and file with the Commission such additional Registration Statements in order to
register for resale under the Securities Act all of the Registrable Securities, (ii) cause the related Prospectus to be amended or supplemented
by any required Prospectus supplement (subject to the terms of this Agreement), and, as so supplemented or amended, to be filed pursuant
to Rule 424, (iii) respond as promptly as reasonably possible to any comments received from the Commission with respect to a Registration
Statement or any amendment thereto and provide as promptly as reasonably possible to the Holders true and complete copies of all correspondence
from and to the Commission relating to a Registration Statement (provided that, the Company shall excise any information contained therein
which would constitute material non-public information regarding the Company or any of its Subsidiaries), and (iv) comply in all material
respects with the applicable provisions of the Securities Act and the Exchange Act with respect to the disposition of all Registrable
Securities covered by a Registration Statement during the applicable period in accordance (subject to the terms of this Agreement) with
the intended methods of disposition by the Holders thereof set forth in such Registration Statement as so amended or in such Prospectus
as so supplemented.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
If during the Effectiveness Period, the number of Registrable Securities at any time exceeds 100% of the number of shares of Common Stock
then registered in a Registration Statement, then the Company shall file as soon as reasonably practicable, but in any case prior to
the applicable Filing Date, an additional Registration Statement covering the resale by the Holders of not less than the number of such
Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Notify the Holders of Registrable Securities to be sold (which notice shall, pursuant to clauses (iii) through (vi) hereof, be accompanied
by an instruction to suspend the use of the Prospectus until the requisite changes have been made) as promptly as reasonably possible
(and, in the case of (i)(A) below, not less than one (1) Trading Day prior to such filing) and (if requested by any such Person) confirm
such notice in writing no later than one (1) Trading Day following the day (i)(A) when a Prospectus or any Prospectus supplement or post-effective
amendment to a Registration Statement is proposed to be filed, (B) when the Commission notifies the Company whether there will be a &ldquo;review&rdquo;
of such Registration Statement and whenever the Commission comments in writing on such Registration Statement, and (C) with respect to
a Registration Statement or any post-effective amendment, when the same has become effective, (ii) of any request by the Commission or
any other federal or state governmental authority for amendments or supplements to a Registration Statement or Prospectus or for additional
information, (iii) of the issuance by the Commission or any other federal or state governmental authority of any stop order suspending
the effectiveness of a Registration Statement covering any or all of the Registrable Securities or the initiation of any Proceedings
for that purpose, (iv) of the receipt by the Company of any notification with respect to the suspension of the qualification or exemption
from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any Proceeding
for such purpose, (v) of the occurrence of any event or passage of time that makes the financial statements included in a Registration
Statement ineligible for inclusion therein or any statement made in a Registration Statement or Prospectus or any document incorporated
or deemed to be incorporated therein by reference untrue in any material respect or that requires any revisions to a Registration Statement,
Prospectus or other documents so that, in the case of a Registration Statement or the Prospectus, as the case may be, it will not contain
any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they were made, not misleading, and (vi) of the occurrence or existence of any pending
corporate development with respect to the Company that the Company believes may be material and that, in the determination of the Company,
makes it not in the best interest of the Company to allow continued availability of a Registration Statement or Prospectus; <U>provided</U>,
<U>however</U>, that in no event shall any such notice contain any information which would constitute material, non-public information
regarding the Company or any of its Subsidiaries, and the Company agrees that the Holders shall not have any duty of confidentiality
to the Company or any of its Subsidiaries and shall not have any duty to the Company or any of its Subsidiaries not to trade on the basis
of such information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Use its best efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order stopping or suspending the effectiveness
of a Registration Statement, or (ii) any suspension of the qualification (or exemption from qualification) of any of the Registrable
Securities for sale in any jurisdiction, at the earliest practicable moment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
Furnish to each Holder, without charge, at least one conformed copy of each such Registration Statement and each amendment thereto, including
financial statements and schedules, all documents incorporated or deemed to be incorporated therein by reference to the extent requested
by such Person, and all exhibits to the extent requested by such Person (including those previously furnished or incorporated by reference)
promptly after the filing of such documents with the Commission, provided that any such item which is available on the EDGAR system (or
successor thereto) need not be furnished in physical form.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
Subject to the terms of this Agreement, the Company hereby consents to the use of such Prospectus and each amendment or supplement thereto
by each of the selling Holders in connection with the offering and sale of the Registrable Securities covered by such Prospectus and
any amendment or supplement thereto, except after the giving of any notice pursuant to Section 3(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
Prior to any resale of Registrable Securities by a Holder, use its commercially reasonable efforts to register or qualify or cooperate
with the selling Holders in connection with the registration or qualification (or exemption from the registration or qualification) of
such Registrable Securities for the resale by the Holder under the securities or Blue Sky laws of such jurisdictions within the United
States as any Holder reasonably requests in writing, to keep each registration or qualification (or exemption therefrom) effective during
the Effectiveness Period and to do any and all other acts or things reasonably necessary to enable the disposition in such jurisdictions
of the Registrable Securities covered by each Registration Statement, provided that the Company shall not be required to qualify generally
to do business in any jurisdiction where it is not then so qualified, subject the Company to any material tax in any such jurisdiction
where it is not then so subject or file a general consent to service of process in any such jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
If requested by a Holder, cooperate with such Holder to facilitate the timely preparation and delivery of certificates representing Registrable
Securities to be delivered to a transferee pursuant to a Registration Statement, which certificates shall be free, to the extent permitted
by the Purchase Agreement, of all restrictive legends, and to enable such Registrable Securities to be in such denominations and registered
in such names as any such Holder may request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
Upon the occurrence of any event contemplated by Section 3(d), as promptly as reasonably possible under the circumstances taking into
account the Company&rsquo;s good faith assessment of any adverse consequences to the Company and its stockholders of the premature disclosure
of such event, prepare a supplement or amendment, including a post-effective amendment, to a Registration Statement or a supplement to
the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, and file any other required document
so that, as thereafter delivered, neither a Registration Statement nor such Prospectus will contain an untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
under which they were made, not misleading. <FONT STYLE="text-decoration: none double">If the Company notifies the Holders in accordance
with clauses (iii) through (vi) of Section 3(d) above to suspend the use of any Prospectus until the requisite changes to such Prospectus
have been made, then the Holders shall suspend use of such Prospectus. The Company will use its best efforts to ensure that the use of
the Prospectus may be resumed as promptly as is practicable. The Company shall be entitled to exercise its right under this Section 3(j)
to suspend the availability of a Registration Statement and Prospectus, subject to the payment of partial liquidated damages otherwise
required pursuant to Section 2(d), for a period not to exceed 60 calendar days (which need not be consecutive days) in any 12-month period</FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
Otherwise use commercially reasonable efforts to comply with all applicable rules and regulations of the Commission under the Securities
Act and the Exchange Act, including, without limitation, Rule 172 under the Securities Act, file any final Prospectus, including any
supplement or amendment thereof, with the Commission pursuant to Rule 424 under the Securities Act, promptly inform the Holders in writing
if, at any time during the Effectiveness Period, the Company does not satisfy the conditions specified in Rule 172 and, as a result thereof,
the Holders are required to deliver a Prospectus in connection with any disposition of Registrable Securities and take such other actions
as may be reasonably necessary to facilitate the registration of the Registrable Securities hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
The Company shall use its best efforts to maintain eligibility for use of Form S-3 (or any successor form thereto) for the registration
of the resale of Registrable Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
The Company may require each selling Holder to furnish to the Company a certified statement as to the number of shares of Common Stock
beneficially owned by such Holder and, if required by the Commission, the natural persons thereof that have voting and dispositive control
over the shares. During any periods that the Company is unable to meet its obligations hereunder with respect to the registration of
the Registrable Securities solely because any Holder fails to furnish such information within three Trading Days of the Company&rsquo;s
request, any liquidated damages that are accruing at such time as to such Holder only shall be tolled and any Event that may otherwise
occur solely because of such delay shall be suspended as to such Holder only, until such information is delivered to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<U>Registration Expenses</U>. All fees and expenses incident to the performance of or compliance with, this Agreement by the Company
shall be borne by the Company whether or not any Registrable Securities are sold pursuant to a Registration Statement. The fees and expenses
referred to in the foregoing sentence shall include, without limitation, (i) all registration and filing fees (including, without limitation,
fees and expenses of the Company&rsquo;s counsel and independent registered public accountants) (A) with respect to filings made with
the Commission, (B) with respect to filings required to be made with any Trading Market on which the Common Stock is then listed for
trading, and (C) in compliance with applicable state securities or Blue Sky laws reasonably agreed to by the Company in writing (including,
without limitation, fees and disbursements of counsel for the Company in connection with Blue Sky qualifications or exemptions of the
Registrable Securities), (ii) printing expenses (including, without limitation, expenses of printing certificates for Registrable Securities),
(iii) messenger, telephone and delivery expenses, (iv) fees and disbursements of counsel for the Company, (v) Securities Act liability
insurance, if the Company so desires such insurance, and (vi) fees and expenses of all other Persons retained by the Company in connection
with the consummation of the transactions contemplated by this Agreement. In addition, the Company shall be responsible for all of its
internal expenses incurred in connection with the consummation of the transactions contemplated by this Agreement (including, without
limitation, all salaries and expenses of its officers and employees performing legal or accounting duties), the expense of any annual
audit and the fees and expenses incurred in connection with the listing of the Registrable Securities on any securities exchange as required
hereunder. In no event shall the Company be responsible for any broker or similar commissions of any Holder or, except to the extent
provided for in the Transaction Documents, any legal fees or other costs of the Holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<U>Indemnification</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Indemnification by the Company</U>. The Company shall, notwithstanding any termination of this Agreement, indemnify and hold harmless
each Holder, the officers, directors, members, partners, agents, brokers (including brokers who offer and sell Registrable Securities
as principal as a result of a pledge or any failure to perform under a margin call of Common Stock), investment advisors and employees
(and any other Persons with a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any
other title) of each of them, each Person who controls any such Holder (within the meaning of Section 15 of the Securities Act or Section
20 of the Exchange Act) and the officers, directors, members, stockholders, partners, agents and employees (and any other Persons with
a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or any other title) of each such
controlling Person, to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities,
costs (including, without limitation, reasonable attorneys&rsquo; fees) and expenses (collectively, &ldquo;<U>Losses</U>&rdquo;), as
incurred, arising out of or relating to (1) any untrue or alleged untrue statement of a material fact contained in a Registration Statement,
any Prospectus or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of
or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements
therein (in the case of any Prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading
or (2) any violation by the Company of the Securities Act, the Exchange Act or any state securities law, or any rule or regulation thereunder,
in connection with the performance of its obligations under this Agreement, except to the extent, but only to the extent, that (i) such
untrue statements or omissions are based solely upon information regarding such Holder furnished in writing to the Company by such Holder
expressly for use therein, or to the extent that such information relates to such Holder or such Holder&rsquo;s proposed method of distribution
of Registrable Securities and was reviewed and approved in writing by such Holder expressly for use in a Registration Statement, such
Prospectus or in any amendment or supplement thereto (it being understood that the Holder has approved Annex A hereto for this purpose)
or (ii) in the case of an occurrence of an event of the type specified in Section 3(d)(iii)-(vi), the use by such Holder of an outdated,
defective or otherwise unavailable Prospectus after the Company has notified such Holder in writing that the Prospectus is outdated,
defective or otherwise unavailable for use by such Holder and prior to the receipt by such Holder of the Advice contemplated in Section
6(c). The Company shall notify the Holders promptly of the institution, threat or assertion of any Proceeding arising from or in connection
with the transactions contemplated by this Agreement of which the Company is aware. Such indemnity shall remain in full force and effect
regardless of any investigation made by or on behalf of such indemnified person and shall survive the transfer of any Registrable Securities
by any of the Holders in accordance with Section 6(f).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Indemnification by Holders</U>. Each Holder shall, severally and not jointly, indemnify and hold harmless the Company, its directors,
officers, agents and employees, each Person who controls the Company (within the meaning of Section 15 of the Securities Act and Section
20 of the Exchange Act), and the directors, officers, agents or employees of such controlling Persons, to the fullest extent permitted
by applicable law, from and against all Losses, as incurred, to the extent arising out of or based solely upon: any untrue or alleged
untrue statement of a material fact contained in any Registration Statement, any Prospectus, or in any amendment or supplement thereto
or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be
stated therein or necessary to make the statements therein (in the case of any Prospectus or supplement thereto, in light of the circumstances
under which they were made) not misleading (i) to the extent, but only to the extent, that such untrue statement or omission is contained
in any information so furnished in writing by such Holder to the Company expressly for inclusion in such Registration Statement or such
Prospectus or (ii) to the extent, but only to the extent, that such information relates to such Holder&rsquo;s information provided in
the Selling Stockholder Questionnaire or the proposed method of distribution of Registrable Securities and was reviewed and expressly
approved in writing by such Holder expressly for use in a Registration Statement (it being understood that the Holder has approved Annex
A hereto for this purpose), such Prospectus or in any amendment or supplement thereto. In no event shall the liability of a selling Holder
be greater in amount than the dollar amount of the proceeds (net of all expenses paid by such Holder in connection with any claim relating
to this Section 5 and the amount of any damages such Holder has otherwise been required to pay by reason of such untrue statement or
omission) received by such Holder upon the sale of the Registrable Securities included in the Registration Statement giving rise to such
indemnification obligation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Conduct of Indemnification Proceedings</U>. If any Proceeding shall be brought or asserted against any Person entitled to indemnity
hereunder (an &ldquo;<U>Indemnified Party</U>&rdquo;), such Indemnified Party shall promptly notify the Person from whom indemnity is
sought (the &ldquo;<U>Indemnifying Party</U>&rdquo;) in writing, and the Indemnifying Party shall have the right to assume the defense
thereof, including the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all fees and expenses
incurred in connection with defense thereof, provided that the failure of any Indemnified Party to give such notice shall not relieve
the Indemnifying Party of its obligations or liabilities pursuant to this Agreement, except (and only) to the extent that it shall be
finally determined by a court of competent jurisdiction (which determination is not subject to appeal or further review) that such failure
shall have materially and adversely prejudiced the Indemnifying Party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
Indemnified Party shall have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof, but
the fees and expenses of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1) the Indemnifying Party
has agreed in writing to pay such fees and expenses, (2) the Indemnifying Party shall have failed promptly to assume the defense of such
Proceeding and to employ counsel reasonably satisfactory to such Indemnified Party in any such Proceeding, or (3) the named parties to
any such Proceeding (including any impleaded parties) include both such Indemnified Party and the Indemnifying Party, and counsel to
the Indemnified Party shall reasonably believe that a material conflict of interest is likely to exist if the same counsel were to represent
such Indemnified Party and the Indemnifying Party (in which case, if such Indemnified Party notifies the Indemnifying Party in writing
that it elects to employ separate counsel at the expense of the Indemnifying Party, the Indemnifying Party shall not have the right to
assume the defense thereof and the reasonable fees and expenses of no more than one separate counsel shall be at the expense of the Indemnifying
Party). The Indemnifying Party shall not be liable for any settlement of any such Proceeding effected without its written consent, which
consent shall not be unreasonably withheld or delayed. No Indemnifying Party shall, without the prior written consent of the Indemnified
Party, effect any settlement of any pending Proceeding in respect of which any Indemnified Party is a party, unless such settlement includes
an unconditional release of such Indemnified Party from all liability on claims that are the subject matter of such Proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the terms of this Agreement, all reasonable fees and expenses of the Indemnified Party (including reasonable fees and expenses to
the extent incurred in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section)
shall be paid to the Indemnified Party, as incurred, within ten Trading Days of written notice thereof to the Indemnifying Party, provided
that the Indemnified Party shall promptly reimburse the Indemnifying Party for that portion of such fees and expenses applicable to such
actions for which such Indemnified Party is finally determined by a court of competent jurisdiction (which determination is not subject
to appeal or further review) not to be entitled to indemnification hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Contribution</U>. If the indemnification under Section 5(a) or 5(b) is unavailable to an Indemnified Party or insufficient to hold
an Indemnified Party harmless for any Losses, then each Indemnifying Party shall contribute to the amount paid or payable by such Indemnified
Party, in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party in connection
with the actions, statements or omissions that resulted in such Losses as well as any other relevant equitable considerations. The relative
fault of such Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether any action in
question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission of a material fact, has
been taken or made by, or relates to information supplied by, such Indemnifying Party or Indemnified Party, and the parties&rsquo; relative
intent, knowledge, access to information and opportunity to correct or prevent such action, statement or omission. The amount paid or
payable by a party as a result of any Losses shall be deemed to include, subject to the limitations set forth in this Agreement, any
reasonable attorneys&rsquo; or other fees or expenses incurred by such party in connection with any Proceeding to the extent such party
would have been indemnified for such fees or expenses if the indemnification provided for in this Section was available to such party
in accordance with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 5(d) were determined by pro rata
allocation or by any other method of allocation that does not take into account the equitable considerations referred to in the immediately
preceding paragraph. In no event shall the contribution obligation of a Holder of Registrable Securities be greater in amount than the
dollar amount of the proceeds (net of all expenses paid by such Holder in connection with any claim relating to this Section 5 and the
amount of any damages such Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission
or alleged omission) received by it upon the sale of the Registrable Securities giving rise to such contribution obligation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
indemnity and contribution agreements contained in this Section are in addition to any liability that the Indemnifying Parties may have
to the Indemnified Parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Remedies</U>. In the event of a breach by the Company or by a Holder of any of their respective obligations under this Agreement,
each Holder or the Company, as the case may be, in addition to being entitled to exercise all rights granted by law and under this Agreement,
including recovery of damages, shall be entitled to specific performance of its rights under this Agreement. Each of the Company and
each Holder agrees that monetary damages would not provide adequate compensation for any losses incurred by reason of a breach by it
of any of the provisions of this Agreement and hereby further agrees that, in the event of any action for specific performance in respect
of such breach, it shall not assert or shall waive the defense that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>No Piggyback on Registrations; Prohibition on Filing Other Registration Statements</U>. Except for the shares of Common Stock issuable
upon exercise of any warrants issued to the Placement Agent in the transactions contemplated by the Purchase Agreement, neither the Company
nor any of its security holders (other than the Holders in such capacity pursuant hereto) may include securities of the Company in any
Registration Statements other than the Registrable Securities. The Company shall not file any other registration statements other than
the Registration Statement or Form S-8 relating to equity securities issuable in connection with the Company&rsquo;s share option or
other employee benefit plans, including inducement grants, during the prohibition period set forth in Section 4.12(a) of the Purchase
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Discontinued Disposition</U>. By its acquisition of Registrable Securities, each Holder agrees that, upon receipt of a notice from
the Company of the occurrence of any event of the kind described in Section 3(d)(iii) through (vi), such Holder will forthwith discontinue
disposition of such Registrable Securities under a Registration Statement until it is advised in writing (the &ldquo;<U>Advice</U>&rdquo;)
by the Company that the use of the applicable Prospectus (as it may have been supplemented or amended) may be resumed. The Company will
use its best efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable. The Company agrees and acknowledges
that any periods during which the Holder is required to discontinue the disposition of the Registrable Securities hereunder shall be
subject to the provisions of Section 2(d).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Amendments and Waivers</U>. The provisions of this Agreement, including the provisions of this sentence, may not be amended, modified
or supplemented, and waivers or consents to departures from the provisions hereof may not be given, unless the same shall be in writing
and signed by the Company and the Holders of 50.1% or more of the then outstanding Registrable Securities (for purposes of clarification,
this includes any Registrable Securities issuable upon exercise or conversion of any Security), provided that, if any amendment, modification
or waiver disproportionately and adversely impacts a Holder (or group of Holders), the consent of such disproportionately impacted Holder
(or group of Holders) shall be required. If a Registration Statement does not register all of the Registrable Securities pursuant to
a waiver or amendment done in compliance with the previous sentence, then the number of Registrable Securities to be registered for each
Holder shall be reduced pro rata among all Holders and each Holder shall have the right to designate which of its Registrable Securities
shall be omitted from such Registration Statement. Notwithstanding the foregoing, a waiver or consent to depart from the provisions hereof
with respect to a matter that relates exclusively to the rights of a Holder or some Holders and that does not directly or indirectly
affect the rights of other Holders may be given only by such Holder or Holders of all of the Registrable Securities to which such waiver
or consent relates; <U>provided</U>, <U>however</U>, that the provisions of this sentence may not be amended, modified, or supplemented
except in accordance with the provisions of the first sentence of this Section 6(d). No consideration shall be offered or paid to any
Person to amend or consent to a waiver or modification of any provision of this Agreement unless the same consideration also is offered
to all of the parties to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be delivered
as set forth in the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Successors and Assigns</U>. This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns
of each of the parties and shall inure to the benefit of each Holder. The Company may not assign (except by merger) its rights or obligations
hereunder without the prior written consent of all of the Holders of the then outstanding Registrable Securities. Each Holder may assign
their respective rights hereunder in the manner and to the Persons as permitted under Section 5.7 of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>No Inconsistent Agreements</U>. Neither the Company nor any of its Subsidiaries has entered, as of the date hereof, nor shall the
Company or any of its Subsidiaries, on or after the date of this Agreement, enter into any agreement with respect to its securities,
that would have the effect of impairing the rights granted to the Holders in this Agreement or otherwise conflicts with the provisions
hereof. Except as set forth on <U>Schedule 6(g)</U>, neither the Company nor any of its Subsidiaries has previously entered into any
agreement granting any registration rights with respect to any of its securities to any Person that have not been satisfied in full.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Execution and Counterparts</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall
be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to
the other party, it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered
by e-mail delivery of a &ldquo;.pdf&rdquo; format data file or any electronic signature complying with the U.S. federal ESIGN Act of
2000 (e.g., www.docusign.com), such signature shall create a valid and binding obligation of the party executing (or on whose behalf
such signature is executed) with the same force and effect as if such &ldquo;.pdf&rdquo; signature page were an original thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be
determined in accordance with the provisions of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Cumulative Remedies</U>. The remedies provided herein are cumulative and not exclusive of any other remedies provided by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Severability</U>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to
be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Headings</U>. The headings in this Agreement are for convenience only, do not constitute a part of the Agreement and shall not be
deemed to limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Independent Nature of Holders&rsquo; Obligations and Rights</U>. The obligations of each Holder hereunder are several and not joint
with the obligations of any other Holder hereunder, and no Holder shall be responsible in any way for the performance of the obligations
of any other Holder hereunder. Nothing contained herein or in any other agreement or document delivered at any closing, and no action
taken by any Holder pursuant hereto or thereto, shall be deemed to constitute the Holders as a partnership, an association, a joint venture
or any other kind of group or entity, or create a presumption that the Holders are in any way acting in concert or as a group or entity
with respect to such obligations or the transactions contemplated by this Agreement or any other matters, and the Company acknowledges
that the Holders are not acting in concert or as a group, and the Company shall not assert any such claim, with respect to such obligations
or transactions. Each Holder shall be entitled to protect and enforce its rights, including without limitation the rights arising out
of this Agreement, and it shall not be necessary for any other Holder to be joined as an additional party in any proceeding for such
purpose. The use of a single agreement with respect to the obligations of the Company contained was solely in the control of the Company,
not the action or decision of any Holder, and was done solely for the convenience of the Company and not because it was required or requested
to do so by any Holder. It is expressly understood and agreed that each provision contained in this Agreement is between the Company
and a Holder, solely, and not between the Company and the Holders collectively and not between and among Holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">********************</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal"><I>(Signature
Pages Follow)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties have executed this Registration Rights Agreement as of the date first written above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Imunon,
    INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
PAGE OF HOLDERS FOLLOWS]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">[SIGNATURE
PAGE OF HOLDERS TO IMNN RRA]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Holder: __________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Signature
of Authorized Signatory of Holder</I>: __________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
of Authorized Signatory: _________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
of Authorized Signatory: __________________________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[SIGNATURE
PAGES CONTINUE]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Annex
A</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Plan
of Distribution</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Selling Stockholder (the &ldquo;<U>Selling Stockholders</U>&rdquo;) of the securities and any of their pledgees, assignees and successors-in-interest
may, from time to time, sell any or all of their securities covered hereby on the Nasdaq Capital Market or any other stock exchange,
market or trading facility on which the securities are traded or in private transactions. These sales may be at fixed or negotiated prices.
A Selling Stockholder may use any one or more of the following methods when selling securities:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary
    brokerage transactions and transactions in which the broker-dealer solicits purchasers;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">block
    trades in which the broker-dealer will attempt to sell the securities as agent but may position and resell a portion of the block
    as principal to facilitate the transaction;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">purchases
    by a broker-dealer as principal and resale by the broker-dealer for its account;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    exchange distribution in accordance with the rules of the applicable exchange;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">privately
    negotiated transactions;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">settlement
    of short sales; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    transactions through broker-dealers that agree with the Selling Stockholders to sell a specified number of such securities at a stipulated
    price per security;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">through
    the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    combination of any such methods of sale; or</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    other method permitted pursuant to applicable law.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholders may also sell securities under Rule 144 or any other exemption from registration under the Securities Act of 1933,
as amended (the &ldquo;<U>Securities Act</U>&rdquo;), if available, rather than under this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Broker-dealers
engaged by the Selling Stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions
or discounts from the Selling Stockholders (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser)
in amounts to be negotiated, but, except as set forth in a supplement to this Prospectus, in the case of an agency transaction not in
excess of a customary brokerage commission in compliance with FINRA Rule 2121; and in the case of a principal transaction a markup or
markdown in compliance with FINRA Rule 2121.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the sale of the securities or interests therein, the Selling Stockholders may enter into hedging transactions with broker-dealers
or other financial institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they
assume. The Selling Stockholders may also sell securities short and deliver these securities to close out their short positions, or loan
or pledge the securities to broker-dealers that in turn may sell these securities. The Selling Stockholders may also enter into option
or other transactions with broker-dealers or other financial institutions or create one or more derivative securities which require the
delivery to such broker-dealer or other financial institution of securities offered by this prospectus, which securities such broker-dealer
or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Selling Stockholders and any broker-dealers or agents that are involved in selling the securities may be deemed to be &ldquo;underwriters&rdquo;
within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers
or agents and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts
under the Securities Act. Each Selling Stockholder has informed the Company that it does not have any written or oral agreement or understanding,
directly or indirectly, with any person to distribute the securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is required to pay certain fees and expenses incurred by the Company incident to the registration of the securities. The Company
has agreed to indemnify the Selling Stockholders against certain losses, claims, damages and liabilities, including liabilities under
the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
agreed to keep this prospectus effective until the earlier of (i) the date on which the securities may be resold by the Selling Stockholders
without registration and without regard to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement for
the Company to be in compliance with the current public information under Rule 144 under the Securities Act or any other rule of similar
effect or (ii) all of the securities have been sold pursuant to this prospectus or Rule 144 under the Securities Act or any other rule
of similar effect. The resale securities will be sold only through registered or licensed brokers or dealers if required under applicable
state securities laws. In addition, in certain states, the resale securities covered hereby may not be sold unless they have been registered
or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is
complied with.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
applicable rules and regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously
engage in market making activities with respect to the common stock for the applicable restricted period, as defined in Regulation M,
prior to the commencement of the distribution. In addition, the Selling Stockholders will be subject to applicable provisions of the
Exchange Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of the
common stock by the Selling Stockholders or any other person. We will make copies of this prospectus available to the Selling Stockholders
and have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including
by compliance with Rule 172 under the Securities Act).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SELLING
SHAREHOLDERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
common stock being offered by the selling shareholders are those previously issued to the selling shareholders, and those issuable to
the selling shareholders, upon exercise of the warrants. For additional information regarding the issuances of those shares of common
stock and warrants, see &ldquo;Private Placement of Shares of Common Stock and Warrants&rdquo; above. We are registering the shares of
common stock in order to permit the selling shareholders to offer the shares for resale from time to time. Except for the ownership of
the shares of common stock and the warrants, the selling shareholders have not had any material relationship with us within the past
three years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below lists the selling shareholders and other information regarding the beneficial ownership of the shares of common stock by
each of the selling shareholders. The second column lists the number of shares of common stock beneficially owned by each selling shareholder,
based on its ownership of the shares of common stock and the warrants, as of ________, 2025, assuming exercise of the warrants held by
the selling shareholders on that date, without regard to any limitations on exercises.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
third column lists the shares of common stock being offered by this prospectus by the selling shareholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
accordance with the terms of a registration rights agreement with the selling shareholders, this prospectus generally covers the resale
of the sum of (i) the number of shares of common stock issued to the selling shareholders in the &ldquo;Private Placement of Shares of
Common Stock and Warrants&rdquo; described above and (ii) the maximum number of shares of common stock issuable upon exercise of the
related warrants, determined as if the outstanding warrants were exercised in full as of the trading day immediately preceding the date
this registration statement was initially filed with the SEC, each as of the trading day immediately preceding the applicable date of
determination and all subject to adjustment as provided in the registration right agreement, without regard to any limitations on the
exercise of the warrants. The fourth column assumes the sale of all of the shares offered by the selling shareholders pursuant to this
prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of the warrants, a selling shareholder may not exercise any such warrants to the extent such exercise would cause such selling
shareholder, together with its affiliates and attribution parties, to beneficially own a number of shares of common stock which would
exceed 4.99% or 9.99%, as applicable, of our then outstanding common stock following such exercise, excluding for purposes of such determination
shares of common stock issuable upon exercise of such warrants which have not been exercised. The number of shares in the second and
fourth columns do not reflect this limitation. The selling shareholders may sell all, some or none of their shares in this offering.
See &ldquo;Plan of Distribution.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="text-decoration: none; font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-decoration: none; text-align: center; width: 23%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name
    of Selling Shareholder</B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-decoration: none; text-align: center; width: 23%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none"><B>Number
    of shares of Common Stock Owned Prior to Offering</B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-decoration: none; text-align: center; width: 25%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none"><B>Maximum
    Number of shares of Common Stock to be Sold Pursuant to this Prospectus</B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-decoration: none; text-align: center; width: 23%; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none"><B>Number
    of shares of Common Stock Owned After Offering</B></FONT></TD></TR>
  <TR STYLE="text-decoration: none; font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-decoration: none; text-align: center; vertical-align: bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-decoration: none; text-align: center; vertical-align: bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-decoration: none; text-align: center; vertical-align: bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-decoration: none; text-align: center; vertical-align: bottom">&nbsp;</TD></TR>
  <TR STYLE="text-decoration: none; font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-decoration: none; text-align: center; vertical-align: bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-decoration: none; text-align: center; vertical-align: bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-decoration: none; text-align: center; vertical-align: bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-decoration: none; text-align: center; vertical-align: bottom">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Annex
C</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>Imunon,
INC.</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling
Stockholder Notice and Questionnaire</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned beneficial owner of common stock (the &ldquo;<U>Registrable Securities</U>&rdquo;) of Imunon, Inc., a Delaware corporation
(the &ldquo;<U>Company</U>&rdquo;), understands that the Company has filed or intends to file with the Securities and Exchange Commission
(the &ldquo;<U>Commission</U>&rdquo;) a registration statement (the &ldquo;<U>Registration Statement</U>&rdquo;) for the registration
and resale under Rule 415 of the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), of the Registrable Securities,
in accordance with the terms of the Registration Rights Agreement (the &ldquo;<U>Registration Rights Agreement</U>&rdquo;) to which this
document is annexed. A copy of the Registration Rights Agreement is available from the Company upon request at the address set forth
below. All capitalized terms not otherwise defined herein shall have the meanings ascribed thereto in the Registration Rights Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
legal consequences arise from being named as a selling stockholder in the Registration Statement and the related prospectus. Accordingly,
holders and beneficial owners of Registrable Securities are advised to consult their own securities law counsel regarding the consequences
of being named or not being named as a selling stockholder in the Registration Statement and the related prospectus.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOTICE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned beneficial owner (the &ldquo;<U>Selling Stockholder</U>&rdquo;) of Registrable Securities hereby elects to include the Registrable
Securities owned by it in the Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned hereby provides the following information to the Company and represents and warrants that such information is accurate:</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">QUESTIONNAIRE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.
Name.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Full
    Legal Name of Selling Stockholder</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Full
    Legal Name of Registered Holder (if not the same as (a) above) through which Registrable Securities are held:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Full
    Legal Name of Natural Control Person (which means a natural person who directly or indirectly alone or with others has power to vote
    or dispose of the securities covered by this Questionnaire):</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.
Address for Notices to Selling Stockholder:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone:_______________________________________________________________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-Mail:__________________________________________________________________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contact
    Person:___________________________________________________________________________________</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.
Broker-Dealer Status:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Are
    you a broker-dealer?</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
    &#9744; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No &#9744;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    &ldquo;yes&rdquo; to Section 3(a), did you receive your Registrable Securities as compensation for investment banking services to
    the Company?</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
    &#9744; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No &#9744; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    &ldquo;no&rdquo; to Section 3(b), the Commission&rsquo;s staff has indicated that you should be identified as an underwriter in the
    Registration Statement.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Are
    you an affiliate of a broker-dealer?</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
    &#9744; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No &#9744; </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    you are an affiliate of a broker-dealer, do you certify that you purchased the Registrable Securities in the ordinary course of business,
    and at the time of the purchase of the Registrable Securities to be resold, you had no agreements or understandings, directly or
    indirectly, with any person to distribute the Registrable Securities?</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes
    &#9744; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No &#9744;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
    &ldquo;no&rdquo; to Section 3(d), the Commission&rsquo;s staff has indicated that you should be identified as an underwriter in the
    Registration Statement.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.
Beneficial Ownership of Securities of the Company Owned by the Selling Stockholder.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Except
as set forth below in this Item 4, the undersigned is not the beneficial or registered owner of any securities of the Company other than
the securities issuable pursuant to the Purchase Agreement.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Type
    and Amount of other securities beneficially owned by the Selling Stockholder:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.
Relationships with the Company:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Except
as set forth below, neither the undersigned nor any of its affiliates, officers, directors or principal equity holders (owners of 5%
of more of the equity securities of the undersigned) has held any position or office or has had any other material relationship with
the Company (or its predecessors or affiliates) during the past three years.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">State
any exceptions here:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned agrees to promptly notify the Company of any material inaccuracies or changes in the information provided herein that may
occur subsequent to the date hereof at any time while the Registration Statement remains effective; provided, that the undersigned shall
not be required to notify the Company of any changes to the number of securities held or owned by the undersigned or its affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
signing below, the undersigned consents to the disclosure of the information contained herein in its answers to Items 1 through 5 and
the inclusion of such information in the Registration Statement and the related prospectus and any amendments or supplements thereto.
The undersigned understands that such information will be relied upon by the Company in connection with the preparation or amendment
of the Registration Statement and the related prospectus and any amendments or supplements thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF the undersigned, by authority duly given, has caused this Notice and Questionnaire to be executed and delivered either
in person or by its duly authorized agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: __________________________________   </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
    Owner: _____________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PLEASE
EMAIL A .PDF COPY OF THE COMPLETED AND EXECUTED NOTICE AND QUESTIONNAIRE TO:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>7
<FILENAME>ex99-1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IMUNON
Announces Up To $9.75 Million Private Placement Priced At-The-Market Under Nasdaq Rules</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>$3.25
million upfront with up to an additional $6.5 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>LAWRENCEVILLE,
N.J. (May 23, 2025) &ndash; IMUNON, Inc. (NASDAQ: IMNN</B>), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy,
today announced that it has entered into definitive agreements for the issuance and sale of an aggregate of 7,222,223 shares of its common
stock (or pre-funded warrants in lieu therof) and short-term warrants to purchase up to an aggregate of 14,444,446 shares of common stock
at a purchase price of $0.45 per share (or pre-funded warrant in lieu thereof) and accompanying short-term warrants in a private placement
priced at-the-market under Nasdaq rules. The warrants will be exercisable beginning on the effective date of stockholder approval of
the issuance of the shares of common stock upon exercise of the warrants at an exercise price of $0.45 per share and will expire three
years from the date of stockholder approval. The offering is expected to close on or about May 27, 2025, subject to the satisfaction
of customary closing conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.C.
Wainwright &amp; Co. is acting as the the exclusive placement agent for the offering. Brookline Capital Markets, a division of Arcadia
Securities, LLC, is acting as financial advisor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate gross proceeds to the Company from the private placement is expected to be approximately $3.25 million, before deducting placement
agent fees and other offering expenses payable by the Company. The potential additional gross proceeds to the Company from the short-term
warrants, if fully-exercised on a cash basis, will be approximately $6.5 million. No assurance can be given that any of such short-term
warrants will be exercised. The Company intends to use the net proceeds from the offering for working capital and general corporate purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of common stock, pre-funded warrants and short-term warrants described above were offered in a private placement under Section
4(a)(2) of the Securities Act of 1933, as amended (the &ldquo;Act&rdquo;) and Regulation D promulgated thereunder and, along with the
shares of common stock underlying the pre-funded warrants and short-term warrants, have not been registered under the Act or applicable
state securities laws. Accordingly, the shares of common stock, the pre-funded warrants, the short-term warrants and the shares of common
stock underlying the pre-funded warrants and short-term warrants may not be offered or sold in the United States absent registration
with the Securities and Exchange Commission (&ldquo;SEC&rdquo;) or an applicable exemption from such registration requirements. The securities
were offered only to accredited investors. Pursuant to a registration rights agreement, the Company has agreed to file one or more registration
statements with the SEC covering the resale of the shares of common stock and the shares issuable upon exercise of the pre-funded warrants
and short-term warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale
of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such state or jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
IMUNON</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IMUNON
is a clinical-stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body&rsquo;s natural
mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach
from conventional therapies. IMUNON is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas&reg;,
is developed for the gene-based delivery of cytokines and other therapeutic proteins in the treatment of solid tumors where an immunological
approach is deemed promising. The second modality, PlaCCine&reg;, is developed for the gene delivery of viral antigens that can elicit
a strong immunological response.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s lead clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer
that has completed multiple clinical trials including one Phase 2 clinical trial (OVATION 2). IMNN-001 works by instructing the body
to produce safe and durable levels of powerful cancer-fighting molecules, such as interleukin-12 and interferon gamma, at the tumor site.
Additionally, the Company has completed dosing in a first-in-human study of its COVID-19 booster vaccine (IMNN-101). The Company will
continue to leverage these modalities and to advance, either directly or through partnership, the technological frontier of plasmid DNA
to better serve patients with difficult-to-treat conditions. For more information, please visit <U>www.imunon.com.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-Looking
Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>IMUNON
wishes to inform readers that forward-looking statements in this news release are made pursuant to the &ldquo;safe harbor&rdquo; provisions
of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, including, but not
limited to, statements regarding the closing of the offering, expectations regarding the use of proceeds from the offering, the receipt
of stockholder approval, the exercise of the short-term warrants prior to their expiration, and the Company&rsquo;s plans and expectations
with respect to its development programs, are forward-looking statements. We generally identify forward-looking statements by using words
such as &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;expect,&rdquo; &ldquo;plan,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;estimate,&rdquo;
&ldquo;intend&rdquo; and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances).
Readers are cautioned that such forward-looking statements involve risks and uncertainties including, without limitation, risks and uncertainties
related to market conditions and satisfaction of customary closing conditions in the offering, uncertainties relating to unforeseen changes
in the course of research and development activities and in clinical trials, including the fact that interim results are not necessarily
indicative of final results; the uncertainties of and difficulties in analyzing interim clinical data; the significant expense, time
and risk of failure in conducting clinical trials; the need for IMUNON to evaluate its future development plans; possible actions by
customers, suppliers, competitors or regulatory authorities; and other risks detailed from time to time in IMUNON&rsquo;s filings with
the SEC. IMUNON assumes no obligation, except to the extent required by law, to update or supplement forward-looking statements that
become untrue because of subsequent events, new information or otherwise.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Contacts:</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 39%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Media</B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 59%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investors</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jenna
    Urban</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter
    Vozzo</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CG
    life</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ICR
    Healthcare</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">212-253-8881</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">443-213-0505</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>jurban@cglife.com</U></B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>peter.vozzo@icrhealthcare.com</U></B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>imnn-20250523.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWamNebP9z5Z8SekhvWB5bYkKjyksSQIjbiKkIlymUYIK -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:IMNN="http://imunon.com/20250523" elementFormDefault="qualified" targetNamespace="http://imunon.com/20250523">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://imunon.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="imnn-20250523_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="imnn-20250523_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>imnn-20250523_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>imnn-20250523_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://imunon.com/role/Cover" xlink:href="imnn-20250523.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://imunon.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001641172-25-012395-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001641172-25-012395-xbrl.zip
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M,*;M<-X/R +;#&'Y?@=AN4,(R_<[",LW(/'W8%KV[&H!-CZ1'"R$HZ\!@^S
MZELVK;9P],"/;R46ZP1B)PJ?.*UP2N8T"6=TM_/Y\>5/X[.+TZ/7)\/!Z2F\
MKY<_W:O)O7M_=O3+^!QF-WX#1_;X]<F]FZ(1R;]J6G_13GN\?PA3>/^3L$JB
M:MJ/WI8!T^0Q!40L]A!=#TD<./YRBN56928]AAW6P/2]#< (F#B@5!<X*(4M
MOAD./$80^ J]Y$)(*-%+);9F5(_T>_RY017AZ*0!JT/6@%?QOY[$CY\=Q <'
MA_B7=ZRV-.@+Q$,8,G-<@Y@6Y;*ZQD'0!Q35B6WS7>P8W4BDQRL#L8Z9)DI,
MZK5;%=0[.:T5D[RYKLCN=Z.FFC%C&_>Y[D5!P>Z:8M=BQ"6Y +9T!L;()L4M
M83RSNJ+U6']+4W=KFF-W$4KN47O1=;4L,NG(FU)Q[7!075.';O4QE4 \+LM+
M>TGT]EHXO*/7'L%=5=N"83<6Q.^22WR-.*CTLJKPC>88D5!+O+6\9IR?*><+
M;P''*-R#<Z^>6/2=H=YM11YR04S!=L%FQPWZ[7I9-(9+A&J(G5BU&.XGBL(%
M[*\*'Y^;6NC_[D<7\(<S"&Y8KFZ8&CSCI_L__/!?&.R(.R#C%E8/''&FXZ%U
MD>[FK?'!%;++X^@'O/.>>95>]W=;4M*)<?A1@  91[B>67Y%( #&G_;!H%N1
MA:JK=_:CD[#0BA=">'+-/6V6D_*>5WD":U,KE]'!^%D")P5XG0@V!!E3Z8=X
M(YB/.C78Z']W?_2@"#L@JRY:D=.=U*5>$J:35>L)L6_FD;KL3+E5>X9:1L0
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MA8OKC%/S)EUDAZ-X1/7!CHY'%\<UZG []"79!^PPG+(YTDMQNJG"S82#S@.
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MY]P8W:LW0Q(:XD/&WEVH&. I^ Z90T4.(_!V+<T<&_>-\85NV@LW#,N $#
MR?D>X51?\GL,^N;XP[#'))_@]*(V2B\K9V2+ZXN0H%B9,V]G%6[)M$9_&*L0
MMK@##-UH";*'@&J!'!+^9ZT-J_>L)*9[=[B@783UXU+48<IG2&,6% !C*ZS.
M]0>VAPS_1S+'\A3;]V91+S.#<TAAC6"63$CCN]Y4V?XISHXJ9\D,STR;RHTQ
M6T5=_&R#5"0GSBS_(G.8$S)2\_S)44(<)J8P77&G0M"&[01KU!2- 6F4R8(<
MTR1[@5I(1]M[T#,"%%4=>^,$Q;7:P-+KDCG#:J!6)0@&[E/OG.D.W-BC2MZ
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MBEBB(.>A&\;U[0-E6-R]U!@H>Y%J?(ANE'I^#;9*6E]!U56U*'S1%)6CP)A
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M>+X!2"*Y)7'U!@HX +](Y&]:]HNXD9?D=C<Q@1,NCZ5<#V>SI\2!;8 YUX*
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M!5<YVB=PQ99QBC]+%/PS-YF/O(\AQO-@%@7>IQFL@11SG@KLA%J6M'M"/6?
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MS\&7IP)>WX/HB!VOJT>4KE=HVUIUU(4*++UF^?H;U-,J?0OEQ!;<I!E[P.N
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MC$S*^%,<7XO,@E0R4$@7CN<"4=(+7L,./MJ<Q(I4P?HL/#PTS0&:/Y%)46T
MN95(/4#]IL"J<.9?:HY<27SS6-KI8IHJ45*U/J>S_YQ,32ZLC%#/-5*RN3UZ
MDDX1=]26T&SC-VTL428;F+DV4<YT.%8887,F,,5S=-:XO0 L)%K./1)8)+?L
M:(L;'JC/B8-YZ<X=OGF**Z)6L=OFQXY+0^&,F8OVD^[(H&&"IMA6G$]DL53T
M8P^538K5_48. I[FU-6#W%6<K3?'-N6$AH&ZP:ZCX,B.ZLQPHB:M^HIE)] D
M#$'T)Q#/5'71Y)9E@*QQ7ST9W%>WZ;YZ\D#=5X.^\67+.@3;JDM4-Z4BBSK0
M_PE$31EAYX)%NH&/5/1FO!OQ$G]AVN?4Q-0$\ZS;TYJMZX<',\J-!MVWV=(=
MF@<VR,$Y4 P<_6?/*;>AG?TB7DVAJRO\8"P: ,SPZY,,*5J^7L= 2:%F5@EJ
MU33T2LCZKNVEG, UM(R.O6@_*NZI\(27@ !N,SXULM0Y1Z-^N#L>($808]?W
M:&9_N*O-%N#6&IZO6^MI;ANK;7JA&@"KBU:=C9 F3BR?'1\4PO8G,>O4I@T3
M"/PD_J3X**BWE*Z^H#:$>GCR!!& L< ""D+P319$3BL!^XL*+O/H>(D'\-3R
M)A?\0VM$*J&^\3VWM'E?NG:^EY!-+R27-6!&8(..Y7:;/7$2FUJO>9H%BXR1
MF[BU9V,)/7>_/F>X/3AIB?/VKF;"'@ZG.*%099E8'VT+^7/,%$Y,9W"ATHN'
M IJFAM85;$=*02NL1T6&K%*':/$M%R ?&;$MB59JMA> 3.^:M\T<8V\*AL9K
MH]<WA=K,R@'S[#N6JMNR.*N-4]M'3T>>VXT'C$$3"Z!"6PI6T-8YPPA?P"Q2
MQ/@Q6#/4K _;;/3Q<O;;8\J=]4FEDG<7F'IDNL"BQ ,#*&V79F=56Z9HWW]E
M1/HQF!9MG0T9/([?P4S:I84CM7I?H.6-F)U])K>3(\&=C1@A4G0&XH6S!OL@
MGS#L2:IRZ1&(MY9:&Y8ZO<UZ,7>=HF/RC79Y$6JA*QW# Z90K_?7S$+L>\VJ
M:R]VA8+V)(C(Z9/&1K_)5;R@ZL@ND6*;P68F?:9=Q7(C>,:[J;-E\#7,E;K4
MGB*X0T<!46RWIT!@\VJ @77/[+8"2MU_OD3-XMDI:X)(QO7*26'^4;+3U(0@
M=J)=)(MG.Y-= 0LQ^6X42FTW6;#,%V/BL8 78,2+1&;S:9,7H/47'<@NL2*=
MXOV="M!4+\IT@Y) "3$:9&?1BJ:J QAM^H0.)U+DC2\R8VA2V K4DZ@4_7F>
MZ#X''+,AHT@*1SIX!'*!5D.F-8M.6$+8F:(K78"Q6H49.LV<=PQG?85U+P)?
MK?%O$W6)#DL,!I6T&<2ML2<W#<8ZIEX0PM+*BKP-6[LDP^-]%N6VZPKQ=%#,
ME-P;'J, H<&<H!#?5%IGC$?_DN!H#;SP"Q/ZW6CU]2+^(4;4,#R(>*_1)T6_
MDR3"T&04<#38"W5C8#*FQ8>=6P@_;Q-_QHM.1J@NF[!'@Y8?JA"?TNR*JI1"
MS">DG!I_$N2!7B(U5Q2)($C+/)=>&MC&C#1ZG%TD70!;(_M,&_Z=&H^<2R7J
M<J.*REQCERXTEK-!\JA!P-HZD@)5;F0(I*(T52@L6NJK-#'UT;I:NEEGKCG"
MLGDA;8#647I\5[[]*=Q>:B9L@8+=9%+3&KTYD7;NVZP)=^+!&-WWV*\[C9;D
M4NIUAWKHEDGE-6[YIX-;_C;=\D\'M_R@<=Y@66>(E*,]L)+H0RYI$P!ECBFN
M))P5&TM&08GG5K.K0P_["3*(_D[^35_K "X:@'H3@<J9))G.'LD#G99/LL$F
M6#D/T10-K#"!\V)CA\#MZ]"E204M<%;Q H0>:I"8@;7$A!J2)N@:/,^CY457
MUI*W?AN/9D7%%HQT];CK2VH:C[YF5E/SS+2> X=SIUE-O2JBU7$HI;2N$/JY
M3T"R-TEY:LEEZCK/(8]I4QF83>/A4(YS?)'61)VTUX:NAI[<V )(Z;QCZ_EM
M.**,?8 TA""2J%(:?V+=7MAF:-H6 !-^R>T@I-SF2GY@,)3?XF(*IG>4JJPJ
M!BB4&T[_:\&@?$0+--:0F\?,T$WU:A2@E@J\NEXJGKN]V[2T8A$0YSJV1)6A
MZ\JW/0@4G?%M:F&X'1'7!3#T?UAG(9QNW=JZA>(*&-$$ 92#LL2B*XFNB(%U
M3,>-*%#O45J808!H;18CQ;W3M@)VF4#;:%)"Y"-J!M2YV=T48J[BZ%IDH(I@
M1856#:SB*'8R; ZH QQE7:"JPEJ2=B4RM(5G]%M=P3WON*0*<*=FDP8P>&ZU
M"E8J:N)FVMI?[LP[U,J?)2WKVR*/0-L.VC"E;=O%$PQMTB"ALE(R+"7!TV=7
MD:Y.M;%KRA[(D=Q7&&Y&*N"]F]@M&UC4)K$H*<,#F_M#?'Z^FA!:3.JERQ<O
MT"%U$4^DKT@*]B_5,E!_FX[,>EV^Q[FI&M>S'<\\ .6WXDZ1I.\:WB(D?!7E
MR%D*>LX"37](HBG?B\-S#CAR!+2_)+R]]:/NO.;PB/$HU4 YS&0$AF,5Z!9X
M.]JC'/F]N;1_?!HMHRG^P!B2NC4 LEF=ZN-BU_I,BO..+/QK;8>#VO =C03:
M:_:;_>J<,8JV,7R,]6;QD_1%^(=G@I'-ZB%CZK/N0MRL8QX3R0394FQIC1JE
MRQP#AL('S@Q:D-=R*,9J *GR(/()W28_2X>BI5.7Y_O5^O33O?T#BD7-/=H9
MCZR V2Y^ML;)^6QP<MZFD_/9X.0<9/4-ZYS>@M&7(00RRL*WMN,72]S7*Q)6
MT93;3/;6;DI=>U,%#MGQI!%C2&N5K!=,)C-8\2ZF55<#7/GZ4TS(X,4TCR<=
M #V!VVTS]!QRU+R2F#.7[-@M&(]J3<_Z>C-K#,4.*<9=+F)*<27T1#^=N59-
MQ8@Y;@65Z2ZMMZ;63Y.#[38GQZDWW<'8?VG\+^QSM-6FW)>62E'5;+?6A[/9
MYQ,4J1LU^F39=AM]/H6(J'YG:@+&A21 N3UA1!A;2![MWO6["SA'S<:&?]H]
M_E!;BF<KG^K=/SUKR^WBN652_9YS/DDF.M2EV$Q@?Z %JH%"SM88S_42Q)9G
M=>>/D.A?XD1RY^"S;"8)/%X=.&%"4@D\38:;HU R<<&YC!B2JM#JH33<VM"2
M0NB,AV6$J<D#-EGUQB7BYK$36!0<1+,Y@<[IT"8)C/'L\=[^WRB;),O-G:=D
MIZPJ#6!HQUW:00M.JN6Y8P/"^>OT >I@&9NBZZ('H\KJ_S53C[8-=] !!).?
MK79K-9E4!^#5YNOCX?G0$?&!$+\P&584$*L5%\:P8U@%8#QMV-?M' 31$J<A
M&RBX<4Z:./=1:KZ<7P<3U97^K:]S>SDPK^.:Y"[)9$*#NM6+[OG0P_^<\"4"
MR\I^>)U79U@QT-)@A:E47<99Y5Z+4G>AMAW*.L;FU$VG+PW2#RH;XY$+YL,/
MH9TV,\%3R=;";TU+5 S3UH& 6FJML.7'.9Z#2!4QW+O0TLP4,H&PI1O:@_&!
MY04^OBZ57^G60< (G%W6M&*80 \#D%P\I]%.I'/P)?6.D[[49P(CN506.T1<
MGUZ %OM^+92W?7Z F3&$$LF9U/\"*N$:!_^];'#KEXEJ0&R*04SJ>(*YRW76
MDRFLPTE#YOVC"ZPW4!;_(@ )H-D \OP0/[C(KA .BO]MM)H>YM[+V\.@QML1
M,90\6"UI3FT# 37$.6A<9C0]O 7< ]T"JU2\&+Z]#80EKB2)E+/6R0<D]?[X
M3YQTC<!<NG,9H2E/T=-L<2K7)8T_L2@I,H*DY'EQUK8]4UOQ5G>[#_K3!NE/
M2GMYT833K=\<+&ZV[;P&+XM%E;IMJ:2I$QZV4<^12 W^-[-\(Z>;VK=M%4A8
M^+54RS:_[$!$FT1$<R:B4]WNE@7+88$RURCA'FO1'?2DDP$>LG;72HDCXJW$
M+$IMJHL_@*6PB(>B.)73*\ P(8N=VC6DHT3X9JL6"CQ$L"-<'T3;0N7G*M]U
MPXQX2VS(U<5\N5:!H<,^'4%Y VW<1T7$J?.TR2WCAX9EQG:&&IZ0RZBD0IIN
MG_0AB IGQVM%&7L_UOW@PUW=S+MZ;L)ZQVZ5G#DMN:\GS;!74(MZG5834 =B
M;MZ&>7'D^R:KU] M@E4'&I8@-1%B2K9STADZWAH&4AUA(+3I?2T6/ TMB9':
MU[0PU7^.]NR$Z[B+!&F&3L8\A<E9V<49P11C$QJJ93/(_7"">W5<:1>86U?,
M%VTZ(K.*;&[BHIX8A%U ]CJ] (,([OL/<(BLUK8$)]>>DK;>L(D('YC9-Y"^
M9NZT2%WCXL4 91<:=DDC'BKJGP.-97M'LYZ-GLP(D18$F1U!1[>,7:R)FOTP
M1,UN,VKVPQ U&T3A=47A!8O"H\_ KDR5VAO, %<Y:H[MJJNX.13]2O)LKS+C
M/ITZOP^U1L=NC*L+4[I79N=<9$CRD$ _M76-UI.TRS66=^0E>FFS:8JN')95
MJ-'1Z]WAW7B1\063HKLT=9-NDW8.WK&9)Z 3G8"J!$.CU>L4T7VH@AM59,=?
M8.922VXT(1_VRJ%*[C:,IVB9>K2(XL2V#"8_EL38]I:SN836 BXR1,T@XM05
MD7\$X9)G8*HZHY [D_*:C1#^?>]T+Y@K]&LDP='I\2\GW&=GCHC;CQ^#QK]W
MOA<&5U=7>[-L6N&[]N U.@QIWRT5P%3F %.]!&IFR%MMQ_A5$]H^60DI41R1
MFT%<76147( M(00;Q]LH37N[=A6TX?4F%!22$X=TR\[9=R*3X[(5Q(H! 8_5
M_?A>TDFV2R#?<Z85,]/Z!7-C"4?^770E;AN@/EVD3/EM4WE"QR?*O)+:6J+-
MF+!K4B(:PUL(RVF)G:W;&RHZ$5.GPNG:/M#!.MQLZOI3L!FJ125X GZ*^AE5
MYO,GOD<OY@J3J?VE[L%@0A,F4UWR"NNOX>SP@2 VB2 ^B6N/.FMPH9"'DXPL
M(+07/0PP:3^-V/A%4+A<@%^:G"1&[U-R3=P8U$XHQDVL"Q23A+J/ RO+&%BC
M2H65H4N,8[+<HLGI9$6EY\YL"SM=]A$Z$W;M;Z%OT=76='[RG(U827G%"F,D
M&&>A.!782RX+BDRV@.NVE%I5?IFTI(O9!8_!<03@\6 'G&R>>9S.G%8E*->C
M!-:?\MW$)B1LG$\O!-]/= @*<TW0SU@RX*[Y1M 4(JF%<!.H26'C/J+7I <@
M(*$ *EH 8EY6G(O-6BEF$9C004FX!$@4-=TIUH49)7680"\.(DY>.NJY)002
MA3>B (-&YP%^Z! _5X3PX>(RV$NEIXZE+->BU8'?;1*_2YC?_<JM21RI=R&?
MM+CY4.[-=9I*&G-T-\6N0[.,)" I7]CG3@D^B:;APQ:[CCUCJ%YI>!*"(6$_
MJ $:;!8%#<KZYE'3PK:R0AQ(/.@3MKALQH^&B'GOU.HA-7PD-ZLE0 \#W@M8
M.4$<)$7I@F7T+^J!Y6 ZU5YD-;+ZVT)Y1=!,S"F6Z*V08@VNQ-'P<XT^LK4Q
M;5U;ZZ"428-(3$XIL^UI)*-EML)-.]K1-N?,)>/1$!_#-,D*T[D@S:3N;3QB
M3XP@,,@T:O4X4A')#8]:@(.<B^U& B(-VXG-OB_B94CBMR@RD-EL@$5\*@%Z
M0PCL7COM:6&4$0V[),EA.5<[,LJ3\2\L*0=W:4$BO!GDWLG@DADGD<U"Z6$!
M;ZD-T4PW(E%7ZS]PC6*J>AS$0;F@[*7":CLF,[&9%5Q?$@5B^]?2?&^C4-$@
MT!(P1-B(9-273*?CKK>E^5R])A48<ZF501'V3J#833EM-BUW8TU.XS"Z.$WD
MJ9E?C GSL(V_YM[.VZ96B'*2T=4B:#93T0M<P\!/27:0AIO2P%'CD21[,E>2
M+/$HP%DFJB?RUL)ZW%.RMQU!I:0!G&Y,EE&?NMI/0JS#8QJ14E9*1IG&;J(H
MKUDGXA:<URAOU_S*D]N-:F#9U6G$B?/2T<KFN>#?06F4#"B0^$7F,Q6MZMI>
M5HXSE9OF$3PZ43R[9TU25A/.P;.?)JJ\4I)Y:8H3Z95FX;S6T%E)XR>-G& ,
M +%3.5DU?DBOIT1,>7Q0.:XS?8YQW>;L_V?+_^YX+493NET]Z3Z?@WQPI9!?
M/\?H^R)*X/7'KW9.M7\=D3T1+>!GN%?9U>[+[X]?W=5BOW4\^\<AGGV;\>P?
M'V@\>].YRS<Q)X]/QJ,_CL].CDY/@S]^/?IX]/[GT/<7UCQ?<>&7*[!)Z7H=
M_$0MSE#7B8G1)+N\.^_4W9^P91HNDZ@SD1NOQN,AG;SF.[HJ#D>Y_@ MO.<[
M??$LO[GN^^YPGX$!V6F]>8_;?/*?WQW<>$]O4QC3#21;#5T0SX-JN50Y AC!
M(*]?'2^JE(K2<-;')V^ NE^_<M=##'5#3LZ0VC,2'U_E%+]XBAL_PZ=W/<5-
M(IT-/8S;G-;KU?/>.?7KE-='[[O]K>SZ[T!,WVQ:I'=OW*P&LOC&TSI#=^[]
MH@NQ!>^5HGX_'#W?O?H_F!QZ>/;[QZ/QZ,/A+T?!^Y^#7]^_>WOT\33X^?V[
M=^__./V_]W5M7^+K^<?#\O!XWAR]7X,39OMO?J]5V<<4SMX'Q[^=G 0?/Q[>
M4\;0N_2[/=/;UN\H?,HAJ^?!_^O\WWU8SLMCL_?W(Y( $W:"(7 .AU5YD>7P
MQ"S@+S*N\.#SP67=]S.ZAY>C[5!ZCN$^K.W^G +9&E]R#,,Y?'7%_S1X Z\^
M/OG]Z,[$^K?6[7\:=/M!M]_ RTUI<;>JFKQ^A?B1::H^CT>'F&[KQ83N&:>Z
MWWP6#N)#@GCR( 7?8MC::0]\7]>TA6GM1X36>*H2ZO5 C1HN!"#3QT%N>:1P
M49%U\H&#%T+9A6XWFR4E!.-T&,I(8PA;+"A8Z",J6U5%.1XMHE4H>(JP"DH\
MA3]#&"-) @TWDR1V &=P:CBC3"<5R<0]B8I9]*_@3;2,RR@)?HOR3ZJ6TUQ0
MLPKU>7H1I><JQ%GHATII%3^/IMQFB^J[-;*QN_*<DJIGNBX,8:(NJ=.SEWE\
M=J$*;OIF$!<C[-GPF7^7JO.LC"D/&WX/.[0'7"UH.RO\,::TTBI25<=_G5.N
M&OZ(VQ(6C"]0R)OLQ)_?$6WOFV9KFI ?<>>M(7/D*^<?/-[[\6ZW_58"_'=
M'/_QTP\__G1;T[SC7&8@ISB-\A7/<))GGU2.BJ-7IT&)WNX'L<N,^$>/9@J8
M2T[:^Q1+%I92LY\70RQR*Z;UM?/J!V+YZM.Z3YQKDH!2PM,C_:>7*U&[#ZP@
M6RRY5@O5NKHF!?]'?;_ >B UQ[2%D IO4@4# 6?7"H\S#4+)B]-IO$04G$SK
M;I&4^3D<="#RK9C6P!$W\50>+$?4&E<ARMR*6H.Z;-#C4,+5L ^X-/OP'\8Z
M1^[\1(AL QENQ;0&GK6)I_)@>1:Z;7%NV@F&'7!LA_H.@+B\0C=6L_V9?LE
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M*5B(# K:Y<47\#,">(QR;/)<Y5P4,ZF*.%4%XK?B=+BO*..VQ@M3-J,'Z<>
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M_9/#OP?G%W__T/_K#^,\JUX%>[O3*KA()G$9',<WP5D^B;*0/PB#\[A(QC_
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MZ'($>P,6]<HLV>VOT%M1R=QR!HNKIYQ[X+Y15K;;H6N1_%VX'GA--1_G&[Z
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M@%C>>N:]1>;C[J^R&W9TQWP:DUX"#XJ !]UGED8%^M_H)U<YO$"$O.UMY+Z
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M;8BF3),/V:3)F60%SABA]%^=\\V)>1<J);AW&9L$3(&:PVT_+&+,;A$T'SK
M,3W0@0IJ*!RBWBO4A#C;37\^B%+RF:M?D^\<1W08DQ\Z+Z S%P5,OQYC=57D
ML\LK:D^>PN8Q+1Q3E"/,3P\.X!?Y* %=JYR#DCRQ87V'GWL'+C?9V-9<M$D4
ML>L?,828!Z("!=(@J40"@>QM,UR.T&*9I-8@YKZ(+T%'EYP?2F&C5)$IJH.5
MGCH*D&7&L/"C:3GGU911:CQS?G3 2?9!_75_N^DYU%!A=UTF*C./F_5^CZL
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MS?[TIAV^:)IUG?YBNE:@20<W<6F%ABUCB@NG9OP,F=)6;TWXR:I4X4;!+&A
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M.$:D.8$KSQF87VUR'CE(^$H:8^XT;0XR,V:J<%$PERKA-2XL)VWC[>D[Y8N
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MW!I)).U&<X/@(VC.&0BP85]4] :"$NQVN&HJ ]H<1)P@JZ74L97.(, BRG,
M2S0OV7O& &7RO,58+C3U66<V>W9-AJ78]C-R917LYQI\G<6@-TL"T1&FTL\+
MWGSC.$H9#2^<E&E$ZK'AL#1[U82&#>6/[&?"R!M/B&CYLYCY*)&)@WUKA48D
M\8L4:/6:2]?%O\W'E+UV62M+JA"O5+2K9-<^NB/BL@5?RKZK)373)%#41'?D
M5<W"P\1>!9Q-//#0"#).PB25FII@87*KZG3V^GR3)469!V",L1^=$H.8,#,8
M1]/H(B[]!,"Z"87\/RZ3,%M2Y,\A?Y:^MUSB((Q0*/KFLBIYA\2R0VRW)7KB
M4!31K)(C-'2"/,+14,H2@>B@JAV9+NAQJ9(>9S-"IM'U* %]?A*Q=LI]W^V8
M:I^H!$N50C)F95#CN<4B(*Q*;'>:3<27N]X$S%O=OGG,5MZ(N#49UJ554$17
MW]%TM2$%]^+2R!:X,+E,GH-HF:$J5VGJ8REGDQ<68W>MID3]%-H,WT1^U%37
MU^;1W>B&CV-8"4._=42' B@?$YOD#R]:<Q$H)Y9XVRAIVP1%(I#0E%1ZI:/G
M+D5.*]<P>G/5-M+9\C82&W,4,MC_$DU2;-,3)X:!%V5RE:0QWCVY6Y.9=_H%
MY>\F3&S/!8!EL.[S-58K5=->1NJR@1<WI:F$NI@B76^FT82K$10-\=^<#NL(
MCF0"5U2IPRCR_>:,K<FP?A/[BV_JFNU%9RD:2_HT27&\]AOIN2VZ2H$RXA:A
M-$RCL"!U!/&NHU[,>I@84AY+O5 ,CF!KN_%-HVO<"*&APNUB,L*!B+E,A6A_
M[+!7\,HQ7%NH/:&6"5H:G^.):.R87($WC]&E6$?CQ"ITI\&Q@4]-.DA#$54[
MV"65.U3_<E;<=68M WAB3HDE#ON,XWX,P!GISJE)<F+ C(EA[6M!-2JB:QFM
M-=+-"5V387UAI+*J&RS&1)^H$<7:M C<VDEM&PAFK=N)*O]944J5_J3WJE!X
M9F*PDK"7TL&!L-_"[AKJ.B]BM):ZWPQYTAHA<SO6"ORH;JWR.ZE6SO)JV8DK
M8O(_9F.MB:H+U!G!0E^O/I5-XR&VBFN0KY.),VJ<L^;*=3U6FP.X)L/R!O0H
M![7^ TH9!X^0+S3RM"93I_V<YF/F+L;;?<I20>G31HA(DK:@U;2=J9@[)4C>
M)KY$-#VZ67ZD1WS*=VQ\Y5/(_X+; 'UY,U !$R)-)V6OU?EH47NJB)?%A\HL
M2,+H.;2+T.#&H>A9C8N)-&C&["63Y9Y/TS@\<ID,$]'!N5!;^]NY<^:UUAA,
M#]6E+TA.Y6-6+0F*4MJA&*#"9,IGD8;?<9&?L>6IMF_OPGH&?]%^LV_.UYH,
M*Z/S]2$F]+]M95[*1PC\JQ>_0L5-:6I4T3!+E$.GB)&8B_Z12<Q PX1#;;@)
M@1]#YKGN=J3C* [EVF8K_1ZJ&\:WW&7O_U_#?^LZEN^_$O[>NF/=\?#=UAF5
M]9@C(I*P/>]SY-4K>V^?'=Z;;OD@(U6+5QO6#4"XEQL@W+T"X5YN@'"/4H!]
MEZRKPR.X^ _/CP9G9\$O'P:G@^/W;OP?R[!0B6&O"(NH[5:!(2N'E$'-\TS5
M(;*S;MV**I.D*"O.$$&_\IBRDNZORL@?)J_-2"M;.OG2Z]:#=H17JY![0N?1
M$F6K-] @])ZHTPW"1@T6_JH_#/:/<9!'?WGR_-8CL@7,?2S]W2VTO)[SX_("
MY.-\-HL+Y(J"1O;>'4[G&0)##X_V87?OU50#+:KO:6G4^V2'O,+KIG&UOG7/
MO;KAA?+82^^Y^QSSG0QP?;;@DW=[B]?6OFH>]TV*%,_9M_W_NJPHZ5#N2]9L
M3YYC>'BE(8CF=]^7Z)T:&WMZ*#5!>8.Q\6IC;-RKL?'JW]G8:-\U1@%8*]/#
M[3,%P'TW LW[79[LP:\?#O<.S[N=?I,:M"Z&X#(1M4Z#.#H^/]P?=#O'[X/!
MKX/3_<.SP9J/Z'LOR_>U),[SUX&Q)KJ=-G/B,8SUT3E;MG9[ 9&<4>Q1BE,*
MJBC&%(32 =C^G_Q7HR?WJ-4M2G&/ZR0V9:'5.[8H2I1,[%*Q4G]6B(D)'E24
MFF9)LS/)*S7,D9&VJAIOX)7V1%(5$UQU"T>'$L!]_'Z>-1[0UO,>:'ZT]-V.
M4,XCNPKN >+S@/VP!7L+"?/,0@_SK[W7CV@6[I?'8.68Z-T.ZN^VT?X/XN^.
MKN$4$S980^P_9P2;.,-TS?)-D!>/;!;^+99V8A"CH1!8-9#,M]*Q1,@K:<A.
MPJ EZP@%PCR-7$JJ<CXL514:K(P1MB>6T(L4*9Y<9-/H:S*=3]L[)S>E5^]7
M:A'Z6<J<#CBF0&U++ZE\Q[T1L3S&7?X@]](+N)?2F))]F(.+*H[7*2,I&\XJ
MUFEK79S(27N?T_;H0=[MDDN 4:TXS:\WM]F=#NBNT3W_M_R_-36,'F2I[IS,
MV3N3]2Q6):TGN2I&>?!+?S_H2X&](Y+\W_< KOD:;H[;9JDV2[59JLU2W8_R
M^;(' _C\#FXHROB&*^PPNXK+*K>*W-J*)F:.9ZJ88&1^E<BO5#E!4#W'\431
M?9UJ(OG@  T7L*TN(J<J*]4<= K!3H+=GUZ\X$K/G,SS?=UK:[YOOI-3^^]G
MAW\]ZI]_/N6@RX?CCP>#TW\\QI&N]1HR1H1X-OA\HVXZP*Q\>-4-TGKE_]9V
M;M9\:=\>OK-0^[#$IFA0P%_DS,O@+SV"W[]A^==VHM9\G?41;EK?.SG&:SLU
M:[ZR!'^[WZ7=K.T#=?\ %-W7W<Y=+.'C7]8;X) _;$"0RT&0/F1V@UU<8^SB
M778YL*&*>W<*L7IT2_&]\'WRP76,B_TZR)#G*WWRKG^&-O6GP1&LU/OCTT\W
M#&Z8I^,_Z@B_QU%IR[I_?M?$.H?OMLYS+!:$KC"%$N#24H:A6#((&0U L")B
M,)C/D.)84Z@F&9&ZH4-L.SC(B1MN7MJ_LH%S7*=S^SNF8+?X'G>V7]TQ?GI)
M&O9:;A(XK]W.S_V/GP?!Z6!_</CSX"!LWBJT+S!^*#QMAI>M4B2"1:SY!$MQ
MOU;Y8YBE?Z<<TF]/0,3^?@>/@@E'WSZ]CE_YAQO6V\^@[SS[_,X>V?=(1EW]
M?=_7MOI]";'WW-<M!7["#IX425;UUFS=[B;O^*97K\%$W-VFZ(_'H/*4WTLV
M_9O+HW7*"6_0'6C4FP%\KP&<7.:9B.LF0-MZ#6;M5V,PC9*4.UT3FFV<"8]1
M+BQ3(]9O5==^6WY#\&*]!OCOMT)_0+7E;LA'_EV5;(Q,CE]S_[QEAW^'@;<#
M_M!69-WB78.EW!B.=[X/W,*'W$\-CGK=(N,:S+,_[@@W.WVST]MVNK( VB[S
M1[/1OQ,+V&.B\EX^)-7V,O3-CV^"XQE5$7H=?(S*:@/&N0,PSG?F$%ZZ"PQZ
MASD\]XX/_H9G[-F'\T\?W_U_4$L#!!0    ( -H[NUI+ME+F2DD  "GD 0 )
M    97@T+3,N:'1M[7UK;]MFMNYW ?H//#DSA73 N+FUG2:9 +*M--X[L;-M
MI^U@,-B@),IF0Y$:DK*C^?5GW=XK25E.[<1R5& FB43QO:]W79[UK)=O3M^]
M?=7MO'PS'.S#GP'^]_+TX/3M\-7+[_E/^/9[^?KE[M'^/X*3TW^\'?[]P33/
MJN?!XT?S*CA-9G$9',:7P7$^B[*0/PB#D[A(I@_@A_#3]]?]W8M@%A5G2?:P
MRN?/ WA<?S#*JRJ?R6=5_*EZ&*7)6?8\&,=9%1</7KU\?71X:K?W<!K-DG3Y
M_*H6Z=DR^4_,'7SPZKML5,Y?O/P>7P@S\OY/CH7Z;/[G]KY(SL[5@))L$N.K
M'R7930[GY>ZKX:?S9)14W<ZSG:<OO]]]=6-C^V;6Z8]%6273Y>VNU.'PX/3-
M\+C;.7US<!*<#/<^'!^<_B,X/#H.X'/UP<'P)'@-'_WVYF#O3> ^"G\?_CX\
MWCLX&>R^'09O!K\.@]WA\# X'OYR<'(Z/![N![]!(_[[!H?[\,.]-X/#7X;!
MWM&[=P<G)P='A]U.O6GS;7#T&GZ(LF%P.@P.L)&W!X/#O6'PX3U\.SC$OKQ[
M?XJ/OCX^>B>=.![0)Q\.]X>UEP_V3O&MCW]^^C0,!O#O=T-X;+_;Z>&#WZ63
M?R_R%^[SWQ7T83_$0<#_[>T='>\?'/[R]A]A\&Z LW<*4P!O?4VCAP&='+VE
MT0[?GP;O/QR??!C ^IT>48?AJ;W3 Y@UIZ\T0NC*:;?3WNUC_V6#7P<';VD=
MW'D(\5F8KD$ [S\\@1_C-]C/DP^[_P7MP^]#:L+IQ/'P?SX<'%,W3F!A7C=U
M M<1WTR30$M!JSUX__[MP1YUA1?+^MG;P6\G.]XVPM=X;X<E_T OH+6533:4
M?MB_Q3F'^7[_=KC_RY!ZLW=T>#CD07)O@MVCPT'P^F!_"$\?_R(=_G!(DWB$
M1R!X>P032.^$=^S"'OL >]UT9V<KP:XKP6Z^]W"QO'\[V).#,?@%_@A^&QS#
MGCZ]T4OFRP_K]*C;@<,,\O $#L&;P3$< -CH*/I(&ASM_7?PY8>H=LM&S:>\
MO2JBK)SF!9RKQ7P>%^.HC&FJ#V:++,_";N?@<&]G<[?-5<-4:U<?WRE)U;WA
MV[?O!_MX<?W]P:,'].^3]X,]]>]KS\%E,JG.\=%'?X4.G!ZK-US$196,HU1-
M!(B_1DT'-?B7I_OJ9_*ZGQ[]U7TZC:?531Z^WZ("IK *3LZC(BZ?=SO_R__I
M63O=?U7OU@\X1N^K1NU-GG]"/[BQ3A^4Y2+N=O:C"CYZ%RV#)S^%P9-'3WZP
M>XTFU>DQ_AT7_&;W]J;>2<U:]>.;U:I1/0%QKFZJP+FH4%6[2M+WJO-8Z9XO
M/Z@M^O+[#Z^4[@GB!$[5-(%^5>=1%4(GBN B2A=Q4,3C.+F()V% ^[C;@6^2
MJ@RBLH0I*/V7O\G325PX[T[* *8EJ5)\R6*>9P'^!*37#-Z238)R,?HC'E=P
MDNF+-)DE550E.;P<GHT_@11*RI@>Q>_'>39)Z.MNYSPNXB2+IO"RH(PK['9U
M'@91!4\O@PKF%5\!/>9'\.<G53[^>$Z]# ;S>9'#, /<^?Y(#C)H!;X;J@[@
M0\[ L$=Y1C,R+Q+X?QC!#\\?/0KF.[.=H(<K_(^\^!CL)15WIA_(X"?8'LXT
M3@[-QGD10P^>]H-E'$%WLPSFO"BC8AGD4WJBL3MA@ -()O&DV^&%2Z8PG^-S
M;@%>GN4P%\%I$4V2[ Q^LPR;.Y#,9O$D@4_3)<QBFN:7^+SU.W]Z3F']8.IQ
M(6HST^V,%A4U7>$*T>2'.#NPU.6X2$8Q;3"<O_FB&)_#)1-,BWP6R&4*@QWO
MP#(&^W$:78(@A44OYGG!K7D=V<MG<UAMNWW<9M <"=^@)$D<]*+2WFG1!,_N
M##9F@%U<P-$M>&IJ!T5DN;/TL"C0[@QZ0_L)[ _XI1X+[(9QC,_D6<SMPR9Q
M?Q%0B] @S+]J!YY,TP F)_[W E9:SH->\/?X5IB5,IC$TR2+)T$"+X/QX*0\
MZ8WZV OK=?#748RKEZ!XIZDN%_ %;)6<UQY/?00O&69GT5E,DS$X@XU(?QO%
MU64<\WZ5.:85>[.SMP-M)-DE^7Z"[Z(9W,![.2S8V[=[(6VM"?821DQWR1.^
M2V[.Y/GZ(OGKWS&/=GZX82_;AU>RE[J=Q[C7=P+X:!]W&DM;_FPOFH-T3N&'
M$Q'ABQ*7&S8&GO<<#_PE[E:U1UE$R]X^CRYBVE"S.,I@:Y9&:N-FMC=EMP/=
M6130-@SCO3I99GMZ4J#^A"L0>%?2?GS*^Q%.$IS&L]K^KJR37, =@]=<5.4@
MB4F85?E7W<@WONZ-6QD&]7\>/@Q>)W$Z>1Z\!^'P E[P[T6<C?&'+X*C.>V)
MY]B0;)L7P:^H,,#7P<.'XI9_N7_PJ^KE5>Z*'_&S45Z 6-2?[:81B,K',#EE
MGB83- 2N8VW(V\9PGT7S$KJF_N:8%TV'X1KVAE@0S8H[FVF^-6/-K9K5%\'I
M<@[M#XIHE(Q?!(?1+.:9/\QQ/A_;/_I>_0J_8;O!5LU??@_3WK "([B*/SX<
MQ7#>X-US6E5[57YL=B)!A]^[BR@?&WO>:='N* Z M\.]/">;/21;Y#_1(E_I
M&_3!O1KO[2XA]O:K#"OJV\M&FJ9EXNT8!5(L":VFDOY6@H4W!_46!=4D&"U=
ME70&%R8HI+-H IHGW-"78#G%:%#!W^=147FV5D%_ELHJ,E97H_4B!A3^C(42
M/>H;%MBG29RB/;14.K&ZKV%$43!9@,T"9N)X@2-XO_\:Q/Q\B<H^&)(5FD;P
MAOCA+$K2H =MR5^CJHK&YZ@I]-7,'.:5*.ZZGPDKP.@20ZL,FF&5!DV(DN>=
M0I/! "?;UTKJ+[2UDIUNY[<$IIN; +LO36"ZX.%>TB?3H?>X[YA@.%^]!+[$
MY[/%;,2/6X^4,/89F!]E(IK-204_BHH)[)X*+'!2G=[#1LHG9!&)EM;M.*;$
MI(\]8,VM;YF#VG*$1HU=#E8\+EX9)1.VH-@'("J?+!U]$9V!<G:&+W"-&K(&
MX0&8#\?D"LIY/$:WQ$2M0S2?IW ;C]+&Q8)UODQP&Y$7$R>G",91>0[3^EU1
MXIS#_)S'H%),BN@RP[T7!1]@:T(#,%$5M#B*LH_=SB)+XY(-8_P]_4,/&$SN
M<3Q90#M.]\STC?NPGV'*T *[W@AVX#-X\./#',XF'(*TVVD8IK83"U #8+PP
M[5FNYAN/!9CR\%?LS-DBPOE$WP(\0=IY4(&B@>\SW\%7H+Q'1?(?.G9T'O ]
MNNUNQ\RQ:19[6UW"#BYQD^$&@1_A?CY36K\<US&(K"(JE@W; XT&ZY7XB_GY
MLD2-*\4S7!2Q-I3-]O#$P"*KX$!;[P;QIL4<&"?0CIQP;W]%%R ):"VT$T#;
M .I1?-<(#6&U ?BT3!=I*B(Q&9_C-HD;AN<.(&CI_Y3V*>ASH)W2'D)?1<Y_
M@LY6YAGT<0D;+QI7LG?TH43'CSJ5JC,DL7#[-$JT4IU)GFZK(SN@<!8DI]58
M2YXXJ^LP;8NT(K="IN>XI%LG"N9@R6'_9;8KV%2I):C6F'W/3HRG4W38P&]A
MM""V1 CEBTKON=KKP7+D]TOOO!:@VU&&MA_L&M?38AW-UC[K7<4N'UELM6?4
M@M(HNAVX9S)RL!3Q&$P16-1S(TBO;D*_5LE<\NSI.><>.$UJ:4N7(SF[2+O#
MV\H^SV8W7/(%I&Z;W07<'"CM\+J!Y\C[.Z]TXQF] ?3$W5?>\,E\)I]P# <!
M)'$T'L?S"G>UVD/Z_(+6,/Z8Y9=I/#EC+2!"JUU\S_!;WO1:84$?9\D.8=F-
MH'O 3Z+Y>>A=3UJY:=J/_@;Q/']K;%0\J;H)2V:P$G0&<Y^Q*B2*DUPCD<A^
MWG0E7C4@1<09/(W&_*Y\>JL!Q*^FH-Y3O7ODZ=VDRK#*C6?#TA?PT,U9N!6Q
M[SM>Z0F&<_87W!/0^1_1976%!YOTSV['**"NGN4HG_=N/3[#D_5DZ[2Z3:?5
MDZW3ZHX>B\T?UIBD[YY89\9 80%\,,4[F710<DQ8]BK?M.S,YPBI:)EP>8/B
M<9:4E00:Z9XF <L?D_X9!FRKHE:"QEVU*,F^B=B.KL3R4:%71W/ GZ&AG,8M
M]@BY7Y1:14I)5O?'1&F94Y10V2.^9Z;;T:X94MIH"D9+"KJ4K!C)#5$S;N5V
M,'9-S:+!AB6:C[>0P /@E>UZN*-DP^NK!.<T'_&<D7\GN4A(F?]G;_!PMQ_T
M?N__"S_O#?HA= 2F]/F]V\#-Y_):5T7M/O@,X&A=>#HWR?IO;;AS/ S6]<%?
M-.,>+NK:;[GQE8-=*5DG:_[W]Q;TU_I#:02XW: +N;S>@(RE_)R<E7BP?_UM
M\%[A6VRGI8TLF:.XF/BN1-?VOEY/FAP<8JLV^S[0RH6M?FX\QFA_&H^(04E<
MIQL@W(S_+^JK2X8<C)-HJ:$V-3@.2NS>DY5=NEY/5/]7=LGN@(8ND6-E'F-<
M'B=-K@BX^A9I5*!/=4+NINMTYCR'WJ@[I><B5XX7<%_]^.A1;T3^QF-JA[I[
M^.X$;]?9(CVCJ+TRD. 2C>%O<)>4&AIPO?ZDT65)("S:( XJBOSJHC/D<]MK
MH&[C."'W:>]3ZWZ_7F<^YW T;6K<04ONTVXR84OO>CV19ARK5$8&NR,;)W.8
M<S5;[Z+B8URQ:Q+]*WR#[Z9YCO?_6?!VY_U.T#,FJ/[&18A=IW]1J3V*HLV9
M==&.?3X\UKJMGC61$G]>VI3FV$X6Y*%L/CGN8?"/X34G!.2#X\<5-UYUF9,T
MH:8L\!WL[FR<+J@Q<98[3^I W?6Z,4YS]K1]SHC[5XFJ:^YA'&32<!>M?Y"2
M:=W;RH]=^SC9VR.JQ?!67$]?[&HRL=GKKJ(M.Z\M\5XXJM!M <H?[SQI4^NW
M*OQ6A0<5?O>^J?#7%MY>"-Z+\Q'.F%W,@G@@+>P%BJ0O=(37-,P?;BWS[;%6
MQ_KW;_Y8MP8QR02]S!?I!'UXF!- >A EY,0.1,S.(<@PCIL7$XSC7J\CJ)):
MF3ZU-XN"I9N^1'^LZZ5$]Z1YH(@8OG(>9=?4ENL@GITO(\,>/=WYP<_";I%B
M3Q_CHUO'_Y5YJJ-H_/&LR.$ZPAA97CQ'3W45/WAU,*WAQZ(B5MDOB2BN#9N!
MH__H,\=<@W9H@GL:>(,KU?HIJ-:]GQ62T$E>&(PK;@&SSE"AGC/^KB4$8*?L
M"(J@@C[%!)44-TW3F\S9<H AW0X-@%U/^//H8TQ@A7E>4F*'1F?QR^$U-I+M
M&PD3WX-A&8=+,K' ",IP([$:2M[=DHS<4'EXQIBN4Q'N5F& $4!6E)7:I 9D
M,TZC1:FN$[*GX_)Y@(9E4O<B=3N<7I@%:4**)+2. 2#>S)'G4^+^C)*)2:"K
MN:54&(T<07 >_[V(2\X*E"^R&(]197G3<*A]C;;QW%@.9LYIJ;7GK9ZOWHA0
M6S4/*Z4V_OS\Z:,@VIGM=#N-F:%P^)X]?_2D/7>T'P;H*H59/CK=^Y]=[!#^
MY?>Z6]F>S8L\7<SP<D6L-W8>E$$,;\_92]@VQ2:'](IYQ=%Z_4'#0?M9H-/C
MQJVANHUSW.W4)IG66<;3T 3ZOZ8\B%+O">?U$</),[-6\!7*Q?=)]C$XFL,W
ML@5PA%%0)G#NH@)QZV=1)DA82AT^B[,Q0E''XUC<LSEE0$\7V;A2J#1NA60R
M=:K/TS_+RXIBI)A0J3>V@P6J];S,=9]#@M'W)GVZ>A#&2BH0@DW+4,!C28&2
M" ?""=ND.34CC<@!;Y_S* M0(,UCDDJX;$4$%R(F4Z=P"?"U>9;G(%"@(;CN
M1#:\U_EQW-PL^B,O<*=BY!O!([$1'=9-2.MA8S=Q'2V JT &42UU@:DRUAC]
M_?B;^!-T6="I?'QU<'H>)5J$*5CK_1/VUX<Z/=U"G6X3ZO1T"W6ZH\?B'@Q+
MJW88U["4NF[GJVAUGFI$=]156MTD@J&OUD9:];VUE9'[I.1A5UGK^15V%68;
M*75%M@-]:0@I"OV+WX-=G!M^'#IB/?^[3<KRF4KCGUFF;N?FE,;ZFEU#9P1]
M9FVEL6I4&F56Z0O^S*P%Z'=19<X<M"^/E$QMLE4YMRKGQEU"=^EN#6YN7).^
MC.D&WPDW];L8=FN6C$L_^=??&5]E&A\^H@#YQNR/M8.!-[[M$Z'!X?QS.[E>
M.6P_8 #%19_7\_+&J%XUN7M-LI])XJD(WDU)S)S!KH3+J>0U=SN#L]BDD0H^
M&QX:%S%RHPF$#'W5F&_6C)<2'K=)S#E[^O-1E))[6_V:W-PXHOV87,;(A'-:
MP.QW.VJ,U7F1+\[.Z7WR%+X>D]LQT3K"9/M@#WZ23Q*0_^42+NZ9C1';_VVP
MYW+&36UIJM6TB+WT"$CCX!1#N.2%)*8%I#?H&X0_-'DEPG^.5U2EIX["8]FX
M#:</$P_C<Z#\M=B#@^4G>-)NO^E=>&O"]CI+5): O-;]/:X"7&-*-<OQ!LXR
M,)[SZ4-ZW*+-ZW9L9!7A+!\_>X;XRW(Q(VV_EM/N#A-5">)FJ!2;$W1&I64;
M,@:.T3%SX)@L#Y4G0;<X9R;+$NKMQ6J">E!EQ6>1C^OS]V>HW7SM$<Z\GK2
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M>BSN@9^DP5&"OU8699.;Y,"#A%K<3Z[*:M@&:ZI,J'+VD$%,7,"1Q4O4[1#
MU?!P^3A4QW[U. -\C<_7A9O5N"C(S,"#&+7E;*R9NH1TT;5UD?5,L0KAQXO,
M^(4\;0")T<2@\,@:0]'_[=9Y2FU/?K<CMUA),&#<#F35"US70A%^[1MIPQ"Q
M7_/L\>$[1H6P+(GQZYBVF77.?*,$MIQQ2BK'8F#\BN)]O-I$:<[B(PI);5A?
M99YDKJO+9H!CDGEBFB!UU]-VO_8FW=X/:^[1"]JBN ?CK(R8E@Z%V.YB^?"
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MB;3ZRID9_*AA$C1V# ,3L17]:TJ"7)-.LCEAA5$)DB7.,Y4H(CRN/ P]D^[
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MKS,-)ASX;KHZS3W7:E8P1Y)T3ZOBS-FA]4+DGHBPG,W'AU.L:(+9L 72*%
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M='&&#@IZSSD"OQ66 ZVF%_GB3-'JN,5>[<"Y(JYI87EPZ&'X3.#Q)EQ#/O5
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MVY+-6 GU?J+QV8\1=>W67$F+N+,FXV4_)7>PB(&.EG36CI:"OA3F!F?)D'2
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M5_8@QN0655NTE"^HT.-7G.^&FDHW<"&HDE%F6S801TRH_!:V.NG#C=. PO0
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M9N1*4)W%'I47!X4UQ6@L)M)ZI 8WUI.@5HVR[#R^YM7<ZZ->A,N :(@U=LU
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M.K,)!YREZI%6YT,<-\G.P62EM-GD7!- I*4M@0":W':/J,OV0^C]<<)GR5[
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MR^WQQ+ 6S%YUSHY;!(+'K6(J@P=:O\1]]_UU_.')XP\9.^WQ#&NYG*WZ[T_
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M04CF'^P(L;84SHEC+5JI$93RS!(ENGD1).(<93-#%VL(.H^E]\3K5F+!'__
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M]0K02CTC5E:!?E>5H+P6V^^7US==RT]RL]XD_UKAE,@M_P502P,$%     @
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M1L^R  !D/@0 "@              @ $     97@Q,"TQ+FAT;5!+ 0(4 Q0
M   ( -H[NUI0=!,EU5H  +[0 @ *              "  ?>R  !E>#$P+3(N
M:'1M4$L! A0#%     @ VCN[6ODX^ER(1   7,(!  D              ( !
M] T! &5X-"TQ+FAT;5!+ 0(4 Q0    ( -H[NUHR.HQKZ$<  $W2 0 )
M          "  :-2 0!E>#0M,BYH=&U02P$"% ,4    " #:.[M:2[92YDI)
M   IY $ "0              @ &RF@$ 97@T+3,N:'1M4$L! A0#%     @
MVCN[6H)+0>*]#@  D#\   H              ( !(^0! &5X.3DM,2YH=&U0
M2P$"% ,4    " #:.[M:F+-4)> ?  !VY   "P              @ $(\P$
M9F]R;3@M:RYH=&U02P$"% ,4    " #:.[M:_I-N*28#  #<"P  $0
M        @ $1$P( :6UN;BTR,#(U,#4R,RYX<V102P$"% ,4    " #:.[M:
M2&LYG/T*  !_A@  %0              @ %F%@( :6UN;BTR,#(U,#4R,U]L
M86(N>&UL4$L! A0#%     @ VCN[6D9-9Z!3!P  T%<  !4
M ( !EB$" &EM;FXM,C R-3 U,C-?<')E+GAM;%!+!08     "@ * $L"   <
%*0(    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="imnn-20250523.xsd" xlink:type="simple"/>
    <context id="AsOf2025-05-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000749647</identifier>
        </entity>
        <period>
            <startDate>2025-05-23</startDate>
            <endDate>2025-05-23</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-05-23" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-05-23" id="Fact000004">0000749647</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-05-23" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-05-23" id="Fact000010">2025-05-23</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-05-23" id="Fact000011">IMUNON, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-05-23" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-05-23" id="Fact000013">001-15911</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-05-23" id="Fact000014">52-1256615</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-05-23" id="Fact000015">997     Lenox Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-05-23" id="Fact000016">Suite 100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-05-23" id="Fact000017">Lawrenceville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-05-23" id="Fact000018">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-05-23" id="Fact000019">08648-2311</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-05-23" id="Fact000020">(609)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-05-23" id="Fact000021">896-9100</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-05-23" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-05-23" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-05-23" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-05-23" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-05-23" id="Fact000026">Common     stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-05-23" id="Fact000027">IMNN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-05-23" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-05-23" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 23, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 23,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-15911<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">IMUNON,
INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000749647<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">52-1256615<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">997
    Lenox Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Lawrenceville<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">08648-2311<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(609)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">896-9100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IMNN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imunon.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
    <File>imnn-20250523.xsd</File>
    <File>imnn-20250523_lab.xml</File>
    <File>imnn-20250523_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>26
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "IMNN",
   "nsuri": "http://imunon.com/20250523",
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "schema": {
     "local": [
      "imnn-20250523.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "imnn-20250523_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "imnn-20250523_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 23
   },
   "report": {
    "R1": {
     "role": "http://imunon.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-05-23",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-05-23",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://imunon.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
